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ABSTRACT
Isobenzofuran, a member of the benzo[c]heterocycles, is an extremely reactive molecule
with unusual electronic properties. In this thesis we investigate the integration of isobenzofuran
subunits into conjugated optical materials.
We discuss the properties of isobenzofuran, its role in organic chemistry, and the
synthesis of isobenzofuran containing materials in the context of the other well known
benzo[c]heterocycle, isothianaphthene. Isothianaphthene has been used in conducting polymers
and organic fluorophores as a proquinoid unit, and we posit that isobenzofuran, due to its
intrinsic instability, would display greater proquinoid character. To study this effect, we
developed a synthetic route to integrate isobenzofuran into near-infrared donor-acceptor type
fluorophores. These dyes, the IBF-NIADs, exhibit red-shifted absorption and emission over
corresponding isothianaphthene containing dyes, thus highlighting the effective proquinoid
nature of isobenzofuran.
With the fundamentals of the IBF-NIAD dyes developed, we then expanded the series
into a library of fluorophores for near-infrared fluorescence imaging application. Due to low
absorption, autofluorescence, and scattering in the near-infrared region, near-infrared
fluorescence imaging has the potential to provide non-invasive diagnostic techniques. In
particular, our interest lay in imaging P-amyloid plaques, a hallmark pathology of Alzheimer's
disease. We tailored our dye series by modifying the conjugated backbone and the electron-
donating group in order to optimize their photophysical properties, minimize their aggregation in
aqueous solution, and maximize their optical response on binding to P-amyloid fibrils. Through
these efforts we developed several fluorophores that exhibit large bathochromic shifts on
binding, with concomitant increases in fluorescence intensity and lifetime, and absorption and
emission spectra that extend well into the near-infrared. With the Backskai group at MGH, we
found that most of these dyes stain P3-amyloid plaques in transgenic APP/PS 1I mouse brain tissue,
and efforts are underway to test their in vivo imaging potential.
Finally, we present our initial synthetic work in integrating isobenzofuran into donor-
acceptor-donor oligomers for nonlinear optical applications.
Thesis Supervisor: Timothy M. Swager
Title: John D. MacArthur Profesor and Head of the Chemistry Department
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Chapter 1
Introduction to Fluorescence Imaging
1.1 Introduction to Fluorescence
1.1.1 Preface
With the 2008 Nobel Prize in Chemistry awarded to Osamu Shimomura, Martin Chalfie,
and Roger Tsien for the discovery and development of Green Fluorescence Protein (GFP),' this
has been an auspicious year for fluorescence imaging. GFP was first isolated from Aequorea
victoria, a jellyfish, by Shimomura, who later identified the chemical structure of the fluorophore
subunit (Figure 1.1).2 The gene for GFP was cloned, and then recombinantly expressed in model
organisms E. coli and C. elegans by Chalfie. 3 Tsien determined the mechanism of fluorophore
formation, and demonstrated that it occurs autocatalytically in the presence of oxygen.4 In the
intervening years, the spectrum of fluorescent proteins has been broadened to include blue, cyan,
yellow, and red variants." The great strength of this technology lies in ability of the GFP gene to
0 be spliced into an organism's genome, thus giving rise to
HO. 0 fluorescent fusion proteins which can be viewed in living cells and
"'N OHH tissue by fluorescence microscopy. This innovation has opened
Figure 1.1 The
fluorescent unit of GFP numerous protein interactions and other biological events to visual
inspection, 6 revolutionizing the way cellular processes are viewed. The example of GFP
beautifully illustrates the inherent power of fluorescence imaging: illuminating and elucidating
the processes of life that were previously invisible and unknown.
1.1.2 History of Fluorescence
Fluorescence is a form of photoluminescence by which a molecule, after having been
promoted to an excited state by absorption of a photon, emits a photon as it relaxes to its ground
state. Nicolas Monardes, a Spanish botanist and physician, reported the first observation of
fluorescence in 1595, 7 when he noted the blue color at surface of water steeped with Pterocarpus
indicus, a tropical hardwood. Both Sir Isaac Newton and Robert Boyle also studied this effect. In
1833 David Brewster observed that, when view from the side, leaf extracts appear red when the
solution is illuminated with white light. The name "fluorescence" was not bestowed on this
phenomenon until it was investigated by George Gabriel Stokes in 1852. Stokes split the solar
spectrum with a prism, and then passed a glass containing a solution of quinine sulfate through
the refracted light.8 In the visible spectrum, the solution remained colorless. However, when the
glass was moved into the invisible ultraviolet region, the quinine solution emitted a "beautiful
celestial blue colour" (Figure 1.1). In his original manuscript, Stokes named this effect dispersive
reflexion, but later coined the term fluorescence, invoking fluorspar, a fluorescent mineral. 9
Visible Spectrum
Sunlight Prism W a *
Ultraviolet Spectrum * *
,,I
Figure 1.2 A diagram of Stokes' experiment. In the visible region, the quinine sulfate solution is
colorless. In the UV region, it glows blue.
1.1.3 Basic Principles of Fluorescence
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Figure 1.3 A Jablonski diagram. IC stands for internal conversion. ISC stands for intersystem
crossing
As fluorescence will be a central theme of this thesis, we will first lay out its basic
principles. The Jablonski diagram (Figure 1.2) was constructed for the purpose of visualizing the
possible processes surrounding the interaction of molecules and light. Absorption of a photon
promotes a molecule from the ground state (So) to an excited state, typically one of the
vibrational levels of S1 or S2. The excited state may then relax back to the ground state via
several different pathways. Non-radiative transition between two electronic states of the same
spin multiplicity (i.e. S2 -' SI) is termed internal conversion and is accompanied by a loss of
vibrational or rotational energy, typically to the solvent. Emissive relaxation from the So -- Si is
called fluorescence. It should be noted that fluorescence is almost always an S1 -- So transition
(Kasha's Rule), 10 with a notable exception being azulene, which exhibits an emissive S2 -' So
_4, ;IC
c
2  /1-~ s*~ IC
#iji~i~
i ;
i
i
i%i .-'" ---
transition." As the absorption from So can be to higher vibrational levels than S1, and as the
decay from S, can be to higher vibrational levels than So, energy is lost in the subsequent internal
conversion processes, and the fluorescence emission spectrum is typically at lower energies and
longer wavelengths. The difference between the absorption maximum and the fluorescence
emission maximum is termed the Stokes' Shift. The third possible fate of the excited state is
intersystem crossing, in which the S1 state transitions to the first triplet excited state, T1. From
T 1, de-excitation can occur by non-emissive internal conversion or by a radiative process called
phosphorescence. As the T1 -- So transition is forbidden, the rate constant for phosphorescence is
substantially slower than that for fluorescence. T1 is lower in energy than SI, and thus
phosphorescent emission is red shifted from fluorescent emission.
Apart from Stokes' Shift, there exist other characteristics of fluorescence emission that
are pertinent to the work presented herein. Quantum yield is defined as the ratio of excited
molecules that relax to the ground state with emission of a photon via fluorescence, or more
simply, the ratio of the number of photons emitted to the number of photons absorbed. Quantum
yield can also be defined as the ratio of the rate of radiative decay from S1 -* So (krs) to the sum
of the rate of radiative decay from S1 -- So and the rate of none radiative decay from S, -- So
(kSnr) (Equation 1.1).
DF = kk (1.1)k' + ksr
The excited state lifetime Ts is defined in Equation 1.2.12
1
TS (1.2)ks + k r
Thus fluorescence quantum yield can be proportional to the fluorescence lifetime (Equation 1.3).
(D = k s (1.3)
Fluorescence lifetime is the average time a{ molecule spends in the excited state. If the exited
state experiences single exponential decay (Figure
/e 1.3, Equation 1.4), then the lifetime can be defined
as the time it takes for the fluorescence signal
T time 0 intensity to reach lo/e.
Figure 1.4 Single exponential decay of
a fluorescence signal. Io is the intensity I= 1 eT  (1.4)
at time 0
1.2 Fluorescent Probe Mechanisms
There are several mechanisms by which a fluorophore may be integrated into a sensory
scheme. The most basic is staining, wherein a dye accumulates in a certain structure, such as a
cellular component, and that structure can then be viewed by fluorescence. DAPI (4',6-
diamidino-2-phenylindole) is a well known stain for DNA which exhibits blue fluorescence.' 3 A
dyes may also be covalently bound to molecules, such as a protein, so that the location and
interactions of that molecules can be viewed by fluorescence. GFP and other fluorescent proteins
are commonly employed for labeling studies as genetically engineered organisms can express the
labeled protein in situ. Both of these methods depend on the local concentration of fluorophores
as a method of obtaining contrast.
A responsive probe, on the other hand, experiences a physical change that modulates its
optical properties, and thus provides a mechanism for contrast. This response can take several
different forms. An analyte can covalently modify a dye, and thereby change its photophysical
properties. This sensory mechanism may function by disrupting an aromatic system, thereby
extinguishing its fluorescence signal, as observed in the interactions between squaraines and
thiols (Figure 1.5). 14 Cleavage of a functional group that is quenching fluorescence signal, such
as cleavage of a peptide group by a protease, yields a "turn-on" response. 15 Similarly, cleavage
of one of a pair of FRET molecules can change the wavelengths of absorption or emission.16
Chemical modification by an analyte can also build conjugation, and form a fluorescent
system. 17
Peptide Y N 0 OR Protease HN 0 OR
Weak fluorescence Strong flourescence
N O
S02
S HOCI
N. <N N NN N
I I I I
Non-fluorescent Fluorescent
R-  SR
,I R
Fluorescent Non-fluorescent
370 n 
0
FRET 515 nm 370 nm 450 nm
Figure 1.5 Fluorescent probes that undergo covalent modification. See text for discussion
Fluorescent probes may also be constructed with molecular recognition units. In this
design, non-covalent binding of the analyte to the fluorophore modulates the fluorescence
response. The response can be quenching, turn-on, or wavelength change, depending on the
nature of the electronic interaction between the molecular recognition element and the
fluorophore. The most common electronic interaction, photoinduced electron transfer (PET), has
been studied extensively for cation sensing.1 8 In PET an electron from the HOMO of the receptor
is transferred to the HOMO of the fluorophore in its excited state, thus quenching its
fluorescence. On binding, the HOMO of the donor group is lowered, PET is disrupted, and
fluorescence is activated (Figure 1.6).19 Crown ethers, cryptands, cyclodextrins, and calixarenes
have all been used as cation recognition elements. If the recognition unit is linked to a donor-
acceptor pair, binding can modulate the wavelengths of absorption and emission. Cation
interaction with a donor will reduce the electron-donating character, and thus blue shift the
spectrum, 20 while contact with the acceptor will enhance its electron withdrawing properties,
resulting in a red shifted spectrum.
LUMO PET LUMO
HOMO H H O M O  OMO HOMO
Anthracene Crown Ether Anthracene Crown Ether
00C 0
N N
Weak fluorescence Strong fluorescence
Figure 1.6 Example of a PET fluorescent cation sensor.
A probe's interaction with its environment can also alter its photophysical properties, and
SHNPh t is type of response will be most relevant to this thesis.0 HN
H . For many 
organic fluorophores, the molecule 
becomes
I more polarized in the excited state, thus gaining a largerPRODAN TNS
Figure 1.7 Donor-acceptor dipole moment. The more polar excited state will interact
polarity probes PRODAN and
ANS more strongly with its molecular environment.
Consequentially, the excited state is stabilized, the energy gap between the ground and excited
states is decreased, and the spectra are shifted to the red. In more polar solvents or environments,
this effect, termed solvatochromism is more pronounced. If the polarity of the probe is increased
by addition of a donor-acceptor pair, then the dye will experience larger solvatochromatic shifts
(Figure 1.6).21 Typically, the shift to longer wavelengths is associated with a decrease in
quantum yield, due to increased environmental quenching. 22 The rigidity of a dye's environment
can also affect its photophysical properties, especially if the conjugated system of the dye is
flexible. In a rigid medium, rotational and vibrational processes that couple the ground and
excited states and promote internal conversion are minimized, and thus quantum yield is
increased.23 A flexible molecule can also be planarized by interaction with a rigid environment,
thus increasing conjugation in the dye backbone, decreasing the HOMO-LUMO gap, and red
shifting the absorption spectrum. 24
1.3 Near-Infrared Fluorescence Imaging
1.3.1 Basic Principles
In recent years, fluorescence imaging exploiting near-infrared (NIR) light has attracted
much attention, as it affords the opportunity for non-invasive, in vivo imaging.
2526 In the NIR
region of the spectrum (650-900 nm) the main biological chromophore, hemoglobin, experiences
a dramatic decrease in extinction coefficient (Figure 1.7), thus photon absorption in tissue is
10 6 greatly decreased. A simple demonstration 
may serve
u to illustrate this concept: the light from red laser
105
pointer applied to the thumb will transmit through the
104 o tissue, while the light from a green laser pointer will
10 not. Tissue autofluorescence is also low in this region,
1000
%- thus minimizing background signal,27 as is photon
100 . 4 scattering. These characteristics allow NIR light to
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Figure 1.8 Absorption spectraof penetrate several centimeters2 9  into tissue, thus
(red) oxy-hemoglobin and (black) enabling non-invasive imaging of biological structures.
hemoglobin
1.3.2 Available Fluorophores
n"r
x  n= 1, 2, 3
R RN ..... X,Y= O, S, C(CH 2)
R= substituted alkyl, aryl
Cyanines
Indocyanine Green
Figure 1.9 Cyanine dyes
The most common NIR
fluorophores are the cyanine dyes.
Structurally, these dyes consist of two
heterocycles linked by a polymethine
chain (Figure 1.9). Numerous derivatives
of these dyes have been synthesized,
spanning a broad spectrum of
wavelengths, and many are commercially
available, including indocyanine green (ICG), which has been approved by the FDA for use in
human subjects. While cyanines may exhibit good quantum yields (up to 50%),30 they have small
Stokes' shifts and are formally charged, thus limiting access to certain biological environments,
like the blood brain barrier.
Another common class of NIR fluorophores is BODIPY dyes, which are comprised of a
dipyrromethane complexed with a difluorinated boron atom (Figure 1.10). BODIPY dyes also
span a broad spectrum of wavelengths, with several derivatives absorbing and emitting in the
NIR region. 3 1 Due to the conformational rigidity of the central unit, BODIPY fluorophores enjoy
high quantum yields.32 Water solubility of these compounds has proved problematic, though
recent work has started addressing this compatibility issue.2 0
O CO 2tBu CN
N O N
N, N Rhodamine 800
F F B ;**F FF F
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Figure 1.10 Examples of NIR dyes. See text for discussion.
Other classes of dyes that extend into the NIR include benzo[a]phenoxazines such as Nile
blue and its derivatives, 33 Oxazine dyes such as AOI-987, 34 and rhodamines (Figure 1.10). 3 5
These compounds all exhibit modest quantum yields, and moderate Stokes' shifts. As charged
compounds, these dyes face similar biological limitations to cyanine dyes, except for AOI-987,
which can penetrate the blood brain barrier. Terylenes, rigid NIR dyes with high quantum yields
have been studied primarily for optoelectronic devices, such as fluorescence solar collectors, 36
but they have also recently been explored in our group as emissive components of organic
nanoparticles. Squaraines are built on a donor-acceptor-donor zwitterionic framework, and have
been implemented into various NIR ion sensors. 37 Tsien and coworkers have recently reported
NIR fluorescent proteins. 38 Quantum dots, fluorescent inorganic semiconducting nanocrystals,
can also absorb and emit in the NIR region, 39 though organic coatings are required for
biocompatibility.40 In Chapter 2, we will discuss the synthesis of a new class of NIR
fluorophores based on a donor-acceptor framework.
1.3.4 Applications of NIRF Imaging
NIR fluorescence (NIRF) imaging has been applied to many types of tissues and
pathologies, a brief review of which we will provide here. Vasculature mapping was one of the
earliest applications of NIRF, and, as ICG is FDA approved, is feasible for use with human
subjects. ICG has been used clinically to detect posterior uveitis, a swelling in the back of the
eye. 41 It has also been employed to image brain vasculature to locate aneurysms in humans 42 and
heart vascular to locate myocardial perfusion in pigs. 43 Atherosclerosis in living mice has been
imaged using a cyanine based probe activated by cathepsin B.4 4 A cyanine-folic acid conjugate
has been explored for imaging inflammatory joint disease.45 Numerous examples of tumor
imaging have been reported, including methods exploiting protease detection,46 albumin-
activated indocyanines, 47 quantum dots,4 8 and cyanine labeled angiogenesis inhibitors 49 and
antibodies. 50 Oxazine derivative AOI-987 has been used to
HO / detect P-amyloid plaques, 34 along with donor-acceptor dye,
NC CN NIAD-4. 24 The later, while providing excellent contrast with
significant changes in its spectroscopic properties on binding,
Figure 1.11 NIAD-4
does not absorb and emit far enough in the NIR for true non-
invasive imaging. Chapter 2 of this thesis will discuss modification to the NIAD-4 framework to
shift it into the NIR, and Chapter 3 will integrate the resulting dyes in detection schemes for [3-
amyloids.
1.3.5 Imaging Techniques
Several techniques exist by which NIR
fluorescence images may be obtained, including
cDocame
fluorescence reflectance imaging (FRI),
Ltce fluorescence molecular tomography (FMT), and
fluorescence lifetime imaging (FLIM). The most
basic of these methods, FRI, uses a light source
with a defined bandwidth, often a laser, to excite
Figure 1.12 Fluorescence reflectance
imaging apparatus contrast agents in the tissue. These fluorophores
then emit light, typically at a longer wavelength, which is then collected by a filtered CCD
camera located on the same side of the tissue as the light source (Figure 1.12). Often an image is
also obtained without fluorescence filters for calibration purposes. While FRI provides a
relatively straightforward, inexpensive method for imaging, it is limited in its depth of tissue
penetration to a few millimeters, as reflectance at the surface dominates the background signal.5
In order to detect fluorophores at depths more the a few millimeters, and in order to
create a composite 3D image, fluorescence molecular tomography must be employed. In this
technique, light is directed at the target from multiple points in a cylindrical optical imaging bore
(Figure 1.13), and both fluorescence and absorption measurements are obtained. This data is then
compiled52 to form a 3D reconstruction of fluorophore concentration in the analyzed tissue.
FMT data can be combined with high-resolution FRI to correlate the tomographic data with
biological features.
d
9 f
Figure 1.13 Diagram of an FMT apparatus. (a) computer (b) optical controller (c) input fiber
optic cables (d) optical bore (e) output fiber optic cables (f) fiber optic array (g) CCD camera
Both FRI and FMT depend largely on fluorophore concentration to obtain contrast,
though, as previously discussed, responsive probes help mitigate this effect. Fluorescence
lifetime, however, is a characteristic of a fluorophore and its environment, and is thus
independent of concentration. Scattered light and tissue autofluorescence typically have
relatively short lifetimes, thus longer lifetime probes, especially those with longer lifetimes in the
bound state, can provide high contrast, even in the absence of weak fluorescent signal.53
Fluorescence lifetimes can be measured by phase-modulation, in which the excited light is
modulated with a frequency between 100-200 MHz, and the modulated fluorescence signal is
detected. The phase shift between it and the frequency of excited light, along with the
modulation depth of the fluorescence signal, are used to calculate the lifetime. Single photon
counting may also be used to calculate lifetime. In this technique, the fluorophore is excited by a
short pulse, and then single photons are detected and timed, and this data is used to reconstruct
the decay curve. FLIM may be used in conjugation with tomographic techniques for 3D lifetime
imaging. 54
Another technique that exploits absorption of long-wavelength light is multiphoton
microscopy. In this method, a fluorophore is excited by two low energy photons that would not,
St
s,
Figure 1.14 Diagram of
(blue) single photon
absorption and (red) two-
photon absorption
under normal circumstances, promote the molecule to an
excited state (Figure 1.14) For two-photon absorption to
occur, the photons must arrive with 10-18 seconds of each
other in and with precise spatial overlap, thus necessitating
the use of an ultra-fast laser. 55 As the intensity of the laser
drops off as the square of the distance from the focal plane,
only the fluorophores at the focal point are excited, and thus
minimizing "out of focus" fluorescent signal. Because longer
wavelength are used for excitation, fluorophores with
absorption energies outside the NIR can be imaged with NIR light, thus allowing for deeper
tissue penetration.
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2.1 Introduction
2.1.1 Isothianaphthene
A unique group of compounds, the benzo[c]heterocycles are bicyclic aromatic structures
composed of a five-membered heterocycle perched symmetrically atop a six-membered ring
(Figure 2.1). The proclivity of the six membered ring to attain its stable, aromatic benzene form
H drives the reactivity and electronic properties of these
& A p molecules. Isothianaphthene (1) and isobenzofuran (2),
1 2 3 4 the sulfur and oxygen containing moieties respectively,
Figure 2.1 Benzo [c]heterocycles have received the most attention in the literature, and a
comparison of the two as components in conjugated materials will be the central theme of this
chapter.
Isothianaphthene (ITN), first synthesized in 1963,1 was first integrated into a material in
1984 when Wudl and coworkers achieved its electropolymerization. 2 Poly(isothianaphthene)
(PITN) proved to have unusual electronic properties, with a bandgap of 1-1.2 eV, about 1.0 eV
less than poly(thiophene). Thus, PITN originated a group of materials known as low bandgap
polymers, which are of particular interest in organic electronics due to their high intrinsic
conductivity and increased optical transparency in a doped state. 4 In the intervening years, new
synthetic methods for PITN and its derivatives have been reported, along with other low
bandgap polymers, a full discussion of which an interested reader may find in several reviews. 5,6
Other than transparent conductors, PITN has been explored as a component material for a
variety of applications, including photovoltaics 7 and materials with nonlinear optical properties.8
After PITN's initial report, its electronic properties were studied both theoretically and
experimentally in order to ascertain the root of its decreased bandgap. Polyaromatic compounds
have two resonance structures: aromatic and quinoid. In the case of polythiophene and its
derivatives, the HOMO of the aromatic form
Aromatic Quinoid
n n resembles the LUMO of the quinoid form, and
the LUMO of the aromatic form resembles the
LUMO .. n HOMO of the quinoid form. With increasing
sOM .. contribution of the quinoid structure, the
HOMO n"n
HOMO is destabilized, the LUMO stabilized,
n n and the gap between them diminished (Figure
2.2).9 In the case of isothianaphthene, the
Figure 2.2 A diagram of the HOMO and
LUMO structures of the aromatic and aromatization of the six membered ring
quinoid forms of PITN and poly(thiophene) stabilizes the quinoid resonance structure, thus
increasing its contribution, and decreasing the band gap. The structure of PITN has been shown
by 13C NMRI1 and Raman1 spectroscopy to be largely quinoidal, though its end units have more
aromatic character. 12
Apart from PITN, isothianaphthene has also been employed in controlling the bandgap of
oligomeric materials. Several groups have reported the synthesis of ITN and ITN-thiophene
mixed oligomers' 3 for OLED applications. In the area of fluorescent compounds, the integration
of ITN red-shifts both the absorption and emission of donor-acceptor type fluorophores. 14 The
proquinoid nature of ITN stabilizes the charge-separated form of these dyes, thus disrupting their
aromaticity and decreasing their bandgaps. In earlier work, our group demonstrated the utility of
this principal with myelin contrast agents NIM-1 and NIM-2 (Figure 2.3).15 NIM-2 experiences
40 nm and 150 nm red-shifts in its mwax absorbance and emission respectively. ITN was also
integrated into the NIAD-4 (see chapter 1) framework, with similar effects. The ITN analogue of
NIAD-4, NIAD-6, exhibits a 50 nm red-shift in Xmax absorbance and a 16 nm red-shift in Xmax
emission.16
/S / \ -N Xma x 
abs. :650 nm
S ma em. 670 m The synthesis of ITN\ J max em. : 670 nm
NIM 1 -o oligomeric materials may be
N max abs. : 690 nm achieved in several different ways
S maxem. : 820 nm
(Scheme 2.1). ITN dimers and
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diels-alder reaction of thiophenes
HO k maxabs.: 475 nm
Smax em. : 621 nm annulated with
N CN
NIAD-4 bicylco[2.2.2]octadiene rings. 17
HO / S ' ma.x abs. :545 nm Recently, 1,3-ditrimethylstannyl
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Figure 2.3 The structures and spectroscopic properties However, the most common method
of NIM 1, NIM 2, NIAD-4, NIAD-6, NIAD-15
for ITN synthesis employs
Lawesson's reagent to convert a ketone to a thioketone, which then participates in a ring closure
to form the ITN unit. This transformation has been reported for 1,2-diaryl ketones' 9 and the
ketone-alcohol products of grignard condensations with aryl-phthalides.2 0 Diaryl-
isobenzofurans have also be converted directly to isothianaphthenes with Lawesson's reagent,21
and this reaction will be discussed in greater detail later in this chapter.
Scheme 2.1 Synthetic Pathways for ITN Oligomers
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2.1.2 Isobenzofuran
Isobenzofuran (IBF), the oxygen containing member of the benzo[c]heterocycles, is both
useful and notorious for its instability. While 1,3-diphenylisobenzofuran was reported in 1905,22
a synthesis of the parent compound was not achieved until 50 years later by Wittig and Pohmer,
Ar S Ar'
and was then only observed as
Scheme 2.2 Wittig's Synthesis of Isobenzofuran
H a transient intermediate that
CH2N2 N CU N
= I + G polymerized spontaneously
upon isolation (Scheme 2.2).23 In the past 50 years, IBF and its derivatives have been studied
extensively, both as compounds of theoretical interest, and as reactive intermediates in organic
synthesis. While we will review some of this chemistry here, we direct the interested reader to
two excellent reviews by Friedrichsen. 24
Much of the theoretical debate revolving around IBF has focuses on its aromaticity, or
lack thereof. Early calculations of the heat of atomization predict a slight resonance energy of
2.4 kcal/mol.2 5 These results are corroborated by AM1 FMO calculations26 which also indicate a
low level of aromaticity. 27 A similar conclusion is reached by comparison of magnetic
susceptible anisotropies calculated with DFT methods.28 On the other hand, initial NMR
studies29 of IBF show that the furan protons are shifted considerably downfield, implying the
0 presence of a diamagnetic ring current characteristic of a degree of
S cN aromaticity. NMR and crystallographic investigation of 1-cyano IBF
Figure 2.4 A stable derivative 5 (Figure 2.4), a rare stable IBF compound, suggests that IBF
IBF derivative.
may be viewed as a 6n aromatic system perched atop a cis-butadiene
fragment based on bond lengths and '3C chemical shifts. 30 Aromaticity has also been implicated
in one ring of IBF by calculations of Nucleus Independent Chemical Shift (NICS), though
reports differ as to which ring.31,32 While diverse opinions about the aromaticity of IBF and its
derivatives abound, views on its general lack of stability and lower comparative stability to ITN,
aromatic or otherwise, are uniform in the aforementioned reports.
In organic synthesis, the intrinsic instability of IBF has proved to be a valuable asset.
Indeed, IBF garners most of its fame as a very reactive diene for Diels-Alder reactions, 33 with
many IBF derivatives only ever isolated as Diels-Alder adducts. This property of IBF has been
exploited in the synthesis of natural products, including 7-deoxydauntonmycinon 34 and
resistomycin 6 (Scheme 2.3). 35 When reacted with an alkyne or benzyne intermediate, IBF
forms epoxynaphthalenes, which can undergo dehydration to form extended polycyclic aromatic
scaffolds. 36 IBF is even known to undergo Diels-Alder reactions with C60.37
Scheme 2.3 Synthesis of Resistomycin
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The synthesis of isobenzofuran and its derivatives may be achieved by numerous
pathways, a sample of which is included in Scheme 2.4. The archetypal synthesis employs the
elimination of either acetylene with the aid of dipyridyl tetrazine,38 or ethylene under flash
vacuum pyrolysis conditions. 39 LDA induced elimination of methoxy compound 7 forms IBF,
and further addition of LDA lithiates the 1- and 3- positions.40 Condensation of aryl-lithium or
aryl-grignard reagents with aryl-phthalides followed by dehydration with acetic anhydride (or
HC1) yields diaryl-IBF compounds, 4 1 which may also be synthesized from aryl-aldehyes and
ketamines using a rhenium catalyst. 42 Finally, IBF dimers have been formed by photochemical
exocyclic [2+2+2] cycloaddition.43
Scheme 2.4 Synthetic Pathways for IBF and its Derivatives
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In contrast with the numerous reports that make use of IBF's interesting electronic
properties in organic synthesis, few reports exist that integrate IBF into functional materials,
presumably due to synthetic difficulties stemming from their instability. 44 The most famous IBF
based material is 1,3-diphenylisobenzofuran, a fluorescent probe that reacts with singlet oxygen
to form a non-fluorescent complex. 45 In the field of OLEDS, 1,3-di-p-anisylisobenzofuran 846
and hexaphenylisobenzofuran 947 have been used as a dopant and an electron transport material
respectively. Coatings of Poly(dihydroisobenzofuran) 48 and its functionalized derivatives 49 have
been synthesized by chemical vapor deposition. While poly(isobenzofuran) has been studied
theoretically, 50  no synthesis of this conjugated material has yet been reported, though
photochemically produced IBF-dimers have been recently reported.43
X /MeO / OMe
8 9
Figure 2.5 Isobenzofuran containing conjugated materials. From left to right, 1,3-
diphenylisobenzofuran, a singlet oxygen probe, 1,3-di-p-anisyl-isobenzofuran, an OLED dopant,
and hexaphenylisobenzofuran, an OLED electron transport material. See text for references
The paucity of IBF containing conjugated materials in the literature inspired us to explore
its properties as a component in oligomeric systems. In particular, we believed that IBF would
induce a larger proquinoid effect than ITN due to its lower stability, and would thus provide
materials with reduced band gaps. As we wished to further red-shift the NIAD dye series for
NIRF imaging applications, we deemed the incorporation of IBF subunits a worthwhile pursuit.
This chapter will focus on controlling the band gaps of near-infrared donor-acceptor
fluorophores using ITN and IBF.
2.2 Results and Discussion
2.2.1 Synthesis and Spectroscopic Properties of IBF-NIAD Dyes
After surveying the possible reactions in the literature, we decided upon a route (Scheme
2.5) in which the isobenzofuran core is constructed by condensation of 3-lithiothiophene with an
aryl-phthalide followed by dehydration with acetic anhydride. Phthalides were commercially
available or produced from acid catalyzed condensation of carboxybenzaldehyde 10 with
appropriately substituted benzenes. Lithiation followed by quenching with DMF would produce
aldehydes 13a-d, which would be converted into corresponding dyes 14a-d via the Knoevenagel
condensation with malonitrile.
Scheme 2.5 Initial Synthesis of IBF-NIAD 0-3
H+ R Br
OH H __ 0 1.
H R n-BuLi, THF, -78 OC
O / 2. Ac 2 0, A
10 11a: R= H-: NAa
11b: R= MeO-: 58%
11c: R= Me2N-: 48%
ld: R= TIPSO- : 73%
12a-d
Unstable
1. n-BuLi, THF, -78 OC
2. DMF, -78 OC - r.t.
NC CN
DCM, cat. NEt 3
13a-d
a 1 la is commercially available
a. R= H- b. R= MeO- c. R= Me 2N- d. R= TiPSO-
This route proved impractical due the poor stability of 12a-d, which were prone to
spontaneous decomposition upon purification by column chromatography and concentration.
14a-d
Attempts to install a bromide in the 5-position of the thiophene were similarly unsuccessful.
Small amounts of aldehydes 13a-d were synthesized from crude 12a-d, and proved more
amenable to isolation; thus, we sought to bypass the troublesome unsubstituted thiophenes with
acetal protected aldehyde 15 (Scheme 2.6). This method afforded adehydes 13a-d and IBF-
NIADs 0-3 (14a-d) in fair yields. TIPS protection was employed in the synthesis of IBF-NIAD
3, though the susceptibility of the dicyanomethylene group to cleavage by fluoride necessitated
the use of strong acid for deprotection.
Scheme 2.6 Improved Synthesis of IBF-NIAD 0-3
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Figure 2.6 Absorption (red) and normalized fluorescence spectra (blue) of IBF-NIADs 0-3 in
MeOH and CHCI3.
Table 2.1 Spectroscopic Properties of Dyes 0-3
Dye Xmax Abs. (nm) ,max Emission (nm) ( F (M' cm')
MeOH CHC13 MeOH CHC13  MeOH CHC13 MeOH CHC13
IBF-NIAD 0 556 578 658 635 0.077 0.075 34500 46300
IBF-NIAD 1 578 599 686 675 0.078 0.16 13500 37700
IBF-NIAD 2 637 656 790 762 0.0055 0.046 29700 29800
INF-NIAD 3 584 600 696 679 0.049 0.12 41900 35300
The UV-vis and fluorescence spectra of IBF-NIAD 0-3 are shown in Figure 2.6 and their
spectroscopic properties are summarized in Table 2.1. These dyes absorb in the far-red or NIR
region and emit in the NIR region. Stoke shifts range between 102 and 153 nm in MeOH and 57
and 106 nm in CHC13. Quantum yields range from 0.046 to 0.16 in CHC13 and 0.0055 and 0.078
in MeOH. Compared to the absorption Xmax (MeOH) of NIAD-6 and NIAD-15, IBF-NIAD-3
and IBF-NIAD-2 show 39 and 58 nm red-shifts respectively, demonstrating that IBF is a more
efficacious proquinoidal unit. This result led us to synthesize the ITN containing versions of
IBF-NIAD 0 and IBF-NIAD 1 in order to complete the series for a full comparison.
2.2.2 Synthesis and Spectroscopic Properties of ITN-NIADs
With the IBF dyes in hand, we decided to explore methods by which a corresponding set
of ITN dyes could be obtained. NIAD-6 and NIAD-15 had been previously synthesized by the
route in Scheme 2.7. We sought to expedite this process by converting the IBF dyes directly into
their ITN counterparts. As mentioned above, the transformation of diaryl-isobenzofurans to
diaryl-isothianaphthenes with Lawesson's reagent has been reported in the literature. When we
exposed IBF-NIAD 0 to excess Lawesson's reagent under air and moisture free conditions, no
reaction was observed, even after 24h at room temperature.
Scheme 2.7 Synthesis of NIAD-6 and NIAD-15
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However, when the reaction mixture was exposed to air, the reaction proceeded to completion in
7 hours and furnished the desired product in 87% yield (Scheme 2.8). For IBF-NIAD 1-3, an
anhydrous oxygen atmosphere was required. In the case of IBF-NIAD 2, the dicyanomethylene
acceptor group was cleaved by Lawesson's reagent, presumably to a thioaldehyde. The strength
of the dimethylamino donor group is apparently sufficient to polarize the double bond to the
point at which it is sensitive to Lawesson's reagent. Addition of excess malonitrile and
triethylamine after the completion of the LR conversion reinstalled the acceptor group in good
yield.
Scheme 2.8 Synthesis of ITN-NIAD 0-3
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Although the direct conversion of IBF to ITN has been previously reported, the role of
oxygen has never been studied. As mentioned previously, diarylisobenzofurans are sensitive to
singlet oxygen and to a limited extent, triplet oxygen.51 This reaction results in an endoperoxide,
which in turn rearranges into a diketone, 52 though the mechanism of this particular
rearrangement is not well understood.53 We propose that this conversion occurs for IBF-NIAD
dyes, and that the diketone is then cyclized to the isothianapthene with Lawesson's Reagent
(Scheme 2.9).
Scheme 2.9 The Proposed Mechanism for the IBF to ITN Conversion
0=0
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N CN - CN
CN /N
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The UV-vis and fluorescence spectra of ITN-NIAD 0-3 are shown in Figure 2.7 and their
spectroscopic data is summarized in Table 2.2. The red-shifts in max of absorbance and emission
are listed in Table 2.3, and represented in an esthetically pleasing manner in Figure 2.8. In
general, the red-shifts in absorbance increased with the efficacy of the electron donating group,
with 31 nm for H-, 40 nm for MeO-, 41 nm for HO-, and 58 nm for Me2N-. The red-shifts in
emission were far more modest, between 5 nm and 21 nm, suggesting that the quinoid resonance
structure might not factor heavily in the excited-state energies of these molecules. In general, the
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Figure 2.7 Absorbance (red) and normalized fluorescence intensity (blue) spectra of ITN-NIAD
0-3 in CHC13 and MeOH.
quantum yields for the IBF dyes were higher than their corresponding ITN counterparts, a trend
that we will discuss in the next chapter.
Table 2.2 Spectroscopic Properties of ITN-NIAD dyes
Table 2.3 Red shifts for S-O conversion
Dye ,max Abs. (nm) Xmax Emission (nm) E (M-' cm 1')
MeOH CHC13 MeOH CHC13  MeOH CHC13 MeOH CHC13
ITN-NIAD-O 525 544 637 629 0.061 0.079 20300 24700
ITN-NIAD-1 537 559 672 663 0.046 0.099 15600 17000
ITN-NIAD-2 579 604 785 743 0.0015 0.021 17200 11800
(NIAD-15)
ITN-NIAD-3 545 559 684 667 0.023 0.071 36700 16500
(NIAD-6)
Solvent ITN-IBF 0 (nm) ITN-IBF 1 (nm) ITN-IBF 2 (nm) ITN-IBF 3 (nm)
R= H- R= MeO- R= Me2N- R= HO-
Abs. Em. Abs. Em. Abs. Em. Abs. Em.
MeOH 31 21 41 14 58 5 39 12
CHCl3 34 6 40 12 52 19 41 12
Figure 2.8 IBF-NIAD 0-3 and ITN-NIAD 0-3 in MeOH. From left to right, ITN-NIAD 0, IBF-
NIAD 0, ITN-NIAD 1, IBF-NIAD 1, ITN-NIAD 3, IBF-NIAD 3, ITN-NIAD 2, IBF-NIAD 2.
2.3 Conclusions
In summary, a series of new isobenzofuran containing near-infrared, donor-acceptor type
fluorophores was synthesized. A corresponding set of isothianaphthene containing dyes was
synthesized via direct conversion with oxygen and Lawesson's Reagent. Comparison of the
photophysical properties of both dye sets revealed the greater effectiveness of IBF over ITN as a
red-shifting component in this class of dyes, an effect attributable to the strongly pro-quinoidal
nature of IBF. Subsequent chapters will describe the expansion of the IBF dye series and its use as
a near-infrared fluorescence contrast agent.
2.4 Experimental Section
Materials. Commercial reagents were purchased from Sigma Aldrich, Alfa Aesar, or GFS
Chemicals, and used as received. Dry solvents were obtained using a solvent purification system
(Innovative Technologies, Inc.) and handled under an argon atmosphere, unless otherwise noted.
Flash chromatography was performed using SiliaFlash F60 (230-400 mesh) from Silicycle.
Instrumentation. Melting points were determined in open capillaries using a Mel-Temp II
apparatus and are uncorrected. Proton nuclear magnetic resonance (1H NMR) spectra and carbon
nuclear magnetic resonance (13C NMR) spectra were recorded on a Varian Mercury-300 (300
MHz) or an Inova-500 (500 MHz) NMR spectrometer. Chemical shifts for protons are reported
in parts per million downfield from tetramethylsilane and are referenced to residual protium in
the NMR solvent (CHC13: 6 7.27). Chemical shifts for carbon are reported in parts per million
downfield from tetramethylsilane and are referenced to the carbon resonances of the solvent
(CDCl3: 6 77.0). Data are represented as follows: chemical shift, integration, multiplicity (br =
broad, s = singlet, d = doublet, t = triplet, q = quartet, sp = septet, m = multiplet), and coupling
constants in Hertz (Hz). High-resolution mass spectra (HRMS) were obtained at the MIT
Department of Chemistry Instrumentation Facility using a peak-matching protocol to determine
the mass and error range of the molecular ion, employing either electron impact or electrospray
as the ionization technique. Fluorescence spectra were measured on a SPEX Fluorolog-t3
fluorimeter (model FL-321, 450 W Xenon lamp) using right-angle detection. Ultraviolet-visible
absorption spectra were measured with an Agilent 8453 diode array spectrophotometer and
corrected for background signal with a solvent-filled cuvette. Fluorescence quantum yields were
determined by the optically dilute method54 using cresyl violet perchlorate in methanol (0=0.54)
or zinc phthalocyanine in 1% pyridine in toluene ((D=0.30) as standards and were corrected for
solvent refractive index and absorption differences at the excitation wavelength.
Synthetic Procedures
S 0
H Cat. HCI04
100 OC
0
10 11b 0
OMe
To a solution of 10 (5.0 g, 33 mmol) in anisole (10 ml, 92 mmol) were added 8 drops of 70%
HC10 4, and the solution was stirred at 100 oC for 2 hours. After cooling, the reaction mixture
was poured into water and stirred for 30 minutes. The sticky white product was collected by
suction filtration and was washed with water and saturated sodium bicarbonate. Recrystalization
from methanol afforded lIb as white crystals (4.5 g, 19 mmol, 58% yield, Mp=117-118 OC). 'H
NMR (300 MHz, CDC13): 7.97 (1H, d, 7.6 Hz), 7.67 (1H, td, 7.4 Hz, 1.2 Hz), 7.57 (1H, t, 7.6
Hz), 7.32 (1H, d, 7.6 Hz), 7.19 (2H, dm, 8.8 Hz), 6.90 (2H, dm, 8.8 Hz), 6.39 (1H, s), 3.82 (3H,
s). 13C NMR (125 MHz, CDC13): 170.5, 160.3, 149.7, 134.2, 129.2, 128.7, 128.1, 125.8, 125.4,
122.9, 114.2, 82.6, 55.2. HRMS (ESI): 241.0853 [calc'd for M+H+: 241.0859]. These values are
consistent with data reported in the literature.5
HI
H Cat. HC10 4
N-../
To a solution of 10 (4.0 g, 27 mmol) in N,N-dimethylaniline (8.2 ml, 65 mmol) were added 6
drops of 70% HC10 4 , and the solution was stirred at 100 oC for 2 hours. After cooling, the
reaction mixture was poured into water and stirred for 30 minutes. The light blue product was
collected by suction filtration and was washed with water and saturated sodium bicarbonate.
Recrystalization from acetone afforded 11c as white crystals (3.4 g, 13 mmol, 48% yield, Mp=
193-195 oC) 1H NMR (300 MHz, CDC13): 7.96 (1H, d, 7.6 Hz), 7.65 (1H, td, 7.5 Hz, 1.2 Hz),
7.55 (1H, t, 7.5 Hz), 7.33 (1H, d, 7.6 Hz), 7.10 (2H, dm, 8.8 Hz), 6.90 (2H, dm, 8.8 Hz), 6.37
(1H, s), 2.97 (6H, s). 13C NMR (125 MHz, CDC13): 170.7, 151.1, 150.0, 134.0, 129.0, 128.7,
126.2, 125.4, 123.04, 123.02, 83.5, 40.3. HRMS (ESI): 254.1176 [calc'd for M+H+: 254.1176].
OH - H O
60% H2SO 4
O rt
10 16
OH
10 (2.2 g, 15 mmol) was dissolved in 12 ml of 60% H2 SO 4 and stirred for 10 min at room
temperature. Phenol (1.4 g, 15 mmol) was added in one portion, and the reaction mixture was
stirred for an additional 2 hours at room temperature. The reaction mixture was then poured onto
ice and stirred for 30 minutes. The white product was collected by suction filtration and washed
with water and saturated sodium bicarbonate solution. Recrystalization from 20% aqueous
ethanol afforded 16 as white crystals (3.1 g, 14 mmol, 93% yield, Mp = 161-163 oC). 'H NMR
(300 MHz, CDC13): 7.97 (1H, d, 7.6 Hz), 7.67 (1H, td, 7.5 Hz, 1.2 Hz), 7.57 (1H, t, 7.2 Hz), 7.32
(1H, dq, 7.6 Hz, 0.9 Hz), 7.13 (2H, dm, 8.4 Hz), 6.90 (2H, dm, 8.6 Hz), 6.38 (1H, s), 5.13 (1H,
s). 13C NMR (125 MHz, CDC13): 170.9, 156.7, 149.7, 134.4, 129.4, 129.0, 128.1, 125.8, 125.6,
123.0, 115.9, 82.9. HRMS (ESI): 249.0526 [calc'd for M+Na+: 249.0522]. These values are
consistent with data reported in the literature. 56
O O
TIPSCI
,NH
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OH OTIPS
16 (5.1 g, 23 mmol) was dissolved in DMF (94 ml) along with imidazole (6.8 g, 0.10 mol) and
triisopropylsilyl chloride (9.4 ml, 44 mmol), and the solution was stirred overnight at room
temperature. The reaction mixture was then poured onto ice and stirred for one hour. The white
solid was collected by suction filtration. Recrystalization from methanol afforded lid as a white
crystalline solid (6.4 g, 18 mmol, 78% yield, Mp= 102-103 oC). 1H NMR (300 MHz, CDC13):
7.97 (1H, d, 7.6 Hz), 7.66 (1H, td, 7.5 Hz, 1.2 Hz), 7.56 (1H, tt, 7.4 Hz, 0.8 Hz), 7.33 (1H, dq,
7.6 Hz, 1.1 Hz), 7.11 (2H, dm, 8.4 Hz), 6.87 (2H, dm, 8.7 Hz), 6.37 (1H, s), 1.26 (3H, sp, 6.8
Hz), 1.09 (18H, d, 6.7 Hz). 13C NMR (125 MHz, CDC13): 170.5, 157.0, 149.7, 134.2, 129.2,
128.7, 128.5, 125.9, 125.5, 122.9, 120.2, 82.8, 17.8, 12.6. HRMS (ESI): 405.1855 [calc'd for
M+Na : 405.1856].
1. n-BuLi, -78 OC, THF
Br S Br 2. DMF, THF, -78 OC - rt Br
3. Ethylene glycol, cat. p-TsOH
Benzene, A, Dean-Stark
2,5-Dibromothiophene (6.0 g, 25 mmol) and dry THF (50 ml) were added to a vacuum dried
Schlenk flask under argon and the solution was cooled to -78 OC. n-BuLi (15.6 ml 1.6M solution
in hexanes, 25 mmol) was added dropwise and the solution was stirred at -78 oC for 90 minutes.
A solution of dry DMF (2.5 ml, 32 mmol, distilled from NaH) in dry THF (10 ml) was added,
and the reaction mixture was warmed to room temperature and stirred overnight. The reaction
mixture was then poured onto saturated sodium bicarbonate and extracted with ethyl acetate. The
organic fraction was washed with saturated sodium bicarbonate, water, and brine, dried over
magnesium sulfate, and concentrated in vacuo. The resulting dark, viscous liquid was then
dissolved in benzene (100 ml) along with ethylene glycol (3.2 ml, 57 mmol) and p-
toluenesulfonic acid monohydrate (0.060 g, 0.32 mmol), and this solution was refluxed overnight
in a flask equipped with a Dean-Stark trap. The reaction mixture was then cooled to room
temperature, concentrated in vacuo, taken up in ethyl acetate and washed with saturated sodium
bicarbonate and brine. The organic layer was dried over magnesium sulfate and concentrated in
vacuo. The residue was purified by flash chromatography on silica gel (2:1 hexane:ethyl acetate)
and then vacuum distillation ( 66-70 oC, 190 mtorr) to afford 6 as a clear liquid (2.2 g, 9.4 mmol,
38% yield) 1H NMR (300 MHz, CDC13): 6.95 (1H, d, 3.8 Hz), 6.92 (1H, d, 3.8 Hz), 6.02 (1H s),
4.15-3.95 (4H, m). 13C NMR (125 MHz, CDC13): 143.3, 129.4, 126.5, 113.5, 65.2 HRMS (ESI):
234.9417 [calc'd for M+H : 234.9423]. These values are consistent with data reported in the
literature.57
General procedure for synthesis of aldehydes 13a-d
Br O H
P O
n-BuLi, -78 OC, THF \ /
2. Ac20, A
11a 3. AcOH, rt 13a
n-BuLi (1.4 ml of 1.6M solution in hexanes) was added to a solution of 15 (0.5 g, 2.1 mmol) in
dry THF (7 ml) in a vacuum dried Schlenk flask at -78 oC under argon, and the solution was
stirred at -78 oC for 2 hours. A solution of 3-phenylphthalide 11a (0.45 g, 2.1 mmol) in dry THF
(7 ml) was added dropwise, and the reaction mixture was stirred at -78 oC for an additional hour.
Acetic anhydride (0.23 ml, 2.4 mmol) was added, and the solution was warmed to room
temperature, and was then refluxed for 10 minutes. The reaction mixture was cooled to room
temperature, and was then diluted with ethyl acetate and washed with saturated aqueous sodium
bicarbonate and brine. The organic layer was dried over magnesium sulfate and concentrated in
vacuo. Acetic acid (15 ml of 90% aqueous solution) was then added to the residue, and this
solution was stirred under argon for 2 hours, and then poured into water and stirred for 30
minutes. The red solid was collected by suction filtration and washed with saturated aqueous
sodium bicarbonate and water. Recrystallization from 5% aqueous methanol afforded 13a as red
crystals (0.26 g, 0.86 mmol, 41% yield, Mp = 150-152 oC) 'H NMR (300 MHz, CDC13): 9.92
(1H, s), 7.99-7.92 (2H, m), 7.90 (1H, dt, 8.8 Hz, 1.2 Hz), 7.82-7.76 (2H, m), 7.58-7.49 (3H, m),
7.38 (1H, tt, 7.4 Hz, 1.2 Hz), 7.23-6.99 (2H, m). 13C NMR (125 MHz, CDC13): 182.3, 146.3,
142.3, 140.5, 137.4, 130.6, 129.1, 128.1, 127.2, 125.9, 125.3, 124.5, 122.4, 122.0, 120.6, 119.6,
99.8. HRMS (ESI): 305.0641[calc'd for M+H+: 305.0631]
Br MeO
___I 0
n-BuLi, -78 OC, THF
2. Ac 20, A
3. AcOH, rt
The reaction was carried out on a 2.1 mmol scale, and 13b was obtained as a rusty red powder
after recrystallization from ethanol (0.23 g, 0.69 mmol, 33% yield, Mp = 79-81 oC) 'H NMR
(300 MHz, CDCl 3): 9.90 (1H, s), 7.90 (2H, dt, 9.1 Hz, 2.2 Hz), 7.84 (1H, dt, 8.8 Hz, 1.0 Hz),
7.79-7.75 (2H, m), 7.51 (1H, d, 4.1 Hz), 7.18 (1H, ddd, 8.8 Hz, 3.0 Hz, 0.8 Hz), 7.11-7.02 (3H,
m), 3.90 (3H, s). 13C NMR (125 MHz, CDC13): 182.0, 159.5, 146.5, 142.4, 139.7, 137.9, 137.4,
127.0, 126.7, 125.2, 124.5, 123.4, 121.24, 121.20, 120.6, 119.3, 114.5, 55.3. HRMS (ESI):
335.0741 [calc'd for M+H+: 335.0736]
0 1. Br ( O S I
n-BuLi, -78 OC, THF \ /
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11c 3. AcOH, rt 13c
/N
The reaction was carried out with 2.1 mmol of 15 and 1.8 mmol of 11c in dry THF (40 ml), and
20 ml of 90% aqueous acetic acid were used in the work up. The acetic acid solution was poured
into water, and then small portions of saturated aqueous sodium bicarbonate were carefully
added. The dark product was collected by suction filtration, and was washed with sodium
bicarbonate and brine. Flash chromatography on silica gel (dichloromethane) afforded 13c as a
dark solid (0.38 g, 1.1 mmol, 61% yield) 'H NMR (300 MHz, CDC13): 9.87 (1H, s), 7.88-7.82
(3H, m), 7.76-7.72 (2H, m), 7.46 (1H, d, 4.2 Hz), 7.17 (1H, ddd, 8.8 Hz, 6.5 Hz, 0.9 Hz), 7.04
(1H, ddd, 8.8 Hz 0.9 Hz), 6.83 (2H, dm, 8.8 Hz), 3.07 (6H, s). 182.0, 150.1, 148.2, 143.0, 139.1,
137.7, 137.2, 127.2, 126.7, 125.0, 124.6, 121.3, 120.7, 120.6, 119.4, 118.7, 112.3, 40.2. HRMS
(ESI): 348.1051 [calc'd for M+H+: 348.1053]
0r TIPSO
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2. Ac 20, A
lid 3. AcOH, rt 13d
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The reaction was carried out on a 2.1 mmol scale. After acetic acid workup, the reaction mixture
was poured into water, stirred for 30 minutes, and then extracted with ethyl acetate. The organic
layer was washed with saturated aqueous sodium bicarbonate and brine, and was then dried over
magnesium sulfate and concentrated in vacuo. Flash chromatography on silica gel (2:1
hexane:ethyl acetate) afforded 13d as a viscous red oil (0.47 g, 0.99 mmol, 47% yield) 'H NMR
(300 MHz, CDC13): 9.90 (1H, s), 7.88-7.82 (3H, m), 7.79-7.74 (2H, m), 7.52 (1H, d, 4.1 Hz),
7.18 (1H, ddd, 8.7 Hz, 6.3 Hz, 0.9 Hz), 7.12-7.00 (3H, m), 1.30 (3H, sp, 6.9 Hz), 1.15 (18H, d,
6.9 Hz). 13C NMR (125 MHz, CDC13): 182.0, 156.4, 146.7, 142.5, 139.8, 137.9, 137.4, 127.0,
126.7, 125.2, 124.5, 123.7, 121.3, 121.2, 120.7, 120.6, 119.4, 17.9, 12.6. HRMS (ESI): 499.1733
[calc'd for M+Na : 499.1734]
General Procedure for synthesis of dyes IBF-NIAD 0
0o I\ H NC-%CN I
O cat. NEt 3
CH 2CI 2, rt NC
13a IBF-NIAD 0
13a (70 mg, 0.23 mmol) was dissolved in a solution of malonitrile (15 mg, 0.23 mmol) in dry
dichloromethane (10 ml) and then 3 drops of triethylamine were added and the resulting solution
was stirred overnight, under argon, at room temperature. The reaction mixture was then diluted
with ethyl acetate, washed with water and brine, dried over magnesium sulfate, and concentrated
in vacuo. Flash chromatography over silica gel (dichloromethane) afforded IBF-NIAD 0 as a
purple solid (62 mg, 0.18 mmol, 78% yield). 1H NMR (300 MHz, CDC13): 7.97-7.88 (3H, m),
7.72 (1H, d, 8.7 Hz), 7.66 (1H, s), 7.59 (1H, d, 4.3 Hz), 7.53 (2H, t, 7.2 Hz), 7.48 (1H, d, 4.3
Hz), 7.41 (1H, tt, 7.2 Hz, 1.3 Hz), 7.26-7.14 (2H, m). 13C NMR (125 MHz, CDC13): 149.1,
148.2, 144.0, 140.2, 138.5, 132.5, 130.0, 129.2, 128.8, 128.3, 126.4, 125.9, 125.6, 122.8, 122.2,
121.0, 119.6, 114.9, 114.1, 73.3. HRMS (ESI): 353.0753 [calc'd for M+H+: 353.0743]
MeO MeO
S O I\ HNC CN
/ S / \I SO cat. NEt 3  CN\ CH 2C12, rt
13b IBF-NIAD 1
The reaction was carried out on a 0.18 mmol scale with 10 ml of dry dichloromethane. Flash
chromatography over silica gel (dichloromethane) afforded IBF-NIAD 1 as a purple solid (45
mg, 0.12 mmol, 67% yield). 1H NMR (300 MHz, CDC13): 7.96-7.87 (3H, m), 7.78 (1H, d, 8.7
Hz), 7.73 (1H, s), 7.66 (1H, d, 4.4 Hz), 7.52 (1H, d, 4.4 Hz), 7.31-7.24 (1H, m), 7.16 (1H, ddd,
8.8 Hz, 6.5 Hz 0.9 Hz), 7.07 (2H, dm, 8.9 Hz), 3.92 (3H, s). 13C NMR (125 MHz, CDC13):
160.3, 149.0, 148.9, 144.4, 140.4, 137.9, 132.1, 128.5, 127.4, 126.3, 126.0, 123.0, 122.0, 121.6,
121.2, 119.6, 115.2, 114.8, 114.4, 72.5, 55.5. HRMS (ESI): 383.0845 [calc'd for M+H+:
383.0849]
S o \ HNC ' NCN / O I
S \/ SO cat. NEt 3  CN
CH2C 2, rt 
N
13c IBF-NIAD 2
The reaction was carried out on a 0.25 mmol scale with 15 ml of dry dichloromethane. Flash
chromatography over silica gel (dichloromethane) afforded IBF-NIAD 2 as a green solid (38
mg, 0.096 mmol, 38% yield). 'H NMR (300 MHz, CDCl3): 7.94-7.86 (3H, m), 7.76 (1H, dt, 8.9
Hz, 0.9 Hz), 7.66 (1H, s), 7.61 (1H, d, 4.0 Hz), 7.44 (1H, d, 4.3 Hz), 7.31-7.24 (1H, m, obscured
by solvent), 7.12 (1H, ddd, 8.8 Hz, 6.5 Hz, 0.9 Hz), 6.83 (2H, dm, 9.2 Hz), 3.10 (6H, s). 13C
NMR (125 MHz, DMF-d 7): 152.2, 151.8, 151.5, 144.8, 144.2, 138.1, 132.8, 130.2, 128.3, 127.8,
126.8, 123.2, 122.7, 122.3, 120.4, 118.4, 116.9, 116.3, 113.6, 70.9, 40.5. HRMS (ESI): 396.1170
[calc'd for M+H+: 396.1170]
TIPSO TIPSO
H NC.NCN S
H\ SO cat. NEt 3\ CH2C 2,rt NC
13d 14d
The reaction was carried out on a 0.38 mmol scale with 15 ml dry dichloromethane. Flash
chromatography over silica gel (dichloromethane) afforded 14d as a purple solid (0.11 g, 0.21
mmol, 55% yield). 1H NMR (300 MHz, CDC13): 7.92-7.85 (3H, m), 7.78 (1H, d, 8.9 Hz), 7.73
(1H, s), 7.66 (1H, d, 4.4 Hz), 7.51 (1H, d, 4.3 Hz), 7.31-7.24 (1H, m), 7.15 (1H, ddd, 8.9 Hz, 6.3
Hz 0.9 Hz), 7.05 (2H, dm, 8.9 Hz), 1.30 (3H, sp, 7.0 Hz), 1.15 (18H, d, 7.0 Hz). 13C NMR (125
MHz, CDC13): 157.2, 149.0, 148.9, 144.3, 140.4, 137.8, 132.0, 128.4, 127.3, 126.3, 125.9, 123.1,
122.0, 121.5, 121.3, 120.8, 119.5, 115.2, 114.3, 17.9, 12.7. HRMS (ESI): 547.1837 [calc'd for
M+Na : 547.1846]
HCI HC
EtOH, 60 OC
14d IBF-NIAD 3
8d (13.5 mg, 0.026 mmol) was dissolved in ethanol (12 ml, 200 proof) at 60 oC. Hydrochloric
acid (1.3 ml, 36%) was added and the solution was stirred at 60 oC under argon for 18 hours. The
reaction mixture was cooled to room temperature, diluted with ethyl acetate, and washed with
water, saturated aqueous sodium bicarbonate, and brine, and was then dried over magnesium
sulfate and concentrated in vacuo. Flash chromatography over silica gel (9:1 methylene chloride:
ethyl acetate, then 2:1 ethyl acetate: hexane) afforded IBF-NIAD 3 as a blue solid (8.4 mg, 0.023
mmol, 88% yield). 'H NMR (500 MHz, DMSO-d 6): 9.03 (1H, bs), 6.85 (1H, s), 6.53 (1H, d, 8.5
Hz), 6.42 (2H, d, 8.5 Hz), 6.32 (1H, d, 4.4 Hz), 6.22 (1H, d, 8.9 Hz), 6.08 (1H, d, 4.3 Hz), 5.88
(1H, t, 7.5 Hz), 5.77 (1H, t, 8.0 Hz), 5.65 (2H, d, 8.5 Hz). 13C NMR (125 MHz, DMSO-d 6):
158.9, 150.6, 148.9, 143.2, 143.1, 137.2, 131.9, 129.0, 127.6, 126.3, 125.9, 122.0, 121.7, 121.3,
121.0, 119.3, 116.8, 115.8, 115.0, 70.2. HRMS (ESI): 367.0539 [calc'd for M-H-: 367.0547]
Lawesson's
Reagent(5 equiv) S
CN DCM, rt, air CN
IBF-NIAD 0 ITN-NIAD 0
Lawesson's reagent (7.5 mg, 0.019 mmol) was added to a solution of IBF-NIAD 0 (11 mg,
0.031 mmol) in dry dichloromethane (10 ml) and the reaction was stirred open to air for 3 hours.
Another portion of Lawesson's reagent (52 mg, 0.13 mmol) was added and the reaction mixture
was stirred for an addition 4 hours, monitored by thin later chromatography (dichloromethane).
When the starting material had been consumed, the reaction mixture was purified by flash
chromatography over silica gel (dichloromethane) to afford ITN-NIAD 0 as a purple solid (10
mg, 0.027 mmol, 87% yield) 'H NMR (300 MHz, CDC13): 8.08 (1H, dt, 8.9 Hz, 0.9 Hz), 7.88
(1H, dt, 8.9 Hz, 0.9 Hz), 7.78 (1H, s), 7.74-7.67 (3H, m), 7.59-7.44 (4H, m), 7.37 (1H, ddd, 8.9
Hz, 6.5 Hz, 0.9 Hz), 7.23 (1H, ddd, 8.9 Hz, 6.5 Hz, 0.9 Hz). 13C NMR (125 MHz, CDC13): 149.5,
148.9, 140.2, 139.7, 136.9, 136.0, 133.2, 132.9, 129.4, 129.3, 128.8, 127.4, 125.2, 125.0, 124.6,
122.1, 121.3, 114.7, 113.9, 74.6. HRMS (EI): 368.0429 [calc'd for M+: 368.0436]
Lawesson's
MeO , Reagent MeO/
/ 0 / \ (10 equiv) / S I \\/ s \/ S
N CN CH2C12, rt, 02 NC CN
IBF-NIAD 1 ITN-NIAD 1
IBF-NIAD 1 (11 mg, 0.029 mmol) was dissolved in 10 ml of dry dichloromethane (10 ml) in a
Schlenk flask along with Lawesson's reagent (55 mg, 0.14 mmol), and the solution was cooled to
-78 oC. Anhydrous oxygen was bubbled through the solution for 5 minutes, after which the flask
was sealed, and the reaction mixture was allowed to warm to room temperature and was stirred
at room temperature for 3 hours. A second portion of Lawesson's reagent (55 mg, 0.14 mmol)
was added and the reaction mixture was stirred at room temperature for 6 hours under an oxygen
atmosphere. The reaction mixture was purified by flash chromatography over silica gel
(dichloromethane) to afford ITN-NIAD 1 as a purple solid (8.3 mg, 0.021 mmol, 72% yield). 'H
NMR (300 MHz, CDC13): 8.07 (1H, dt, 8.9 Hz, 0.9 Hz), 7.84 (1H, dt, 8.8 Hz, 0.9 Hz), 7.77 (1H,
s), 7.71 (1H, d, 4.3 Hz), 7.63 (2H, d, 8.9 Hz), 7.48 (1H, d, 4.2 Hz), 7.36 (1H, ddd, 8.9 Hz, 6.5
Hz, 0.9 Hz), 7.21 (1H, ddd, 8.8 Hz, 6.5 Hz, 0.9 Hz), 7.08 (2H, dm, 8.9 Hz), 3.91 (3H, s). 13C
NMR (125 MHz, CDC13): 160.2, 149.4, 149.2, 140.7, 139.8, 136.9, 135.6, 132.9, 130.6, 127.4,
125.3, 125.3, 124.9, 124.7, 123.6, 122.2, 121.3, 114.8, 114.0, 74.0, 55.5. HRMS (EI): 398.0544
[calc'd for M+: 398.0542]
\ 1. Lawesson's
N - Reagent N
/ (10 equiv) S
\I s \/ s
CN CH 2CI2, rt, 02  CN2. Malonitrile N(excess), NEt3
IBF-NIAD 2 ITN-NIAD 2
IBF-NIAD 2 (7.0 mg, 0.018 mmol) and Lawesson's reagent (70 mg, 0.17 mmol) were dissolved
in dry dichloromethane (7 ml) in a Schlenk flask and the solution was cooled to -78 oC.
Anhydrous oxygen was bubbled through the reaction mixture for 5 minutes, after which the flask
was sealed, and the reaction mixture was allowed to warm to room temperature and was stirred
at room temperature for 7 hours. Malonitrile (80 mg, 2.4 mmol) was then added along with
triethylamine (0.1 ml) and the solution was stirred at room temperature under argon for 30
minutes. The reaction mixture was purified by flash chromatography over silica gel
(dichloromethane) to afford ITN-NIAD 2 as a blue solid (4.9 mg, 0.012 mmol, 67% yield). 'H
NMR (300 MHz, CDC13): 8.07 (1H, d, 8.9 Hz), 7.90 (1H, d, 8.8 Hz), 7.74 (1H, s), 7.68 (1H, d,
4.5 Hz), 7.59 (2H, d, 9.0 Hz), 7.45 (1H, d, 4.5 Hz), 7.35 (1H, ddd, 8.9 Hz, 6.3 Hz, 0.9 Hz), 7.18
(1H, ddd, 8.9 Hz, 6.5 Hz, 0.9 Hz), 6.85 (2H, d, 8.9 Hz), 3.08 (6H, s). 13C NMR (125 MHz, DMF-
d7): 152.4, 152.2, 149.3, 143.6, 143.4, 138.1, 135.9, 134.0, 131.2, 128.8, 126.2, 125.9, 123.9,
123.0, 122.2, 121.0, 116.3, 115.8, 113.8, 73.5, 40.6. HRMS (EI): 411.0863 [calc'd for M+:
411.0858]
Lawesson's
TIPSO .. Reagent TIPSO0 ' (5 equiv) S
Sx S
N CH2CI2, rt, 02, CNNC air NC
14d TIPS-ITN-NIAD 3
14d (13.7 mg, 0.026 mmol) and Lawesson's reagent (53 mg, 0.13 mmol) were dissolved in dry
dichloromethane (10 ml) in a Schlenk flask and the solution was cooled to -78 OC. Anhydrous
oxygen was bubbled through the reaction mixture for 5 minutes, after which the flask was sealed,
and the reaction mixture was allowed to warm to room temperature and was stirred at room
temperature for 4 hours. The solution was then opened to air and stirred for an additional 3 hours
at room temperature. The reaction mixture was purified by flash chromatography over silica gel
(dichloromethane) to afford TIPS-ITN-NIAD 3 as a blue solid (13.3 mg, 0.025 mmol, 96%
yield). 'H NMR (300 MHz, CDC13): 8.06 (1H, d, 8.9 Hz), 7.85 (1H, d, 8.9 Hz), 7.76 (1H, s), 7.70
(1H, d, 4.3 Hz), 7.55 (2H, d, 8.7 Hz), 7.47 (1H, d, 4.3 Hz), 7.35 (1H, ddd, 8.9 Hz, 6.5 Hz, 0.9
Hz), 7.20 (1H, ddd, 8.9 Hz, 6.3 Hz, 0.9 Hz), 1.31 (3H, sp, 7.0 Hz), 1.16 (18H, d, 7.1 Hz). 13C
NMR (125 MHz, CDC13): 157.1, 149.4, 149.2, 141.0, 139.8, 136.9, 135.6, 132.9, 130.5, 127.4,
125.5, 124.8, 124.7, 123.5, 122.3, 121.2, 120.7, 114.8, 114.0, 74.0, 17.9, 12.7. HRMS (El):
540.1719 [calc'd for M+: 540.1720]
TIPSO S \ HCI HO
\ s EtOH, 60 OC S
NC CN CN
TIPS-ITN-NIAD 3 ITN-NIAD 3
TIPS-ITN-NIAD 3 (34 mg, 0.063 mmol) was dissolved in ethanol (16 ml, 200 proof) at 60 oC.
Hydrochloric acid (1.66 ml, 36%) was added and the reaction was stirred at 60 oC under argon
for 18 hours. The reaction mixture was cooled to room temperature, diluted with ethyl acetate,
and washed with water, saturated aqueous sodium bicarbonate, and brine, and was then dried
over magnesium sulfate and concentrated in vacuo. Flash chromatography (2:1 ethyl
acetate:hexane) afforded ITN-NIAD 3 as a purple solid (13.5 mg, 0.035 mmol, 56% yield). 'H
NMR (500 MHz, DMSO-d 6): 9.17 (1H, s), 7.70 (1H, s), 7.10 (1H, dd, 8.9 Hz, 0.8 Hz), 7.04 (1H,
d, 4.1 Hz), 6.95 (1H, dd, 8.9 Hz, 0.8 Hz), 6.83 (1H, dd, 4.1 Hz, 0.9 Hz), 6.67 (2H, d, 8.7 Hz),
6.54 (1H, dd, 8.9 Hz, 6.3 Hz), 6.38 (1H, dd, 8.9 Hz, 6.3 Hz), 6.09 (2H, d, 8.7 Hz). 13C NMR (125
MHz, DMSO-d 6): 158.6, 151.7, 147.4, 142.3, 140.6, 136.2, 134.6, 132.8, 130.6, 127.7, 125.4,
125.11, 122.9, 122.5, 122.3, 120.8, 116.5, 115.1, 114.4, 72.4. HRMS (ESI): 383.0310 [calc'd for
M-H: 383.0318]
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Chapter 3
Isobenzofuran Near-Infrared Probes for
3-Amyloid Imaging
3.1 Introduction: Imaging Alzheimer's
As discussed in previous chapters, near-infrared fluorescence (NIRF) imaging has the
potential to provide non-invasive, relatively inexpensive diagnostic tools. One area in which this
technique could prove particularly useful is Alzheimer's Disease (AD), a terminal, progressive,
neurodegenerative condition which afflicts 5 million individuals in the United States.1 Symptoms
include memory loss, cognitive impairment, and dementia.2 The disease is most prevalent in
people over the age of 65, and as the population ages, the number is projected to increase to 106
million worldwide by 2050.3 Currently AD has neither a cure nor a definitive methodology for
diagnosis, with cases evaluated either symptomatically, or via autopsy.
NcVu. Iwr
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Figure 3.1 (a) Human brain afflicted with Alzheimer's Disease (left) and normal brain (right)4 ,
(b) graphic representing P3-amyloid plaques and Tau tangles (Reprinted from reference 8).
Extensive research has been undertaken to elucidate the biological processes associated
with AD 5, though a detailed discussion of this work lies beyond the scope of this thesis and,
indeed, research in this field is continually evolving. The main indicators of AD pathology are
neuronal loss and formation of senile plaques (SPs) and neurofibrilary tangles (NFTs). SPs are
composed of fibrillar aggregates of P-amyloid (AP) proteins. Amyloid proteins are critical for
the function of a heathy brain, however the plaques form when amyloid precursor protein (APP)
is fragmented into 39- 42 amino acid sections, called P3-amyloids, which subsequently build up
and aggregate into plaques. NFTs are aggregates of tau protein. Tau proteins aid the structural
integrity of microtubules 6, which are integral to intracellular transport. In AD, neuronal tau
proteins become hyperphosphorylated and form fibrils, disrupting the neurons transports
systems.7 The exact interplay between these two structures and how they contribute to the
neuropathy associated with AD is not fully understood and is currently a source of debate.8 It is
known that SPs form in the brain before symptoms develop, 9 and many researchers believe their
presence to be pivotal to the progression of AD. 10 Thus, in order to better diagnose AD, to better
understand its biochemistry and progression, and to evaluate effective treatments in murine
models and ultimately in humans, in vivo methods to visualize SPs and NFTs must be
developed."
Several techniques have been explored for imaging AP plaques, including magnetic
resonance imaging (MRI), multiphoton microscopy, positron emission tomography (PET) and
near-infrared fluorescence (NIRF) imaging. Of these, multiphoton microscopy was the first to
N allow in vivo detection of SPs, exploiting Thioflavin S
SO 3Na (Figure 3.2) as a contrast agent.12  Multiphoton
NH2
microscopy has also been used to evaluate the SP labeling
Figure 3.2: Thioflavin S properties of PET lingand PIB. 1 3 Unfortunately,
multiphoton microscopy necessitates removal of part of the skull, and thus the invasive nature of
this technique renders it unsuitable for human subjects. Gd and monocrystalline iron oxide
nanoparticles and have been used to image SPs in vivo in mice with MRI, 14 but the technique
suffers from low resolution, allowing visualization of only the largest plaques.
Of the techniques explored thus far, PET is the most developed technology: numerous
reports of PET imaging agents for AP plaques have been published in the last 10 years, 15
culminating in four compounds, "'F-FDDNP,'6 1C-PIB,' 7 "C-SB13,18 and "C-BF-22719 (Figure
3.3); these have been tested clinically with human AD patients. 20 The results from these studies
are extremely promising, and clearly PET imaging will play a key role in Alzheimer's research.
However, PET suffers certain limitations. It is hindered by the high cost of the associated
instrumentation, its limited availability, and the short lifespan of the radiolabeled contrast agents.
Unless these issues can be resolved or ameliorated, other imaging technologies will have to be
developed to allow widespread diagnosis and early detection of AD.
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Figure 3.3 PET contrast agents. Refer to the text for a discussion.
NIRF imaging, in contrast, can provide high resolution with relatively inexpensive
equipment.2 1 NIR Fluorescent probes should have several design qualities. First, they must pass
through the blood brain barrier (BBB), the tight junctions formed by cerebral endothelial cells
that mediate entry of compounds to the brain. The biological processes that mediate BBB
permeability are extremely complex and our understanding of them is continually evolving,
however, some basic guidelines exist. In general, compounds should have a molecular weight of
less than 500 Da, a log octanol/water (Log P) coefficient 22 between -0.5 and 6.0, and should not
have any formal charge.23 Probes should bind to AP aggregates, and while the structure of these
aggregates has not yet been solved by crystallography or multidimensional NMR, they are
believed to have extensive P3-sheet character with a thin hydrophobic groove along the long axis
of the fibril.24 Thus fluorophores should be relatively planar, allowing for intercalation into this
hydrophobic cavity. In order to maintain contrast between bound and unbound dye, probes
should exhibit a photophysical change upon binding.2 5 An increase in the quantum yield of the
dye provides a "turn-on" response. A change in the wavelengths of absorption or fluorescence
emission can be measured using liquid crystal tunable filters with 10 nm resolution.26 Changes in
the fluorescence lifetime of the dye can be measured with fluorescence lifetime imaging (FLIM)
(see chapter 1 for discussion). 27 In order to maximize
CI-
+ / these effects, the dye should undergo a structural change
on binding, such as planarization or rigidification, thus
Thioflavin T
allowing for a decrease in the molecular vibrational-
HI CN rotational processes that couple ground and excited
NIAD-4 states. This rigidification effect has been studied
( extensively with Thioflavin T (Figure 3.4), which
O BF4- undergoes significant spectral changes (93 nm red-shift
AOI-987
Figure 3.4: Thioflavin T, in absorption maximum, 35 nm red-shift in emission
NIAD 4 and AOI-987 maximum, 12.5 fold increase in fluorescence intenity) 2 8
maximum, 12.5 fold increase in fluorescence intensity) 28
on binding to AP3 fibrils.29 When these factors are all taken into account, we are looking for a
small, neutral fluorophore with a flexible, planarizable backbone.
Two NIR fluorophores have been reported to detect SPs in vivo. The first, AOI-987
(Figure 3.4) is an oxazine dye with absorption and emission maxima at 650 nm and 670 nm
respectively and a quantum yield of 0.41. 30 AOI-987 passes the blood brain barrier (a rare
exception to the 'no formal charge' guideline) and binds to SPs, and, indeed, an increased
fluorescence signal is observed for APP23 transgenic mice over similarly treated wild type mice.
The photophysical properties of AOI-987 do not improve on binding, with a slight decrease in
fluorescence intensity, and thus the spatial resolution of its images are limited.31 Our group has
previously reported NIAD-4, a donor-acceptor dye (Figure 3.4) that also passes the BBB and
binds to SPs.32 Due to its flexible backbone, NIAD-4 exhibits marked optical contrast on binding
to AP fibrils, with a 70 nm red-shift in the absorption maxima and a 400 fold increase in
fluorescence intensity (Figure 3.5). However, NIAD-4's absorption is not far enough into the
NIR to permit imaging without a cranial window. Thus, while NIAD-4 illustrates the
effectiveness of the "smart-probe" design paradigm, such invasive procedures limit its
applicability in murine and human diagnostic techniques and necessitate the development of red-
shifted derivatives.
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Figure 3.5: (top) Absorption and fluorescence spectra of NIAD-4 (4.1 rM) in aqueous PBS
solution in the presence of aggregated amyloid-b protein (10 rM, solid line) and without the
protein (dashed line). (bottom) (a) Image of a coronal section of brain from an aged APP
transgenic mouse labeled with a solution of NIAD-4. White spots are fluorescent signals from
labeled SPs (b) In vivo fluorescent detection of both senile plaques and amyloid angiopathy
using multiphoton microscopy immediately following intravenous injection of 2 mg/kg of
NIAD-4. Images reproduced from reference 32.
Chapter 2 demonstrated that isobenzofuran and isothianaphthene could be used as
proquinoidal components of small molecule donor-acceptor near-infrared dyes, based a similar
framework to NIAD-4. In this chapter, we expand this dye series and modify our basic design to
improve physical and photophysical properties in order to maximize optical response upon A(3
101
binding and ultimately blood-brain barrier permeability. We also install functional handles onto
the dyes to enable integration into other NIR sensing applications. The modifications we explore
include changing the electron-withdrawing group, changing the phenyl ring and the 5-membered
heterocycle in the conjugated backbone, and changing the electron-donating group (Figure 3.6).
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Figure 3.6 Potential modifications to IBF-NIAD series.
3.2 Results and Discussion
3.2.1 AP Binding interactions of IBF-NIAD 0-3
As a starting point in our dye design, we explored the interactions between IBF-NIAD 0-
3 and aggregated P-amyloid proteins. AP3(1-40) protein (Figure 3.7) is the model system most
commonly employed for this purpose in the literature, as it readily forms fibrils with lamellar 3-
sheet structures upon incubation in PBS buffer.27 The results of these binding tests are displayed
in Figures 3.8 - 3.11.
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H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gn-Lys-Leu-Val-Phe-Phe-
Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
Figure 3.7 Amino acid sequence of AP(1-40).
2.5 104
2 104
1.5 104
1 104
5000
b) 8 o10
7 10
6 10'
5 105
4 10
3 10'
2 105
1 105
00 1 1 I I I I
400 450 500 550 600 650 700 750 800
Wavelength (nm)
550 600 650 700 750 800
Wavelength (nm)
IBF-NIAD 0
Figure 3.8 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 0 (2.5 riM) in PBS buffer
(blue solid line) and 10 tM aggregated AP(1-40) in PBS buffer (red dashed line).
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Figure 3.9 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 1 (2.50 tM) in PBS buffer
(blue solid line) and 10 1 M aggregated AP(1-40) in PBS buffer (red dashed line).
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Figure 3.10 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 2 (2.50 tM) in PBS
buffer (blue solid line) and 10 tM aggregated AP(1-40) in PBS buffer (red dashed line).
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Figure 3.11 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 3 (2.74 [tM) in PBS
buffer (blue solid line) and 10 1tM aggregated AP(1-40) in PBS buffer (red dashed line).
Table 3.1 Summary of AtP(1-40) Assay Results for IBF-NIAD 0-3
Dye Xmax Abs. (nm) Xmax Em. (nm) Red-shift (nm) EAp/EPBS I)A/(I)pPBS
(R-) PBS APa  PBS Apa Abs. Em.
IBF-NIAD 0 539 550 665 656 11 -9 1.07 190
(H-)
IBF-NIAD 1 560 612 b 690 52 b 1.06 800
MeO-
IBF-NIAD 2 621 627 b 796 6 b 1.03 20
(Me 2N-)
IBF-NIAD 3 560 603 701 704 43 3 0.85 62
(HO-) I
a AP(1-40) concentration was 10 .IM.'
values are not available or are estimates.
SFluorescence intensity in PBS was undetectable, thus
These results indicate interaction of IBF-NIAD 0-3 with aggregated AP proteins. In all
cases we observed a marked increase in the fluorescence intensity. The shapes of the absorption
spectra of the dyes in PBS buffer suggest the formation of disordered H-type aggregates.
33 This
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. 4
arrangement, in which chromophores stack directly on each other produces a blue shift in the
absorption. However, as can be seen in all of the spectra, there is a shoulder on the red edge of
the absorption that results from a second transition, which comes from a minority species in the
aggregate. Changes to the absorption spectra were modest for IBF-NIAD 0 and 2, with red-shifts
in absorption maxima of 6 nm and 11 nm respectively. This lack of significant red-shift suggests
that the dyes are highly aggregated in PBS solution, and thus only very small amounts are able to
interact with the AP3 fibrils, though those that do interact show a significant turn-on fluorescence
response. The red-shifts for IBF-NIAD 1 and 3 are more substantial, at 52 nm and 43 nm, and
these dyes show significant absorption at 650 nm, with the extinction coefficients at that
wavelength only decreasing by 5% and 7% respectively. Indeed, the absorption maximum of AP3
bound IBF-NIAD 1 is red shifted 13 nm beyond its absorption maximum in CHCl 3. IBF-NIAD
0-3 do not, however, stain SPs when incubated with cerebral tissue sections of an aged APP/PS 1
mouse, and we attribute this negative result to aggregation of the dyes in PBS solution.
3.2.2 IBF-NIAD 4: Integration of Thiophene
The first modification we explored was the replacement of the phenyl ring with
thiophene. We speculated that, due to thiophene's lesser aromaticity, 34 its integration would
further red-shift the absorbance and emission of the dye. Thiophene is also more hydrophilic
than benzene (Log P 1.90 vs 2.0), 35 thus we also hoped to reduce the hydrophobicity of the dye.
The synthesis of this dye is described in Scheme 3.1. Phthalide 3 was produced by Friedel-Crafts
acylation of 2-methoxythiophene with phthalic anhydride followed by reduction of resulting
carboxylic acid 2 with NaBH 4 under basic conditions and cyclization with HC1. This phthalide
was then submitted to the synthetic pathway used for IBF-NIAD 0-3, to afford IBF-NIAD 4.
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Scheme 3.1 Synthesis of IBF-NIAD 4
1. AICI3, DCM ] 1. NaHCO 3  0 Li O
1 OMe o
MeO 2. NaBH 4  -78 C, THF
2. 2 3.HCI S 2. Ac 2 0
1 3. HCI 2 3 3. 90% AcOH
MeO
37% 6%
H 0 I \ NC CN 1
MeO S X / S NMeO S \ S
4 IBF-NIAD 4
7% 88%
The absorbance and fluorescence emission spectra of IBF-NIAD 4 are depicted in Figure
3.12. Compared to IBF-NIAD 1, IBF-NIAD 4 displays a 29 nm red shift in absorption
maximum and 48 nm red shift in fluorescence emission maximum in MeOH, with similar red
shifts in CHCl3. The quantum yields, however, are significantly decreased. This reduction can be
attributed to the internal heavy atom effect, which will be discussed in detail in Section 3.2.3.
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Figure 3.12 Absorbance and Fluorescence Emission spectra of IBF-NIAD 4 and a summary of
its spectroscopic properties.
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Figure 3.13 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 4 (2.50 PtM) in PBS
buffer (blue solid line) and 10 FtM aggregated A3(1-40) in PBS buffer (red dashed line).
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Table 3.2: Summary of AP(1-40) Assay Results
Dye %max Abs. (nm) Xmax Em. (nm) Red-shift (nm) EAp/EPBS (IAp/(IPBS
(R-) PBS APa  PBS APa  Abs. Em.
IBF-NIAD 4 586 601 b 739 15 b 0.77 30
(MeO-Th-)
a Ap(1-40) concentration was 10 tM. b Fluorescence intensity in PBS was undetectable, thus
values are not available or are estimates.
IBF-NIAD 4 also shows changes in its photophysical properties when bound to AP3(1-40) with a
red shift in absorption maximum of 15 nm and a substantial increase in fluorescence intensity. In
in vitro tissue studies with coronal brain sections of an aged APP/PS1 mouse, IBF-NIAD 4
stains SPs (figure 3.14). Unfortunately, the fluorophore does not cross the blood brain barrier,
and thus cannot be utilized for in vivo imaging.
Figure 3.14 Image of a cross section of an aged APP/PS 1 mouse brain stained with IBF-NIAD
4. Image taken with excitation at 685 nm and emission viewed through a 700 nm longpass filter.
The black spots are fluorescent signals indicating staining of SPs by the dye. Image obtained by
Brian Ferrara at Massachusetts General Hospital.
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for IBF-NIAD 4
3.2.3 IBF-NIAD 11-14: Integration of a Furan Subunit
As a next step in our dye tuning process, we explored the effect of exchanging the
thiophene subunit with furan. Furan is more hydrophilic than thiophene (Log P = 1.34 vs. Log P
= 1.90),36 and has lesser aromatic stabilization (RE = 27.2 kcal/mol vs. RE = 43.0 kcal/mol). 37 It
has also been reported that exchanging thiophene with furan in certain fluorescent oligomeric
systems leads to an increased quantum yield in those systems,38 thus we hoped that the
incorporation of furan would prove advantageous to our design. The synthesis of IBF-NIAD 11-
14, the furan containing analogues of IBF-NIAD 0-3, is shown in Scheme 3.2. In general, the
synthetic methods are very similar to the original dye set but with an acetal-protected
bromofuran 6 used in place of a acetal-protected bromothiophene.
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Scheme 3.2 Synthesis of IBF-NIAD 11-14
O HOeOH
Benzene,
Cat. pTsOH
5 A, Dean-Stark
8a: R= H-: 38%
8b: R= MeO-: 25%
8c: R= Me2N- : 25%
8d: TIPSO-: 24%
6
52%
NC CN R
cat. NEt 3
CH 2CI 2, rt
7a-d
n-BuLi, THF, -78 OC
2. Ac20, A
3. 90% AcOH, r.t.
IBF-NIAD 14: R= H-: 82%
IBF-NIAD 11: R= MeO-: 81%
IBF-NIAD 13: R= Me2N-: 77%
9d: TIPSO-: 87%
HCI, EtOH HO
600 C ki,
IBF-NIAD 12
88%
The absorbance and fluorescence emission spectra of IBF-NIADs 11-14 are shown in
Figure 3.15 and Figure 3.16, and their spectroscopic properties are summarized in Table 3.3.
Compared to IBF-NIADs 0-3, IBF-NIADs 11-14 exhibit a slight (4-12 nm) blue-shift in
absorption maxima and a 6-24 nm blue shift in fluorescence emission maxima.
111
MeOH
oL I -I
400 450 500 550 600 650 700 750
Wavelength (nm)
4 104
3.5 104
3 104
2.5 104
2 104
1.5 104
1 104
5000
0 -
400
IBF-NIAD 14
MeOH
5 10
4
4 10
4
3 104
2 10
4
Wavelength (nm)
2.5 104
2 104
1.5 104
1 104
IBF-NIAD 11
Figure 3.15 Absorbance (red) and normalized fluorescence intensity
NIAD 14 and 11 in MeOH (left) and CHCl 3 (right).
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Figure 3.16 Absorbance (red) and normalized fluorescence intensity (blue) spectra of IBF-
NIAD 12-13 in MeOH (left) and CHCl3 (right).
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Table 3.3 Spectroscopic Properties of IBF-NIAD 11-14
Dye Xmax Abs. (nm) kmax Emission (nm) (I E (M-' cm')
MeOH CHC13 MeOH CHC13  MeOH CHC13 MeOH CHC13
IBF-NIAD 14 551 571 640 629 0.11 0.12 26100 40500
IBF-NIAD 11 572 590 678 664 0.13 0.18 36700 46700
IBF-NIAD 12 579 588 686 658 0.10 0.16 37500 41800
INF-NIAD 13 625 646 769 738 0.014 0.076 12700 40100
As predicted, the quantum yield does increases with the transition from sulfur to oxygen,
up to approximately 100% depending on the dye and solvent. As mentioned above, this effect
has been reported previously in the literature and has been attributed to the internal heavy atom
effect. 39 Due to its larger nucleus, the sulfur atom has greater spin-orbit coupling, enabling
intersystem crossing, and thereby lowering the quantum yield.40 This effect is also evident for the
sulfur-oxygen substitution of isothianaphthene to isobenzofuran (Table 3.4). Thus, as the sulfur
is replaced with oxygen in the conjugated backbone, the quantum yields of the dyes increase. It
is also possible that solvation plays a role in this trend, as the ratios of quantum yields in MeOH
and CHC13 are smaller as the number of oxygen molecules in the conjugated backbone increases,
and the gains in quantum yield are more substantial in MeOH than in CHC13.
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Table 3.4 Quantum Yield Comparison of S and O Containing Dyes
R- R R R/ 1
f S \ S \I 0
NC N N C NC CN
D (MeOH) D (CHC13) D (MeOH) D (CHC13) 4 MeOH D (CHC13)
H- 0.061 0.079 0.077 0.075 0.11 0.12
MeO- 0.046 0.099 0.078 0.16 0.13 0.18
HO- 0.023 0.071 0.049 0.12 0.10 0.16
Me2N- 0.0015 0.021 0.0055 0.046 0.014 0.076
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Figure 3.17 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 11 (2.50 rtM) in PBS
buffer (blue solid line) and 10 tM aggregated A13(1-40) in PBS buffer (red dashed line).
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Figure 3.18 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 12 (2.50 rM) in PBS
buffer (blue solid line) and 10 M aggregated AP(1-40) in PBS buffer (red dashed line).
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Figure 3.19 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 13 (2.50 [iM) in PBS
buffer (blue solid line) and 10 tM aggregated AP(1-40) in PBS buffer (red dashed line).
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Figure 3.20 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 14 (2.50 atM) in PBS
buffer (blue solid line) and 10 tM aggregated AP(1-40) in PBS buffer (red dashed line).
Table 3.5 Summary of A(1-40) Assay Results for IBF-NIAD 11-14
Dye Xmax Abs. (nm) Xmax Em. (nm) Red-shift (nm) EAj/EPBS OI)Ap/kPBS
(R-) PBS Apa PBS Apa Abs. Em.
IBF-NIAD 11 536 562 659 678 26 19 0.76 130
(MeO-)
IBF-NIAD 12 572 634 700 691 62 -9 1.24 21
(HO-)
IBF-NIAD 13 608 638 b 772 30 b 1.09 60 b
(Me 2N-)
IBF-NIAD 14 540 591 661 653 51 -8 0.76 290
(H-)
a AP(1-40) concentration was 10 [iM.
values are not available or are estimates.
b Fluorescence intensity in PBS was undetectable, thus
The results of the AP(1-40) assay for IBF-NIAD 11-14 (Figure 3.17-3.20) are generally
improved over those for IBF-NIAD 0-3, with larger red shifts in absorption maxima (Table 3.5).
IBF-NIAD 12 exhibits the strongest response, with a 62 nm red shift in absorption maximum,
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and also a 24% increase in extinction coefficient when bound to AP(1-40). The AP bound
absorption maximum for this dye is red shifted 46 nm over its value in CHC13 solution, and
absorption spectrum of the bound dye extends well into the NIR with extinction coefficient
reduced only by 4% at 650 nm. The peak width for IBF-NIAD 12 is also substantially narrower
than that of IBF-NIAD 3 (143 nm versus 200 nm at half maximum).
IBF-NIAD 12 stains SPs when incubated with brain tissue sections of an APP/PS I1
mouse, as can be seen in Figure 3.21. IBF-NIAD 11, 13, and 14 do not bind to SPs in tissue
staining studies, presumably due to aggregation of dyes in PBS buffer solution. IBF-NIAD 13
does, however, stain white matter (Figure 3.22),41 and may be useful in NIRF imaging of myelin
pathologies, such multiple sclerosis. 42
Figure 3.21 Image of a cross section of an aged APP/PS1 mouse brain stained with IBF-NIAD
12. Image taken with excitation at 685 nm and emission viewed through a 700 nm longpass
filter. The black spots are fluorescent signals indicating staining of SPs by the dye. Image
obtained by Brian Ferrara at Massachusetts General Hospital
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Figure 3.22 Image of (left) a cross section of an aged APP/PS1 mouse brain incubated with PBS
buffer (unstained) and (right) with IBF-NIAD 13. Image taken with excitation at 633 nm. The
red box is added to highlight staining of the white matter. Image obtained by Krista Neal at
Massachusetts General Hospital.
3.2.4 IBF-NIAD 18-19: Controlling Amine Functionality
Our next step in the modifying this series was to attempt to control the functionality of
the amine donor group. We hoped this would afford not only dyes with a free amine, which
would help to decrease hydrophobicity and thus aggregation, but would also to allow the
integration of this fluorophore technology into cleavable sensors, such as have be used to
monitor enzyme activity43 or detect thiols44 and would provide a functional handle for
conjugation to proteins or the addition of other chemical functionality. In order to accomplish
this goal synthetically, we needed a protected amino phthalide, preferably one that could be
cleaved at any step in the synthesis.
Our first attempt utilized the benzyl-protecting group, which would be able to survive the
strongly acidic conditions of phthalide formation and the strongly basic conditions of the
condensation used to form the isobenzofuran backbone. N,N-dibenzyl-aniline (11) was
synthesized from aniline and benzylchloride and was then condensed with 2-
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carboxybenzaldehyde to afford protected phthalide 13, which proved amenable to the standard
dye synthesis procedure (Scheme 3.3).
Scheme 3.3: Synthesis
NH2 BnCIOAc
NaOAc
10
of Benzyl-Protected Dye
qCO 2H
NBn2 C/ HO
Cat. HCIO 4
11
66%
90% AcOH
16
43%
Cleavage of the benzyl protecting groups proved problematic. Hydrogenation with H2 gas or
ammonium ammonium formate and palladium catalyst (Pd/C or Pearlman's catalyst) was
attempted on 13, 14, 15, and 16, and either did not remove the benzyl groups or resulted in
decomposition.
The complications involved with benzyl-deprotection lead us to explore alternate
protection schemes, and we finally settled on benzophenone imine, which is known to be stable
to aryl-lithium chemistry.45 Amino-phthalide 18 was synthesized by the nitration of 3-
phenylphthalide with nitric acid and sulfuric acid,46 followed by reduction with tin chloride. The
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1Li
-780 C, THF
2. Ac20
NCOCN
DCM, NEt 3
15
40%
amine was then acidified, and the protecting group installed by transamination with
benzophenonimine (Scheme 3.4).
Scheme 3.4 Synthesis of IBF-NIAD 18-19
SnCI2
H20, EtOAc
H20
,
EtOAc
17 I ]
24%
1.O
2. Ac20
3. SiO02, Cat. H20
4. NC CN
I. P h DCM, NEt 3
18
82%
20a x= S: 18%
20b x= O: 10%
Cat. HCI -0 X
THF CN
IBF-NIAD 18 x= S: 97%
IBF-NIAD 19 x= 0: 79%
Synthesis of IBF-NIAD 18 and 19 required selective deprotection of the acetal in the presence of
the benzophenone imine, due to reaction of the free amine with the aldehyde under acid or basic
conditions. This was accomplished by stirring the acetal in a DCM-silica gel slurry with catalytic
H20. 47 It should also be noted that selective deprotection of the imine in the presence of the
acetal can be achieved by transamination with hydroxylamine. 48 Final deprotection to afford
IBF-NIAD 18 and 19 was carried out with catalytic HCI in THF.
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Figure 3.23 Absorbance (red) and normalized fluorescence intensity (blue) spectra of IBF-
NIAD 12-13 in MeOH (left) and CHCl3 (right).
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Table 3.6 Spectroscopic Properties of IBF-NIAD 18-19
Dye Xmax Abs. (nm) ,,max Emission (nm) (D E (M' cm')
MeOH CHC13 MeOH CHC13  MeOH CHC13 MeOH CHC13
IBF-NIAD 18 618 620 776 718 0.0076 0.054 12900 26700
IBF-NIAD 19 611 615 755 702 0.014 0.094 24700 28100
The absorbance and fluorescence emission spectra are shown in Figure 3.23, and their
spectroscopic properties are summarized in Table 3.6. Compared to IBF-NIAD 2 and IBF-
NIAD 13, the ,max absorption of IBF-NIAD 18 and IBF-NIAD 19 are blue-shifted by 14-26 nm.
This shift can probably be attributed to the lower electron density on the nitrogen in the absence
of the electron donating methyl groups. The fluorescence emission maxima also experience a
blue shift of 14-44 nm. We observe two emission bands for IBF-NIAD 18 in MeOH, indicating
two emitting species likely due to a partially aggregated state. In addition, the lower molar
extinction coefficient for this molecule in MeOH, as compared to CHC13, suggests that the
chromophore is aggregated. Quantum yields for IBF-NIAD 18 and IBF-NIAD 19 are slightly
increased over their dimethylated counterparts.
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Figure 3.24 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 18 (2.50 M)
buffer (blue solid line) and 10 M aggregated AP(1-40) in PBS buffer (red dashed line).
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Figure 3.25 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 19 (3.68 M) in PBS
buffer (blue solid line) and 10 M aggregated AP(1-40) in PBS buffer (red dashed line).
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Table 3.7 Summary of AfP(1-40) Assay Results for IBF-NIAD 18-19
Dye ,max Abs. (nm) Xmax Em. (nm) Red-shift (nm) EAp/EPBS (IApAI PBS
(R-) PBS Apa PBS APa  Abs. Em.
IBF-NIAD 18 587 624 _ 770 37 b 1.15 3
(H2N-)
IBF-NIAD 19 583 690 760 759 107 -1 1.68 14
(H2N-)
b
a AP(1-40) concentration was 10 tM.
values are not available or are estimates.
F luorescence intensity in PBS was undetectable, mus
The results of the AP(1-40) assay for IBF-NIAD 18 and 19 are shown in Figure 3.24 and
Figure 3.25 and are summarized in Table 3.7. IBF-NIAD 18 exhibits a modest 34 nm red shift in
absorption maximum and 15% increase in extinction coefficient on binding. However, the
spectroscopic changes experienced by IBF-NIAD 19 on binding to AP are more pronounced.
The absorption maximum is shifted to 690 nm, a 107 nm and 75 nm red shift from PBS and
CHCl 3 solutions respectively; the extinction coefficient enjoys a 68% enhancement. Its peak
width is comparable to that of AP bound IBF-NIAD 12 (149 nm versus 143 nm at half
maximum) While IBF-NIAD 19 stains SPs in APP/PS1 tissue, IBF-NIAD 18 does not.
Figure 3.26 Image of (left) a cross section of an aged APP/PS 1 mouse brain incubated with PBS
buffer (unstained) and (right) with 5 [tM IBF-NIAD 19. Image taken with excitation at 633 nm.
Black spots are fluorescent signals indicating staining of SPs by IBF-NIAD 19. Image obtained
by Krista Neal at Massachusetts General Hospital.
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3.2.5 IBF-NIAD 22-25: Exploration of Water Solublizing groups
In order to further decrease the hydrophobicity of our dyes, we explored several different
strategies for the integration of water solublizing groups into our fluorophore design. Our first
thought was to add additional hydroxyl groups to the phenyl ring, and we were able to synthesize
TiPS protected catechol-phthalide 22 and TiPS protected glycol-catechol-phthalide 24 (Scheme
3.5). Unfortunately, the resulting IBF compounds, 23 and 25, were unstable, possibly due to their
ease of oxidation.
Scheme 3.5 Attempted Synthesis of Catechol IBF-NIADs
OH
OHLiS TIPSO
H 60% H2S0 4 , r.t. 2. Ac20 S
O 2. TIPSCI, DMF / 3 3. 90% AcOH
12 imidazole, r.t. 22 OTIPS 23
28% OTIPS Unstable28%
00 O L)i O HO.../O
o ° H° I \0O| HO
OH nBuNI, A 2. Ac 2 0
21 O 3. TBAF21 2 4 /\ 4. 90% AcOH 25
H 12% .O TIPS Unstable
O
60% H2SO4 , r.t.
3. TIPSCI, DMAP
NEt 3, DCM
We also attempted to install a water solublizing chain, in this case a diethylene glycol
methyl ether, onto the acceptor end of the dye (Scheme 3.6). Triethylene glycol monomethyl
ether was oxidized with KMnO4 under basic conditions to carboxylic acid 27. Reaction of this
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acid with oxalyl chloride followed by quenching with N,O-dimethylhydroxylamine
hydrochloride afforded Weinreb amide 28. Condensation of the amide with 2-bromo-5-
lithiothiophene, followed by protection of the resulting ketone gave bromothiophene 29. IBF dye
precursor 30 proved unstable and difficult to isolate, and neither acid nor base catalyst nor the
Lehnert conditions49 were able to effect the Knoevenagel condensation with malonitrile, instead
resulting in decomposition of the starting material.
Scheme 3.6 Attempted Installation of Diethylene Glycol Chain
KMnO4 1O
KOH, H20O DCM, Cat. DMF
26 27 2. MeONH HCI
26%
DCM, H20, K2CO 3
Br S
MeO,,N OR 1. Br~OR 1. n-BuLi, THF, -78 OC
I 2. NH4CI 2. OMe
28 3. HO_ OH 29 O 0
35% pTsOH, Benzene 28% /A, Dean-Stark 7b
3. Ac2 0, A
4. 90% AcOH, r.t.
MeO - MeO 
M 0 OR NC CN 0 ' OR
O\I \NCI CNNEt 3 or NH40Ac
or pyridine, TiCI 4
30 31
Unstable R= r,, O 00
We next looked to the primary functional handle in this dye series, the electron donating
group, as a location for water solubilizing groups. In particular, the addition of a glycol or
propane-1,2-diol group to the oxygen electron donating group looked particularly attractive due
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to their small size and the ease of integration into our fluorophore design and synthesis. Attempts
were made to functionalize IBF-NIAD 3 and IBF-NIAD 12 directly, but with no success, thus,
we had to design protected phthalides to integrate the glycol and propane-1,2-diol groups.
Scheme 3.7: Synthesis of IBF-NIAD 22 and IBF-NIAD 24
O
H O._OH
Bu4NI,
32 160 OC 33
NH
THF, TiPSCI
35
56%
57%
1. O
2. Ac20
3. TBAF, THF
4. AcOH
NC-CN o I
DCM, NEt 3 NC CN
IBF-NIAD 22, x= S: 11% (6% two steps)
IBF-NIAD 24, x= 0: 30% (11% two steps)
Protected glycol phthalide was synthesized in three steps (Scheme 3.7). Phenol was
reacted with ethylene carbonate in the presence of catalytic tetrabutylammonium iodide to form
ether 33, which was in turn condensed with 2-carboxybenzaldehyde under acid conditions to
yield phthalide 34. Installation of a TIPS protecting group was accomplished with imidazole and
TIPSC1. Phthalide 35 was submitted to the standard dye synthesis procedure, with cleavage of
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34
61%
36a, x= S: 52%
36b, x= 0: 36%
the TiPS group with tetrabutylammonium fluoride before hydrolysis of the acetal, to afford IBF-
NIAD 22 and 24.
Scheme 3.8: Synthesis of IBF-NIAD 23 and IBF-NIAD 25
O
S OH OH OH O
S DCM, NEt 3  N. J 60% H 2SO 4
32 37 38 HO
85% 28% O, OH
OOH
pTsOH, DCM 2. Ac20
3. 90% AcOH
39 40a, x= S: 43%
52% 40b, x= O: 42%
NC'CN HO <O \
OH . \X
DCM, NEt3  CN
NC
IBF-NIAD 23, x= S: 55% (24% 2 steps)
IBF-NIAD 25, x= O: 41% (17% 2 steps)
The synthesis of the phthalide with a protected propane-1,2-diol group was also achieved
in three steps (Scheme 3.8). The epoxide of glycidol was opened with phenol in the presence of
triethylamine to yield 1,2-diol 37. Acid mediated condensation of 37 with 2-
carboxybenzaldehyde afforded phthalide 38, which was protected with 2,2-dimethoxy propane to
give acetal protected phthalide 39. Phthalide 39 could also be protected with TiPS, but the acetal
provided superior yields, and better atom economy. Phthalide 39 was submitted to the standard
dye synthesis conditions to afford IBF-NIAD 23 and IBF-NIAD 25. The absorption and
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fluorescence emission spectra of IBF-NIAD 22-25 are presented in Figures 3.27 and 3.28, and
the spectroscopic properties of these fluorophores are summarized in Table 3.8.
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Figure 3.27 Absorption (red) and normalized fluorescence emission (blue) spectra of IBF-NIAD
22 and IBF-NIAD 24 in MeOH (left) and CHCl3 (right).
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Figure 3.28 Absorption (red) and normalized fluorescence emission (blue) spectra of IBF-NIAD
23 and IBF-NIAD 25 in MeOH (left) and CHCl3 (right).
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Table 3.8 Spectroscopic Properties of IBF-NIAD 22-25
Dye ,,,max Abs. (nm) Xmax Emission (nm) ( E (M' cm "')
MeOH CHC13 MeOH CHC13  MeOH CHC13 MeOH CHC13
IBF-NIAD 22 577 597 688 671 0.071 0.14 25500 27400
IBF-NIAD 24 572 589 677 661 0.12 0.16 34200 43800
IBF-NIAD 23 571 589 676 659 0.11 0.15 42700 32000
INF-NIAD 25 572 587 676 660 0.11 0.15 40900 39900
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Figure 3.29 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 22 (2.50 M) in PBS
buffer (blue solid line) and 10 [M aggregated A(3(1-40) in PBS buffer (red dashed line).
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Figure 3.30 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 23 (2.50 rM) in PBS
buffer (blue solid line) and 10 M aggregated A3(1-40) in PBS buffer (red dashed line).
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Figure 3.31 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 24 (2.50 riM) in PBS
buffer (blue solid line) and 10 tM aggregated A3(1-40) in PBS buffer (red dashed line).
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Figure 3.32 Absorption (a) and fluorescence (b) spectra of IBF-NIAD 25 (2.50 tM) in PBS
buffer (blue solid line) and 10 tM aggregated AP3(1-40) in PBS buffer (red dashed line).
Table 3.9: Summary of AP(1-40) Assay Results for IBF-NIAD 22-25
Dye Xmax Abs. (nm) ,max Em. (nm) Red-shift (nm) EAp/EPBS (IAp3PBS
(R-) PBS APa PBS Apa Abs. Em.
IBF-NIAD 22 558 589 685 689 31 4 1.10 100
(glycol-)
IBF-NIAD 23 501 630 594 683 129 89 1.31 6.9
(1,2-diol-)
IBF-NIAD 24 535 633 683 686 98 3 1.39 68
(glycol-)
IBF-NIAD 25 501 634 597 680 133 83 1.39 24
(1,2-diol-)
a A3(1-40) concentration was 10 tM. b Fluorescence intensity in PBS was undetectable, thus
values are not available or are estimates.
IBF-NIAD 22-25 all experience enhanced optical properties when bound to AP(1-40). In
PBS buffer these materials showed a more defined blue shifted band consistent with H-aggregate
formation, and this aggregate is clearly disassembled by AP(1-40). Of this set, the weakest
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response comes from IBF-NIAD 22, with a red shift in absorption maximum of 31 nm, and 10%
increase in extinction coefficient. IBF-NIAD 23, 24, and 25 show similar optical response to
IBF-NIAD 12, with absorption maxima around 630 nm in the bound state and increases in
extinction coefficient of 31-39%. The absorption maxima for these dyes in PBS buffer are blue
shifted compared to IBF-NIAD 12, which contribute to their larger red shifts on binding. IBF-
NIAD 23 and 25 form weakly emissive species, presumably aggregates, with emission
maximum of 594 nm and 597 nm respectively. When the dyes are bound to AP(1-40), they
experience about an 85 nm red shift in fluorescence emission maximum, as well as increased
fluorescence intensity. IBF-NIAD 22, 23, and 25 stain SPs in aged APP/PS 1 mouse brain tissue
(Figure 3.33-3.35). The fluorescence lifetimes of these dyes have also been evaluated (Figure
3.36), and found to increase on binding to AP (Table 3.10), thus opening up the possibility of
using them as NIR FLIM contrast agents.
Figure 3.33: Image of (left) a cross section of an aged APP/PSi mouse brain incubated with
PBS buffer (unstained) and (right) with 5 tM IBF-NIAD 22. Image taken with excitation at 633
nm. Black spots are fluorescent signals indicating staining of SPs by IBF-NIAD 22. Image
obtained by Krista Neal at Massachusetts General Hospital.
136
200 pm
Figure 3.34 Image of (top left) a cross section of an aged APP/PS I mouse brain incubated with
PBS buffer (unstained), (top right) with 5 tM IBF-NIAD 23, (bottom left) a cross section of an
aged APP/PS1 mouse brain incubated with PBS buffer (unstained), (bottom right) with 5 [M
IBF-NIAD 23. Top images were taken with excitation at 543 nm, bottom images with excitation
at 620 nm. Black spots are fluorescent signals indicating staining of SPs by IBF-NIAD 23.
Images obtained by Krista Neal at Massachusetts General Hospital
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Figure 3.35 Image of (left) a cross section of an aged APP/PS 1 mouse brain tissue incubated
with PBS buffer (unstained) and (right) with 5 tM IBF-NIAD 25. Image taken with excitation at
620 nm. Black spots are fluorescent signals indicating staining of SPs by IBF-NIAD 25. Images
obtained by Krista Neal at Massachusetts General Hospital
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Figure 3.36 Fluorescence lifetime of (top left) IBF-NIAD 22, (top right) IBF-NIAD 23, (bottom
left) IBF-NIAD 24, and (bottom right) IBF-NIAD 25. Data collected by Krista Neal atMassachusetts General Hospital.
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Table 3.10 Fluorescence Lifetimes of IBF-NIAD 22-25
Dye v unbound (ps) x bound (ps)
IBF-NIAD 22 200, 1330 (biexponential) 1410 (monoexponential)
IBF-NIAD 23 190, 1240 (biexponential) 1660 (monoexponential)
IBF-NIAD 24 420, 1490 (biexponential) 1320 (monoexponential)
IBF-NIAD 25 990 (monoexponential) 1620 (monoexponential)
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3.3 Conclusions
Table 3.11 Summary of Dye-A3 Interactions
Dye max A~ (nm) Red-Shift (nm) EAp/EPBS (IAp~/I PBS Tissue t
(R-) Abs. Em. Abs. Em. Staining increase
IBF-NIAD 0 550 656 11 -9 1.07 190 No
(H-)
IBF-NIAD 1 612 690 52 a 1.06 800a  No
(MeO-)
IBF-NIAD 2 627 796 6 a 1.03 20 a  No
(Me 2N-)
IBF-NIAD 3 603 704 43 3 0.85 62 No
(HO-)
IBF-NIAD 4 601 739 15 a 0.77 30 a  Yes
(MeO-Th-)
IBF-NIAD 11 562 678 26 19 0.76 130 No
(MeO-)
IBF-NIAD 12 634 691 62 -9 1.24 21 Yes
(HO-)
IBF-NIAD 13 638 772 30 a 1.09 64a No
(Me2N-)
IBF-NIAD 14 591 653 51 -8 0.76 290 No
(H-)
IBF-NIAD 18 624 770 37 a 1.15 30a  No
(H2N-)
IBF-NIAD 19 690 759 107 -1 1.68 14 Yes
(H 2N-)
IBF-NIAD 22 589 689 31 4 1.10 100 Yes Yes
(glycol-)
IBF-NIAD 23 607 683 106 89 1.31 6.9 Yes Yes
(1,2-diol-)
IBF-NIAD 24 633 686 98 3 1.39 68 No Yes
(glycol-)
IBF-NIAD 25 634 680 133 83 1.39 24 Yes Yes
(1,2-diol-)
aFluorescence signal in PBS solution is too
estimates. b White matter staining observed.
weak to quantify, thus values are not available or are
In summary, we have synthesized a library of small, neutral donor-acceptor near-infrared
fluorophores based on the IBF-NIAD design, and have been able to tune the photophysical
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properties by modifying the conjugated backbone and the electron donating group. We have also
been able to install water solublizing groups, and a free amine functional handle for integration
into other sensory applications and bioconjugation. The dyes all experience changes in their
optical properties on binding to aggregated AP3(1-40) (Table 3.11), with red shifted absorption
and increases in fluorescence quantum yield as is consistent with rigidification of the dye's
conjugated backbone. The strongest optical contrast was, in general observed for the less
hydrophobic dyes, indicating that a significant barrier to dye-protein interaction may be dye
aggregation in aqueous media. Changes in fluorescence lifetime were also observed for IBF-
NIAD 22-25. Six of our fluorophores, IBF-NIAD 4, 12, 19, 22, 23, and 25, stain senile plaques
in APP/PSI mouse tissue, and, in general, these are the dyes that exhibit the largest optical
contrast in the aggregated AP3(1-40) assay. Currently, the blood brain barrier permeability of
these compounds is being studied by the Bacskai Group at Massachusetts General Hospital, in
hope of developing new diagnostic methods for Alzheimer's disease.
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3.4 Experimental Section
Materials. Commercial reagents were purchased from Sigma Aldrich, Alfa Aesar, or GFS
Chemicals, and used as received. Dry solvents were obtained using a solvent purification system
(Innovative Technologies, Inc.), and handled under an argon atmosphere, unless otherwise noted.
Flash chromatography was performed using SiliaFlash F60 (230-400 mesh) from Silicycle.
Instrumentation. Melting points were determined in open capillaries using a Mel-Temp II
apparatus and are uncorrected. Proton nuclear magnetic resonance (1H NMR) spectra and carbon
nuclear magnetic resonance (13C NMR) spectra were recorded on a Varian Mercury-300 (300
MHz) or an Inova-500 (500 MHz) NMR spectrometer. Chemical shifts for protons are reported
in parts per million downfield from tetramethylsilane and are referenced to residual protium in
the NMR solvent (CHC13: 6 7.27, DMSO-d 6: 6 2.50). Chemical shifts for carbon are reported in
parts per million downfield from tetramethylsilane and are referenced to the carbon resonances
of the solvent (CDC13: 6 77.0, DMSO-d 6 6 39.23). Data are represented as follows: chemical
shift, integration, multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, quin =
quintet, sex = sextet, sp = septet, m = multiplet), and coupling constants in Hertz (Hz). High-
resolution mass spectra (HRMS) were obtained at the MIT Department of Chemistry
Instrumentation Facility using a peak-matching protocol to determine the mass and error range of
the molecular ion, employing either electron impact or electrospray as the ionization technique.
Fluorescence spectra were measured on a SPEX Fluorolog-3 fluorimeter (model FL-321, 450 W
Xenon lamp) using right-angle detection. Ultraviolet-visible absorption spectra were measured
with an Agilent 8453 diode array spectrophotometer and corrected for background signal with a
solvent-filled cuvette. Fluorescence quantum yields were determined by the optically dilute
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method using cresyl violet perchlorate in methanol (D=0.54) or zinc phthalocyanine in 1%
pyridine in toluene (D=0.30) as standards and were corrected for solvent refractive index and
absorption differences at the excitation wavelength.
Procedure for Aggregation of AP(1-40)
AP3(1-40) (1 mg) was purchased from BaChem as a trifluoroacetic acid salt. 2 mM NaOH
(500 ld) were added directly to the vial, which was then vortexed for 10 seconds. The solution
was then transferred to a 7 ml screw top glass vial equipped with a stirbar. The original vial was
then washed with 2 mM NaOH (5x100 1) and the washings were added to the glass vial. 100
mM NaOH (10 pl) was then added to the glass vial, and the mixture was sonicated for 1 minute.
Water (140 tl) was then added, followed by 2x PBS buffer solution (1.15 ml), and the solution
was stirred at 1100 rpm for 3 days. After approximately 6 hours, the solution became noticeably
cloudy. The solution was vortexed twice a day to break up fibrils forming at the meniscus. The
solution (100 [tM) was either used immediately, or aliquoted into sample vials and stored at -35
C. Aggregation was confirmed by Thioflavin T assay.
Procedure for in vitro AP(1-40) tests
A solution of aggregated AP(1-40) (1.5 ml, 10 tM) was pipetted into a 0.5 cm cuvette. A
solution of dye in DMSO (-0.7 mg in 5 ml) was added to make the final dye concentration 2.50
rtM. The cuvette was vortexed for 10 seconds, and then allowed to equilibrate for 10 minutes at
room temperature before acquisition of UV-vis or fluorescence spectra.
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Synthetic Procedures
O 1. NaHCO 3
- OMe 2 | O
MeO S C2H 2. NaBH 4
O 3. HCI
2.
1 3. HCI 2 3
MeO
To an ice cooled, stirred suspension of phthalic anhydride 1 (3.52 g, 0.0238 mol) in dry
DCM (30 ml) was added aluminum trichloride (5.22 g, 0.0391 mol) in portions. To the resulting
mixture was added a solution of 2-methoxythiophene (2.27 g, 0.0198 mol) in dry DCM (8 ml)
dropwise. The reaction mixture was then allowed to warm to room temperature and was stirred
overnight. The reaction mixture was then poured into ice and concentrated HCl and stirred until
the mixture reached room temperature, at which point the precipitate was removed by filtration.
The precipitate was taken up in 5% NaOH and washed with DCM. The basic solution was then
acidified and extracted with EtOAc. The organic layer was dried with MgSO 4 and concentrated.
The resulting solid was triturated with 1:1 hexane:DCM and collected by suction filtration to
yield 2 (2.3 g, 8.8 mmol, 44% yield) as a crude product. Acid 2 was then dissolved in water (200
ml) with NaHCO 3 (1.37 g, 16.3 mmol), and the solution was heated to 60 oC. Sodium
Borohydride (4.8 g, 0.13 mol) was then added in portions over 2 hours, and the solution was then
stirred for 24h at 60 oC, and 100 oC for 1h. The solution was cooled to r.t. and acidified to pH 2
and stirred overnight. The solution was extracted with EtOAc, and the organic layer was washed
with brine, dried over MgSO 4, and concentrated. Flash chromatography (silica gel, DCM)
yielded 3 (0.25 g, 10 mmol, 12% yield) as an off-white solid.
'H NMR (500 MHz, CDC13): 7.94 (1H, d, 7.8 Hz), 7.71 (1H, t, 7.5 Hz), 7.59 (1H, t, 7.6 Hz), 7.47
(1H, d, 7.6 Hz), 6.82 (1H, d, 4.0 Hz), 6.51 (1H, s), 6.09 (1H, d, 4.0 Hz), 3.85 (3H, s) 13C NMR
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(125 MHz, CDC13): 169.7, 168.4, 148.2, 134.2, 129.7, 126.9, 126.1, 125.5, 124.2, 123.2, 103.3,
79.0, 60.2 HRMS (ESI): 247.0430 [calc'd for M+H+: 247.0423]
1. nBuLi , 1 O / \ H
Br u MeO s S H
-780 C, THF O
41 S OMe
/\ 3 4
2. Ac20
3. 90% AcOH
Bromo-thiophene 41 (0.13 g, 0.55 mmol) was dissolved in dry THF (2 ml) and cooled to -78 oC.
To this solution was added n-BuLi (0.35 ml 1.6 M solution, 0.56 mmol) dropwise and the
solution was stirred at -78 oC for 1.5h. A solution of phthalide 3 (0.12 g, 0.49 mmol) in dry THF
(2 ml) was then added dropwise, and the solution was stirred for an additional 45 min at -78 C,
after which Ac2 0 (0.06 ml, 0.63 mmol) was added. The reaction mixture was allowed to warm to
room temperature, and was then refluxed for 10 min. The solution was then poured into saturated
aqueous NaHCO 3, and extracted with EtOAc. The organic layer was washed with brine, dried
over MgSO 4, and concentrated. The resulting orange viscous product was stirred with AcOH (5
ml of 90% solution in water) for 4 hours at room temperature under argon atmosphere. A small
portion of saturated aqueous NaHCO 3 was added, and the resulting solution was extracted with
EtOAc. The combined organic layers were washed with water and saturated aqueous NaHCO 3
and concentrated in vacuo. The residue was purified by column chromatography (silica gel,
DCM) and recrystalization from MeOH to afford aldehyde 4 (0.013 g, 0.038 mmol, 7% yield)
as a red solid.
1H NMR (500 MHz, CDC13): 9.87 (1H, s), 7.71-7.64 (3H, m), 7.43 (1H, d, 4.1 Hz), 7.22 (1H, d,
4.1 Hz), 7.15 (1H, dd, 8.5 Hz, 6.7 Hz), 7.04 (1H, dd, 8.9 Hz, 6.7 Hz), 6.29 (1H, d, 4.1 Hz), 3.99
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(3H, s) 13C NMR (125 MHz, CDC13): 182.1, 167.7, 143.0, 142.2, 139.7, 137.53, 137.50, 127.5,
125.2, 124.5, 122.5, 121.3, 120.8, 120.5, 119.2, 119.4, 105.1, 60.5 HRMS (ESI): 389.0424
[calc'd for M+H+: 389.0413]
NC CN0\ o 11 H O s
MeO S NEt3, DCM MeO S N
NC
4 IBF-NIAD 4
Aldehyde 4 (0.013 g, 0.038 mmol) was dissolved in DCM (1.5 ml) with malonitrile (0.003 g,
0.045 mmol). Triethylamine (1 drop) was then added, and the solution was stirred for 30 min at
r.t. The solution was then purified by flash chromatography (silica gel, DCM) to afford IBF-
NIAD 4 (0.013 g, 0.037 mmol, 97%) as a blue solid.
1H NMR (500 MHz, CDC13): 7.72 (1H, d, 8.9 Hz), 7.67 (1H, d, 8.9 Hz), 7.63 (1H, s), 7.56 (1H,
d, 4.3 Hz), 7.38 (1H, d, 4.3 Hz), 7.32 (1H, d, 4.3 Hz), 7.25 (1H, dd, 8.7 Hz, 6.6 Hz), 7.12 (1H,
dd, 8.9 Hz, 6.6 Hz), 6.33 (1H, d, 4.3 Hz) 13C NMR (125 MHz, CDC13): 168.9, 148.6, 145.2,
143.9, 140.4, 137.3, 131.8, 128.9, 126.2, 125.8, 124.2, 121.5, 121.4, 120.9, 119.5, 118.5, 115.3,
114.5, 105.5, 71.8, 60.6 HRMS (ESI): 389.0424 [calc'd for M+H+: 389.0413] UV-Vis Xmax: 607
nm (MeOH, e= 18100), 631 nm (CHCl 3, e= 46500)
0 Ho OH 0-Br___ aiA H Benzene, \
5 Cat. pTsOH 6A, Dean-Stark
Bromo-furan 5 (3.0 g, 17 mol), p-toluenesulfonic acid (0.06 g, 0.3 mmol), and ethylene glycol
(3.2 ml, 57 mmol) were mixed together in benzene (100 ml) and refluxed overnight with a Dean-
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Stark trap. The reaction mixture was then cooled to room temperature, concentrated in vacuo,
taken up in ethyl acetate and washed with saturated sodium bicarbonate and brine. The organic
layer was dried over magnesium sulfate and concentrated in vacuo. The residue was purified
with vacuum distillation (40-45 oC, 100 mtorr) to afford 6 as a clear liquid (1.9 g, 8.8 mmol, 52%
yield), which was stored at -35 oC in a nitrogen atmosphere glovebox.
1H NMR (500 MHz, CDC13): 6.42 (1H, d, 3.3 Hz), 6.28 (1H, d, 3.3 Hz), 5.87 (1H, s), 4.18-3.96
(4H, m) '3C NMR (125 MHz, CDC13): 152.9, 122.9, 111.8, 111.3, 97.2, 65.1 HRMS (ESI):
218.9660 [calc'd for M+H+: 218.9651]
o7. 7a o I \ H
Br X Z
n-BuLi, THF, -78C 
2. Ac20, A
6 3. 90% AcOH, r.t. 8a
Bromo-furan 6 (0.40 g, 1.8 mmol) was dissolved in dry THF (8ml) and cooled to -78 OC. To this
solution was added n-BuLi (1.20 ml 1.6 M solution, 1.9 mmol) dropwise and the solution was
stirred at -78 OC for 1.5h. A solution of phthalide 7a (0.35 g, 1.7 mmol) in dry THF (8 ml) was
then added dropwise, and the solution was stirred for an additional 45 min at -78 oC, after which
Ac2 0 (0.20 ml, 2.1 mmol) was added. The reaction mixture was allowed to warm to room
temperature, and was then refluxed for 10 min. The solution was then poured into saturated
aqueous NaHCO 3, and extracted with EtOAc. The organic layer was washed with brine, dried
over MgSO 4, and concentrated. The resulting orange viscous product was stirred with AcOH (15
ml of 90% solution in water) for 4 hours at room temperature under argon atmosphere. The
resulting red solution was poured into water and stirred. A small portion of saturated aqueous
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NaHCO 3 was added, and the resulting solution was extracted with EtOAc. The combined organic
layers were washed with water and saturated aqueous NaHCO 3 and concentrated in vacuo. The
residue was purified by column chromatography (silica gel, 2:1 hexane:EtOAc) to afford
aldehyde 8a as red solid (0.20 g, 0.69 mmol, 38% yield)
'H NMR (500 MHz, CDC13): 8.02 (1H, d, 8.7 Hz), 7.93 (1H, d, 7.3 Hz), 7.84 (1H, d, 8.9 Hz),
7.50 (2H, t, 7.8 Hz), 7.38-7.33 (2H, m), 7.16 (1H, dd, 8.7 Hz, 6.4 Hz), 7.10 (1H, dd, 9.6 Hz, 7.2
Hz), 6.89 (1H, d, 4.0 Hz) 13C NMR (125 MHz, CDC13): 176.1, 152.5, 151.5, 146.9, 135.3, 130.7,
129.0, 128.4, 128.0, 127.1, 126.3, 125.3, 125.1, 121.8, 120.3, 120.0, 107.2 HRMS (ESI):
289.0871 [calc'd for M+H+: 289.0859]
MeO /
1 7b MeO 0 IO
Br 0 0 
0
n-BuLi, THF, -78 
OC
2. Ac 20, A
6 3. 90% AcOH, r.t. 8b
Bromo-furan 6 (0.30 g, 1.4 mmol) was dissolved in dry THF (5 ml) and cooled to -78 oC. To this
solution was added n-BuLi (0.89 ml 1.6 M solution, 1.4 mmol) dropwise and the solution was
stirred at -78 oC for 1.5h. A solution of phthalide 7b (0.30 g, 1.3 mmol) in dry THF (5 ml) was
then added dropwise, and the solution was stirred for an additional 45 min at -78 OC, after which
Ac20 (0.18 ml, 1.9 mmol) was added. The reaction mixture was allowed to warm to room
temperature, and was then refluxed for 10 min. The solution was then poured into saturated
aqueous NaHCO3, and extracted with EtOAc. The organic layer was washed with brine, dried
over MgSO 4, and concentrated. The resulting orange viscous product was stirred with AcOH (15
ml of 90% solution in water) for 4 hours at room temperature under argon atmosphere. The
148
resulting red solution was poured into water and stirred. A small portion of saturated aqueous
NaHCO3 was added, and the resulting red precipitate was filtered, washed with water and
saturated aqueous NaHCO 3. Recrystalization from MeOH afforded aldehyde 8b (0.13 g, 0.324
mmol, 25% yield) as a red powder.
1H NMR (500 MHz, CDC13): 9.62 (1H, s), 7.96 (1H, d, 8.7 Hz), 7.85 (2H, dm, 8.7 Hz), 7.76 (1H,
d, 8.8 Hz), 7.34 (1H, d, 3.9 Hz), 7.13 (1H, dd, 8.9 Hz, 6.4 Hz), 7.06-7.00 (3H, m), 6.82 (1H, d,
3.8 Hz), 3.88 (3H, s) 13C NMR (125 MHz, CDC13): 175.9, 159.6, 152.7, 151.4, 147.3, 134.5,
127.1, 126.9, 125.7, 125.2, 124.2, 123.6, 120.8, 120.4, 120.1, 114.6, 106.6, 55.4 HRMS (ESI):
319.0974 [calc'd for M+H+: 319.0965]
TIPSO /
. 7d - TIPSO / 0
Br 0 / \ 0
n-BuLi, THF, -78C OC
2. Ac20, A
6 3. 90% AcOH, r.t. 8d
Bromo-furan 6 (0.18 g, 0.81 mmol) was dissolved in dry THF (3ml) and cooled to -78 OC. To
this solution was added n-BuLi (0.53 ml 1.6 M THF solution, 0.84 mmol) dropwise and the
solution was stirred at -78 oC for 1.5h. A solution of phthalide 7d (0.30 g, 0.79 mmol) in dry
THF (3 ml) was then added dropwise, and the solution was stirred for an additional 45 min at -78
0C, after which Ac2 0 (0.11 ml, 1.2 mmol) was added. The reaction mixture was allowed to warm
to room temperature, and was then refluxed for 10 min. The solution was then poured into
saturated aqueous NaHCO3, and extracted with EtOAc. The organic layer was washed with
brine, dried over MgSO 4, and concentrated. The resulting orange viscous product was dissolved
in THF (6 ml) and cooled in an ice bath. HC10 4 (2.4 ml, 3N aqueous solution) was added
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dropwise, and the solution was warmed to r.t. and stirred for 3 hours. The resulting red solution
was poured into water and extracted with EtOAc. The combined organic layers were washed
with water and saturated aqueous NaHCO 3 and concentrated in vacuo. The residue was purified
by column chromatography (silica gel: DCM) to afford aldehyde 8d as red amorphous solid
(0.091 g, 0.20 mmol, 24% yield)
'H NMR (500 MHz, CDC13): 9.62 (1H, s), 7.97 (1H, d, ), 7.84-7.76 (3H, m), 7.35 (1H, d,), 7.13
(1H, dd,,), 7.07-7.00 (3H, m), 6.82 (1H, d,), 1.32 (3H, sept,), 1.15 (18H, d,) 13C NMR (125 MHz,
CDC13): 175.9, 156.4, 152.7, 151.3, 147.4, 134.4, 127.1, 126.8, 125.7, 125.2, 123.9, 120.8,
120.6, 120.2, 120.1, 106.6, 17.8, 12.6 (1 missing) HRMS (ESI): 461.2158 [calc'd for M+H+:
461.2143]
/N /~ o
Br 1. 7c \ ,0 I H
n-BuLi, THF, -78 OC
2. Ac 20, A /
6 3. 90% AcOH, r.t. 8c
Bromo-furan 6 (0.30 g, 1.4 mmol) was dissolved in dry THF (8ml) and cooled to -78 oC. To this
solution was added n-BuLi (1.14 ml 1.6 M solution, 1.82 mmol) dropwise and the solution was
stirred at -78 OC for 1.5h. This solution was then added dropwise to a stirred solution of phthalide
7c (0.32 g, 1.3 mmol) in dry THF (25 ml) cooled to -78 oC, and the resulting mixture was stirred
for an additional 45 min at -78 C, after which Ac2 0 (0.15 ml, 1.6 mmol) was added. The
reaction mixture was allowed to warm to room temperature, and was then refluxed for 10 min.
The solution was then poured into saturated aqueous NaHCO 3, and extracted with EtOAc. The
organic layer was washed with brine, dried over MgSO4, and concentrated. The resulting orange
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viscous product was stirred with AcOH (15 ml of 90% solution in water) for 4 hours at room
temperature under argon atmosphere. The resulting red solution was poured into water and
stirred. A small portion of saturated aqueous NaHCO 3 was added, and the resulting solution was
extracted with EtOAc. The combined organic layers were washed with water and saturated
aqueous NaHCO 3 and concentrated in vacuo. The residue was purified by column
chromatography (silica gel, DCM) to afford aldehyde 8c as dark purple solid (0.11 g, 0.33 mmol,
25% yield)
1H NMR (500 MHz, CDC13): 9.6 (1H, s), 7.98 (1H, d, 8.9 Hz), 7.84-7.80 (3H, m), 7.36 (1H, d,
4.0 Hz), 7.14 (1H, dd, 8.7 Hz, 6.3 Hz), 7.03 (1H, dd, 8.9 Hz, 6.4 Hz), 6.82-6.79 (3H, m), 3.06
(6H, s) 13C NMR (125 MHz, CDC13): 175.7, 153.2, 151.0, 150.1, 148.8, 133.6, 127.2, 126.7,
125.6, 124.9, 123.4, 120.7, 120.1, 120.0, 118.9, 112.3, 106.0, 40.2 HRMS (ESI): 332.1291
[calc'd for M+H+: 332.1281]
MeO / MeO /\ I H NCICN O
0 cat. NEt3  CN
\ / CH2CI2, rt /
8b IBF-NIAD 11
Aldehyde 8b (0.050 g, 0.16 mmol) was dissolved in DCM (7 ml) with malonitrile (0.011 g, 0.17
mmol). Triethylamine (1 drops) was then added, and the solution was stirred for lh at r.t.
Hexane (5 ml) was added, and the solution was filtered to yield IBF-NIAD 11 (0.047 g, 0.13
mmol, 81% yield) as a fluffy blue solid.
'H NMR (500 MHz, CDC13): 8.37 (1H, bs), 7.93 (2H, d, 8.9 Hz), 7.85 (1H, d, 8.9 Hz), 7.34-7.20
(3H, m), 7.15 (1H, dd, 8.9 Hz, 6.6 Hz), 7.07 (2H, d, 8.9 Hz), 6.99 (1H, d, 4.0 Hz), 3.91 (3H, s)
'
3C NMR (125 MHz, CDC13): 160.2, 151.9, 149.7, 148.7, 147.3, 138.5, 134.3, 128.5, 127.3,
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127.2, 126.4, 123.2, 121.6, 120.8, 120.5, 115.6, 114.8, 114.6, 109.4, 70.9, 55.5 HRMS (ESI):
367.1086 [calc'd for M+H+: 367.1077]. UV-Vis ,max: 572 nm (MeOH, E= 36700), 590 nm
(CHC13, E= 46700)
TIPSO, TIPSO 
0 I\ H NC CN
O cat. NEt 3  CN
\ / CH 2 012 , rt /
8d 9d
Aldehyde 8d (0.090 g, 0.20 mmol) was dissolved in DCM (10 ml) with malonitrile (0.014 g,
0.22 mmol). Triethylamine (3 drops) was then added, and the solution was stirred for lh at r.t.
The solution was concentrated to 5 ml and was purified via flash chromatography (silica gel,
DCM) to afford 9d (0.089 g, 0.18 mmol, 87% yield) as a fluffy blue solid.
1H NMR (500 MHz, CDC13): 8.32 (1H, bs), 7.88-7.80 (3H, m), 7.26-7.08 (4H, m), 7.02 (2H, d,
9.0 Hz), 6.92 (1H, 4.0 Hz), 1.32 (3H, sept, 7.3 Hz), 1.15 (18H, d, 7.3 Hz) '3C NMR (125 MHz,
CDC13): 157.1, 154.4 (bs), 149.8, 138.2 (bs), 134.2, 128.4, 127.2, 127.1, 126.3, 123.4, 121.5,
120.7, 120.5, 115.6, 114.6, 109.3, 70.6, 17.9, 12.7 (2 missing) HRMS (ESI): 509.2243 [calc'd for
M+H+: 509.2255]
TIPSO\ / HO
HCI, EtOH H O
\I o\ CN C\ o NNC 600 C NCC
9d IBF-NIAD 12
Protected fluorophore 9d (0.048 g, 0.094 mmol) was dissolved in 56 ml of EtOH and the
solution was heated to 60 oC. Concentrated HCl (4.6 ml, 36%) was added dropwise and the
solution was stirred at 60 oC for 24h under argon atmosphere. The resulting mixture was poured
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into water and extracted with EtOAc. The combined organic layers were washed with saturated
aqueous NaHCO 3 and brine, dried over MgSO 4, and concentrated in vacuo. The resulting residue
was purified via flash chromatography (silica gel, 5% MeOH in DCM) and recrystalization from
CHC13 to afford IBF-NIAD 12 (6.5 mg, 0.018 mmol, 19% yield).
'H NMR (500 MHz, DMSO-d6): 10.13 (1H, s), 8.25 (1H, d, 8.9 Hz), 8.15-8.00 (2H, m), 7.95
(2H, d, 8.7 Hz), 7.57 (1H, d, 4.0 Hz), 7.32 (1H, d, 4.1 Hz), 7.22 (1H, dd, 8.7 Hz, 6.4 Hz), 7.16
(1H, dd, 8.7 Hz, 6.6 Hz), 6.95 (2H, d, 8.0 Hz) 13C NMR (125 MHz, DMSO-d 6): 160.7, 158.7,
157.1, 149.5, 147.5, 137.7, 133.3, 128.3, 127.4, 126.3, 126.2, 121.1, 120.9, 120.4, 120.1, 119.9,
116.4, 115.153, 110.2, 68.6 HRMS (ESI): 351.0779 [calc'd for M-H-: 351.0775]. UV-Vis max:
579 nm (MeOH, E= 37500), 588 nm (CHC13, E= 41800)
N H NC CN
0 cat. NEt3  CN
\ / CH 2 CI2 , rt
8c IBF-NIAD 13
Aldehyde 8c (0.016 g, 0.048 mmol) was dissolved in DCM (3 ml) with malonitrile (4.6 mg,
0.072 mmol). Triethylamine (1 drops) was then added, and the solution was stirred for lh at r.t.
The mixture was then purified via flash chromatography (silica gel, DCM) to afford IBF-NIAD
13 (0.014 g, 0.037 mmol, 77% yield) as a green solid.
1H NMR (500 MHz, DMF-d 7): 8.43 (1H, d, 8.5 Hz), 8.16 (1H, d, 8.5 Hz), 8.07 (2H, d, 9.0 Hz),
7.70 (1H, d, 3.8 Hz), 7.41 (1H, d, 4.0 Hz), 7.32 (1H, dd, 8.9 Hz, 6.4 Hz), 7.23 (1H, dd, 9.0 Hz,
6.3 Hz), 6.95 (2H, d, 9.0 Hz) 13C NMR (125 MHz, CDC13): 150.6, 147.1, 144.0, 134.3, 133.2,
130.0, 128.7, 128.4, 127.2, 125.7, 124.3, 121.1, 120.7, 118.2, 115.0, 112.3, 107.3, 104.6, 99.8
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40.2 (1 missing) HRMS (ESI): 380.1391 [calc'd for M-H-: 380.1394]. UV-Vis Xmax: 618 nm
(MeOH, E= 12700), 620 nm (CHC13, e= 40100)
SI\ H NC CN /
O cat. NEt 3  CN
\ / CH 2 CI2 , rt
8a IBF-NIAD 14
Aldehyde 8a (0.050 g, 0.17 mmol) was dissolved in DCM (10 ml) with malonitrile (0.012 g, 0.19
mmol). Triethylamine (3 drops) was then added, and the solution was stirred for lh at r.t. The
mixture was then concentrated to 5 ml in vacuo and purified via flash chromatography (silica gel,
DCM) to afford IBF-NIAD 14 (0.047 g, 0.14 mmol, 82% yield) as a purple solid.
'H NMR (500 MHz, CDC13): 8.38 (1H, bs), 7.97 (2H, d, 7.2 Hz), 7.89 (1H, d, 8.9 Hz), 7.53 (2H,
t, 7.3 Hz), 7.41 (2H, t, 7.3 Hz), 7.32-7.22 (2H, m), 7.17 (1H, dd, 8.9 Hz, 6.4 Hz), 7.02 (1H, d, 4.0
Hz) 13C NMR (125 MHz, CDC13): 147.5, 137.9, 135.0, 133.5, 131.4, 130.3, 130.1, 129.2, 128.8,
128.6, 128.3, 126.9, 125.6, 122.4, 120.9, 120.3, 115.3, 114.3, 109.8, 71.8 HRMS (ESI):
337.0984 [calc'd for M+H+: 337.0972]. UV-Vis Xmax: 551 nm (MeOH, e= 26100), 571 nm
(CHC13 , e= 40500)
NH2 BnCI, KI NBn2
NaOAc
10 11
Aniline 10 (10 ml, 0.11 mol), benzylchloride (25 ml, 0.22 mol), sodium acetate (17.5 g, 0.21
mol) and potassium iodide (0.10 g, 0.60 mmol) were mixed together and the reaction mixture
was heated at 100 oC with stirring overnight. The reaction mixture was allowed to cool to room
temperature then poured into ice water (100 ml) and concentrated ammonium hydroxide (20 ml).
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An oily product came out of solution that solidified upon sitting. The solid was collected by
suction filtration and washed with water. The solid was crushed and slurried in MeOH. A small
amount of ammonium hydroxide was added and then the solution was filtered. The resulting
solid was washed with methanol, water, and again with methanol. The solid was again slurried in
MeOH with a few drops of ammonium hydroxide. After filtration and washing with MeOH and
water, the solid was allowed to dry on the filter overnight to afford aniline 11 (20.5 g, .073 mol,
66%). (Adopted from literature procedure) 50
1H NMR (500 MHz, CDC13): 7.32-7.20 (9H, m), 7.15 (2H, t, 7.3 Hz), 6.78-6.67 (3H, m), 4.63
(4H, s) 13C NMR (125 MHz, CDC13): 149.1, 138.5, 129.2, 128.6, 126.8, 126.6, 116.7, 112.4,
54.1 HRMS (ESI): 274.1592 [calc'd for M+H+: 274.1590]
1cO0 2 H
NBn2 1 C HO
12 CH
Cat. HCIO 4
11 13
NBn 2
Aniline 11 (2.0 g, 7.1 mmol) and 2-carboxybenzaldehyde 12 (1.1 g, 7.3 mmol) were melted
together at 100 oC. HC10 4 (10 drops, 70%) was added, and the reaction mixture was stirred for
12h at 100 oC. The mixture was then cooled to r.t. The resulting blue solid was purified by flash
chromatography (silica gel, DCM) to afford phthalide 13 (0.78 g, 1.9 mmol, 27% yield) as an off
white foam.
'H NMR (500 MHz, CDC13): 7.95 (1H, d, 7.6 Hz), 7.65 (1H, t, 7.5 Hz), 7.54 (1H, t, 7.5 Hz), 7.34
(4H, t, 7.3 Hz), 7.29-7.22 (6H, m), 7.03 (2H, d, 8.9 Hz), 6.70 (2H, d, 8.9 Hz), 6.34 (1H, s), 4.67
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(4H, s) 13C NMR (125 MHz, CDC13): 137.9, 134.0, 129.1, 128.9, 128.7, 127.0, 126.5, 126.3,
125.4, 123.5, 123.1, 112.3, 83.3, 54.2 HRMS (ESI): 428.1628 [calc'd for M+Na+: 428.1621]
O Br0 Bn2N / '- H
1. nBuLi ' \ S
-780 C, THF \ /
2. Ac 20
13 - 3. 90% AcOH 15
NBn 2
Bromo-thiophene 41 (0.40 g, 1.7 mmol) was dissolved in dry THF (8 ml) and cooled to -78 C.
To this solution was added n-BuLi (0.35 ml 1.6 M solution, 0.56 mmol) dropwise and the
solution was stirred at -78 OC for 1.5h. A solution of phthalide 13 (0.74 g, 1.8 mmol) in dry THF
(8 ml) was then added dropwise, and the solution was stirred for an additional 45 min at -78 oC,
after which Ac20 (0.20 ml, 2.1 mmol) was added. The reaction mixture was allowed to warm to
room temperature, and was then refluxed for 10 min. The solution was then poured into saturated
aqueous NaHCO3, and extracted with EtOAc. The organic layer was washed with brine, dried
over MgSO 4, and concentrated. The resulting orange viscous product was stirred with AcOH (20
ml of 90% solution in water) for 4 hours at room temperature under argon atmosphere. A small
portion of saturated aqueous NaHCO 3 was added, and the resulting precipitate was collected with
suction filtration and washed with water. The residue was purified by flash chromatography
(silica gel, DCM) to afford aldehyde 4 (0.34 g, 0.68 mmol, 40% yield) as a purple solid.
'H NMR (500 MHz, CDC13): 9.85 (1H, s), 7.80-7.74 (3H, m), 7.72-7.66 (2H, m), 7.42-7.20
(11H, m), 7.13 (1H, dd, 8.9 Hz, 6.6 Hz), 6.99 (1H, dd, 8.9 Hz, 6.6 Hz), 6.86 (2H, d, 8.7 Hz) 13C
NMR (125 MHz, CDC13): 182.0, 148.9, 147.9, 142.9, 139.2, 137.8, 137.6, 137.3, 128.8, 127.20,
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127.15, 126.9, 126.5, 124.9, 124.7, 121.1, 120.8, 120.7, 119.33, 119.32, 112.7, 54.2 HRMS
(ESI): 500.1695 [calc'd for M+Na+: 500.1679]
Bn2 N/ / \ HNC"C N Bn2N / 0
0 DCM, NEt 3  CNNC
15 16
Aldehyde 15 (0.060 g, 0.12 mmol) was dissolved in DCM (2 ml) with malonitrile (8.0 mg, 0.13
mmol). Triethylamine (1 drops) was then added, and the solution was stirred for lh at r.t. The
mixture was then purified via flash chromatography (silica gel, DCM) to afford 16 (0.028 g,
0.051 mmol, 43% yield) as a green solid.
'H NMR (500 MHz, CDC13): 7.85-7.78 (3H, m), 7.67 (1H, d, 8.7 Hz), 5.57 (1H, s), 7.51 (1H, d,
4.1 Hz), 7.41-7.28 (11H, m), 7.22 (1H, dd, 8.7 Hz, 6.6 Hz), 7.07 (1H, dd 8.9 Hz, 6.6 Hz), 6.87
(2H, d, 9.0 Hz), 4.78 (4H, s) 13C NMR (125 MHz, CDC13): 150.4, 149.6 148.4, 144.6, 137.6,
137.1, 131.3, 128.9, 128.6, 127.4, 127.3, 126.8, 126.5, 125.4, 121.7, 121.5, 120.9, 119.5, 118.6,
115.6, 114.7, 112.8, 70.9, 54.3 HRMS (ESI): 548.1795 [calc'd for M+H+: 548.1791]
0 - 0 0
HNO 3  SnCI2
H2 SO4  H20, EtOAc
NO2  NH2
7a 17 18
Phalide 7a (6.4 g, 0.030 mol) was dissolved in concentrated H2SO 4 (4.3 ml) and the solution was
cooled in an ice bath. Concentrated HNO 3 (3.1 ml) was added carefully, drop by drop, and the
reaction mixture was stirred at 70 oC for lh. The reaction mixture was then poured into ice and
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the resulting solid was collected by filtration. This solid was then stirred in saturated aqueous
NaHCO 3, filtered, washed with water, and dried. Fractional recrystallization from benzene
afforded nitro-phthalide 17 (1.8 g, 0.0071 mol, 24% yield) as a crude product. This product was
dissolved in EtOAc (30 ml) and SnCl2 (6.39 g, 0.034 mol) and water (9 ml) were added and the
reaction mixture was stirred at r.t. overnight. The solution was then filtered, and the filtrate was
washed with water and brine, dried over MgSO 4, and concentrated in vacuo to afford phthalide
18 (1.3 g, 0.0058 mol, 82% yield, 34% over 2 steps).
'H NMR (500 MHz, CDC13): 7.94 (1H, d, 7.8 Hz), 7.65 (1H, t, 7.5 Hz), 7.54 (1H, t, 7.5 Hz), 7.31
(1H, d, 7.6 Hz), 7.00 (2H, d, 8.5 Hz), 6.64 (2H, d, 8.4 Hz), 6.32 (1H, s), 3.83 (2H, bs) 13C NMR
(125 MHz, CDC13): 170.7, 149.8, 147.6, 134.1, 129.1, 128.8, 126.0, 125.4, 125.3, 123.0, 115.0,
83.2 HRMS (ESI): 226.0868 [calc'd for M+H+: 226.0863]
0 0
1. HCI
-- INH
Ph Ph
Ph
NH2  N P h
18 19 Ph
Phthalide 18 (0.90 g, 4.0 mmol) was dissolved in DCM (5 ml), and a solution of HCI (4.5 ml, 1.0
M solution in Et20) was added dropwise with stirring. Hexane was then added, and the resulting
precipitate was collected by suction filtration and washed with hexane. The filtrate was allowed
to dry for 30 minutes on the filter, and was then suspended in DCM (9 ml). Benzophenone imine
(0.72 ml, 4.3 mmol) was added dropwise, and the reaction mixture was stirred for 4 hours at r.t.
The reaction mixture was then poured into water, and extracted with EtOAc. The combined
organic layers were washed with saturated aqueous NaHCO 3 and brine, dried over MgSO 4, and
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concentrated in vacuo. The residue was purified by recrystalization from MeOH to afford
phthalide 19 as an off-white powder (0.61 g, 1.7 mmol, 43 % yield)
'H NMR (500 MHz, CDC13): 7.90 (1H, d, 7.6 Hz), 7.72-7.68 (2H, m), 7.61 (1H, t, 7.5 Hz), 7.51
(1H, t, 7.6 Hz), 7.45 (1H, t, 7.3 Hz), 7.37 (2H, t, 7.6 Hz), 7.30-7.20 (4H, m), 7.08-7.04 (2H, m),
7.00 (2H, d, 8.2 Hz), 6.69 (2H, d, 8.5 Hz), 6.27 (1H, s) 13C NMR (125 MHz, CDC13): 170.5,
168.8, 152.3, 149.7, 139.3, 135.7, 134.2, 130.9, 130.6, 129.4, 129.3, 129.2, 128.8, 128.2, 128.0,
127.7, 125.7, 125.5, 122.9, 121.3, 82.7 HRMS (ESI): 390.1485 [calc'd for M+H+: 390.1489]
Ph
1. nBuLi, THF, -78 0C Ph
Br 0S Ph N / p h
N CN
\ 19 20a
2. Ac 20
3. SiO 2, Cat. H20
4. NC CN
DCM, NEt 3
Bromo-thiophene 41 (0.29 g, 1.2 mmol) was dissolved in dry THF (5 ml) and cooled to -78 C.
To this solution was added n-BuLi (0.80 ml 1.6 M solution, 1.3 mmol) dropwise and the solution
was stirred at -78 oC for 1.5h. A solution of phthalide 19 (0.50 g, 1.4 mmol) in dry THF (8 ml)
was then added dropwise, and the solution was stirred for an additional 45 min at -78 oC, after
which Ac20 (0.16 ml, 1.7 mmol) was added. The reaction mixture was allowed to warm to room
temperature, and was then refluxed for 10 min. The solution was then poured into saturated
aqueous NaHCO 3, and extracted with EtOAc. The organic layer was washed with brine, dried
over MgSO 4, and concentrated. The resulting orange viscous product was passed through a silica
gel column (DCM), and the resulting orange product was dissolved in DCM, to which was added
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silica gel (10 g) and water (0.5 ml), and this suspension was stirred, under argon, overnight. The
suspension was then filtered, and the silica gel was washed with DCM. The combined filtrates
were dried over MgSO 4 and concentrated in vacuo. The red product was taken up in DCM (6 ml)
with malonitrile (0.020 g, 0.32 mmol). Triethylamine (2 drops) were added, and the reaction
mixture was stirred for lh at r.t. The reaction mixture was then purified by flash chromatography
(silica gel, DCM) to afford 20a (0.12 g, 0.23 mmol, 19% yield) as a blue solid.
IH NMR (500 MHz, CDCl3): 7.89 (1H, d, 8.9 Hz), 7.84-7.76 (4H, m), 7.74 (1H, s), 7.56-7.41
(4H, m), 7.34-7.11 (8H, m), 6.90 (2H, d, 8.7 Hz) 13C NMR (125 MHz, CDCl 3): 168.9, 152.0,
149.1, 148.9, 144.3, 139.2, 138.0, 135.9, 132.4, 132.2, 131.1, 130.1, 129.5, 129.0, 128.5, 128.31,
128.27, 128.2, 126.3, 126.1, 125.2, 122.4, 122.0, 121.9, 121.4, 119.3, 115.1, 114.3, 72.7 HRMS
(ESI): 532.1479 [calc'd for M+H+: 532.1478]
Ph
1. nBuLi, THF, -78 C Ph
BrPh yP h I
20b
- N CN0 0 J NC/\ 19 20b
2. Ac2 0
3. SiO 2, Cat. H20
4. NC CN
DCM, NEt 3
Bromo-furan 6 (0.27 g, 1.2 mmol) was dissolved in dry THF (5 ml) and cooled to -78 oC. To this
solution was added n-BuLi (0.80 ml 1.6 M solution, 1.3 mmol) dropwise and the solution was
stirred at -78 oC for 1.5h. A solution of phthalide 19 (0.50 g, 1.4 mmol) in dry THF (8 ml) was
then added dropwise, and the solution was stirred for an additional 45 min at -78 OC, after which
Ac20 (0.16 ml, 1.7 mmol) was added. The reaction mixture was allowed to warm to room
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temperature, and was then refluxed for 10 min. The solution was then poured into saturated
aqueous NaHCO3, and extracted with EtOAc. The organic layer was washed with brine, dried
over MgSO 4, and concentrated. The resulting orange viscous product was passed through a silica
gel column (DCM), and the resulting orange product was dissolved in DCM, to which was added
silica gel (10 g) and water (0.5 ml), and this suspension was stirred, under argon, overnight. The
suspension was then filtered, and the silica gel was washed with DCM. The combined filtrates
were dried over MgSO 4 and concentrated in vacuo. The red product was passed through a silica
gel column (1:1 hexane:EtOAc), and the resulting product was concentrated in vacuo, and taken
up in DCM (5 ml) with malonitrile (0.022 g, 0.35 mmol). Triethylamine (2 drops) were added,
and the reaction mixture was stirred for 1 h at r.t. The reaction mixture was then purified by flash
chromatography (silica gel, DCM) to afford 20b (0.059 g, 0.12 mmol, 10% yield) as a blue solid.
'H NMR (500 MHz, CDC13): 7.85-7.77 (5H, m), 7.52 (1H, t, 7.5 Hz), 7.45 (1H, t, 7.9 Hz), 7.34-
7.22 (6H, m), 7.20-7.17 (2H, m), 7.13 (1H, dd, 8.9 Hz, 6.4 Hz), 6.98 (1H, d, 4.1 Hz), 6.89 (2H, d,
8.9 Hz) 13C NMR (125 MHz, CDC13): 169.6, 152.7, 150.3, 148.1, 139.9, 136.7, 135.2, 131.8,
130.8, 130.22, 130.18, 129.7, 129.2, 129.0, 128.9, 128.8, 127.9, 127.9, 127.2, 126.7, 126.0,
122.7, 121.6, 121.3, 116.3, 115.2, 110.2, 71.8 (2 missing) HRMS (ESI): 516.1711 [calc'd for
M+H+: 516.1707]
Ph. Ph
Cat. HCI
NC CN THF CN
20a IBF-NIAD 18
Compound 20a (0.034 g, 0.065 mmol) was taken up in THF (1 ml). HCI (1 drop, 2 M) was
added, and the reaction mixture was stirred for 30 min at r.t. The reaction mixture was then
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partitioned between 2:1 hexane:EtOAc and HCI (0.5 M). The aqueous layer was separated, made
alkaline, and extracted with DCM. The organic layer was dried over MgSO 4 and concentrated in
vacuo. Flash chromatography (silica gel, 2:1 EtOAc: hexane) afforded IBF-NIAD 18 as a purple
solid (0.023 g, 0.063 mmol, 97% yield).
1H NMR (500 MHz, DMSO-d6): 8.42 (1H, s), 8.05 (1H, d, 8.4 Hz), 7.86 (1H, d, 4.4 Hz), 7.84-
7.75 (3H, m), 7.70 (1H, d, 4.4 Hz), 7.35 (1H, dd, 8.9 Hz, 6.6 Hz), 7.16 (1H, dd, 8.9 Hz, 6.6 Hz)
6.75 (2H, d, 8.4 Hz), 5.99 (2H, bs) 13C NMR (125 MHz, DMSO-d 6): 150.8, 150.7, 150.3, 143.3,
136.2, 131.0, 129.3, 128.6, 127.4, 126.4, 125.6, 122.2, 121.4, 120.5, 119.1, 116.7, 115.8, 115.2,
114.3, 68.8 HRMS (ESI): 366.0714 [calc'd for M-H-: 366.0707] UV-Vis max: 618 nm (MeOH,
E= 12900), 620 nm (CHC13, E= 26700)
Ph..Ph
NV H2N oICat. HCI
CN THF CN
20b IBF-NIAD 19
Compound 20b (0.050 g, 0.097 mmol) was taken up in THF (5 ml). HCI (8 drops, 2 M) was
added, and the reaction mixture was stirred for 30 min at r.t. The reaction mixture was then
partitioned between 2:1 hexane:EtOAc and HCI (0.5 M). The aqueous layer was separated, made
alkaline, and extracted with DCM. The organic layer was dried over MgSO 4 and concentrated in
vacuo. Flash chromatography (silica gel, 2:1 EtOAc: hexane) afforded IBF-NIAD 19 as a purple
solid (0.027 g, 0.077 mmol, 79% yield).
IH NMR (500 MHz, DMSO-d 6): 8.26 (1H, d, 8.9 Hz), 8.05 (1H, d, 9.0 Hz), 7.93 (1H, s), 7.85
(2H, d, 8.7 Hz), 7.56 (1H, d, 4.1 Hz), 7.29 (1H, d, 4.1 Hz), 7.24 (1H, dd, 8.9 Hz, 6.1 Hz), 7.14
(1H, 6.73 (2H, d, 8.7 Hz) '3C NMR (125 MHz, DMSO-d 6): 153.5, 151.4, 150.6, 147.3, 139.2
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(bs), 132.2, 130.7 (bs), 128.6, 127.4, 126.9, 125.6, 121.8, 119.8, 116.9, 116.3, 115.5, 114.2,
109.7, 66.8 (1 missing) HRMS (ESI): 352.1084 [calc'd for M+H+: 352.1081] UV-Vis max: 611
nm (MeOH, E= 24700), 615 nm (CHC13, e= 28100)
OH
OOH
al o I o
60% H2SO 4, r.t. imidazole, r.t.
12 42 . OH 22 OTIPS
OH OTIPS
2-Carboxybenzaldehyde 12 (1.0 g, 6.7 mmol) was dissolved in H2SO 4 (6 ml, 60% aqueous
solution) and stirred at r.t. for 10 min. Catechol 21 (0.73 g, 6.6 mmol) was added, and the
reaction mixture was stirred for 3h at r.t. The reaction mixture was then poured into ice water,
and the resulting mixture was stirred until it reached r.t. The mixture was extracted with EtOAc,
and the combined organic layers were washed with saturated aqueous NaHCO 3 and brine, dried
over MgSO4, and concentrated in vacuo. Flash chromatography (silica gel, EtOAc) afforded x as
a white solid (1.25 g, 5.2 mmol, 79% yield). Phthalide 42 (1.25 g, 5.2 mmol) and imidazole (2.8
g, 41 mmol) were then dissolved in DMF (40 ml). Triisopropylsilyl chloride (1.2 ml, 19 mmol)
was added drop wise and the reaction mixture was stirred at r.t. overnight. The mixture was then
poured into water and extracted with DCM. The combined organic layers were dried over
MgSO4 and concentrated in vacuo. The resulting product was purified by flash chromatography
(silica gel, DCM) to afford 22 (1.0 g, 1.8 mmol, 35% yield, 28% over two steps).
1H NMR (500 MHz, CDCl3): 7.95 (1H, d, 7.6 Hz), 7.65 (1H, t, 7.5 Hz), 7.56 (1H, t, 7.3 Hz), 7.31
(1H, d, 7.6 Hz), 6.81 (1H, d, 8.2 Hz), 6.73 (1H, dd, 8.2 Hz, 2.1 Hz), 6.57 (1H, d, 2.1 Hz), 6.30
(1H, s), 1.29 (3H, sept, 7.5 Hz), 1.16 (3H, sept, 7.5 Hz), 1.10 (18H, dd, 7.5 Hz, 3.1 Hz), 1.02
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(18H, 8.1 Hz) 13C NMR (125 MHz, CDC13): 170.5, 149.8, 148.0, 147.3, 134.0, 129.2, 128.4,
125.9, 125.4, 123.0, 120.4, 119.9, 118.9, 82.8, 17.9, 17.8, 13.1, 12.9 HRMS (ESI): 577.3160
[calc'd for M+Na+: 577.3140]
0O
OH 1. \__jH O 12
OH nBuNI, 160 0C ( OH 0% H2SO 4, r.t.
21 43 44 OH
OH
0
TIPSCI, DMAP O
NEt3, DCM
2/4 OTIPS
OTIPS
Catechol 21 (11 g, 0.10 mol) and ethylene carbonate (8.8 g, 0.10 mol) were stirred together at
160 oC, and then nBu4NI (1.2 g, 0.0033 mol) was added and the mixture was stirred at 160 oC for
5h at which point the evolution of CO2 had ceased. The mixture was taken up in EtOAc, and
washed with water. The combined organic layers were dried over MgSO 4 and concentrated to
afford 43 as an gray solid (8.9 g, 0.058 mol, 58% yield). 2-Carboxybenzaldehyde 12 (2.91 g,
0.019 mol) was dissolved in H2 S0 4 (14 ml, 60% aqueous solution) and stirred at r.t. for 10 min.
Compound 43 (3.0 g, 0.019 mol) was added, and the reaction mixture was stirred for 3h at r.t.
The reaction mixture was then poured into ice water, and the resulting mixture was stirred until it
reached r.t. The mixture was extracted with EtOAc, and the combined organic layers were
washed with saturated aqueous NaHCO 3 and brine, dried over MgSO4, and concentrated in
vacuo to afford 44 as a viscous liquid (2.9 g, 0.01 mol, 53% yield). Phthalide 44 (2.62 g, 9.2
mmol) and DMAP (0.034 g, 0.28 mmol) were then dissolved in DCM (15 ml) and cooled in an
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ice bath. Triisopropylsilyl chloride (3.34 ml, 53 mmol) was added drop wise followed by
triethylamine (2.8 ml, 20 mmol) and the reaction mixture was stirred at r.t. overnight. The
mixture was then poured into water and extracted with DCM. The combined organic layers were
dried over MgSO4 and concentrated in vacuo. The resulting product was purified by flash
chromatography (silica gel, DCM) to afford 24 (2.2 g, 3.7 mmol, 40% yield, 12% yield over 3
steps) as a viscous oil that solidified on standing.
'H NMR (500 MHz, CDC13): 7.95 (1H, d, 7.6 Hz), 7.65 (1H, t, 7.6 Hz), 7.55 (1H, t, 7.5 Hz), 7.32
(1H, d, 7.6 Hz), 6.84 (1H, d, 8.1 Hz), 6.73-6.70 (2H, m), 6.33 (1H, s), 4.08-3.95 (4H, m), 1.26
(3H, sept, 7.8 Hz), 1.15-0.80 (39H, m) 13C NMR (125 MHz, CDC13): 170.6, 150.5, 149.7, 146.7,
134.1, 129.2, 128.9, 125.8, 125.5, 122.9, 120.5, 120.1, 112.6, 83.0, 70.0, 61.9, 17.9, 17.6, 12.7,
11.8) HRMS (ESI): 621.3400 [calc'd for M+Na+: 621.3402]
KMnO 4  0
KOH, H20
26 27
26%
Triethyleneglycol monomethylether 26 (2.5 ml, 0.016 mol), potassium hydroxide (4.5 g, 0.080
mol), and potassium permanganate (9.50 g, 0.060 mol) were mixed together in water (200 ml)
and stirred at r.t. overnight. The solution was then filtered to remove the brown precipitate and
the filtrate was acidified with HCI to -pH 2.0. The solution was then extracted with DCM, and
the combined organic layers were dried over MgSO 4 and concentrated in vacuo to afford 27
(0.77 g, 27% yield) as a clear oil.
IH NMR (300 MHz, CDC13): 8.25 (1H, bs), 4.12 (2H, s), 3.71-3.50 (8H, m), 3.33 (3H, s) 13C
NMR (75 MHz, CDC13): 173.3, 71.5, 70.7, 70.5, 70.1, 68.1, 58.7 HRMS (ESI): 177.0761 [calc'd
for M-H-: 177.0678]
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O
0 CI. kc 1  0
1. 0 MeO, NA, ,lO,. O,DCM, Cat. DMF 1
27 2. MeONH HCI 28
DCM, H20, K2CO 3
Acid 27 (2.16 g, 0.012 mol) was dissolved in dry DCM (60 ml) with DMF (0.2 ml) and the
solution was cooled in an ice bath. Oxalyl chloride (1.4 ml, 0.017 mol) was added dropwise and
then the solution was allowed to warm to r.t. and was stirred under argon atmosphere at r.t.
overnight. The solution was then concentrated in vacuo. The resulting residue was taken up in
DCM (10 ml) and this solution was added to a solution of N,O-dimethylhydroxylamine (0.98 g,
0.010 mol) in water (10 ml). The biphasic solution was cooled in an ice bath, and potassium
carbonate (1.66 g, 0.012 mol) was added and the reaction mixture was allowed to warm to r.t.
and was stirred at r.t. overnight. The layers were then separated, and the aqueous layer was
extracted with DCM. The combined organic layers were washed with saturated NaHCO 3 and
brine, dried over MgSO 4, and concentrated in vacuo to afford Weinreb amide 28 (1.5 g, 0.0072
mol, 60% yield) as a clear oil.
1H NMR (300 MHz, CDC13): 4.24 (2H, s), 3.70-3.42 (11H, m), 3.27 (3H, s), 3.08 (3H, s) 3C
NMR (75 MHz, CDC13): 170.8, 71.7, 71.5, 70.5, 70.4, 68.3, 61.1, 58.7 HRMS (ESI): 244.1161
[calc'd for M+Na : 244.1155]
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pTsOH, Benzene
A, Dean-Stark
2,5-Dibromothiophene (0.75 ml, 6.8 mmol) was dissolved in dry THF (25 ml) and this solution
was cooled to -78 oC. To this solution was added nBuLi (4.5 ml, 1.6M solution, 7.2 mmol)
dropwise and the solution was then stirred for 1.5h at -78 C. A solution of Weinreb amide 28
(1.5 g, 7.2 mmol) in dry THF (25 ml) was then added dropwise, and the solution was stirred at -
78 oC for 4h and was then allowed to warm to r.t. Saturated ammonium chloride was added, and
the reaction mixture was stirred at r.t. overnight. The solution was then extracted with EtOAc,
and the combined organic layers were washed with brine and concentrated. The residue was
dissolved in toluene (20 ml) with ethylene glycol (0.60 ml, 11 mmol) and p-TsOH (0.010 g,
0.053 mmol). The solution was then refluxed overnight with a Dean-Stark trap. The reaction
mixture was cooled to r.t., poured into water, and extracted with EtOAc. The combined organic
layers were dried over MgSO4 and concentrated in vacuo. Flash chromatography afforded 29
(0.70 g, 1.9 mmol) as a brown oil.
'H NMR (300 MHz, CDC13): 6.90 (1H, d, 3.8 Hz), 6.83 (1H, d, 3.8 Hz), 4.03 (4H, m), 3.76-3.71
(4H, m), 3.64-3.56 (4H, m), 3.53-3.47 (2H, m), 3.35 (3H, s) 13C NMR (75 MHz, CDC13): 145.2,
129.6, 125.4, 112.3, 107.0, 75.1, 74.8, 71.8, 71.5, 70.5, 70.4, 65.4, 58.9 HRMS (ESI): 389.0043
[calc'd for M+H+: 389.0029]
HOX
O Bu 4 NI,
32 160 oC 33
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Phenol 32 (9.4 g, 0.10 mol) and ethylene carbonate (8.8 g, 0.10 mol) were stirred together at 160
oC, and then nBu4NI (1.2 g, 0.0033 mol) was added and the mixture was stirred at 160 oC for 5h
at which point the evolution of CO 2 had ceased. The mixture was then purified by vacuum
distillation (60-65 oC, 100 mtorr) to afford 33 as a clear liquid (7.9 g, 0.057 mol, 57% yield).
'H NMR (300 MHz, CDC13): 7.31 (2H, dd, 8.7 Hz, 7.3Hz), 7.02-6.91 (3H, m), 4.09 (2H, t, 4.2
Hz), 3.97 (2H, q, 4.1 Hz), 2.46 (1H, t, 5.7 Hz) 13C NMR (75 MHz, CDC13): 158.5, 129.5, 121.0,
114.4, 69.0, 61.4 HRMS (ESI): 161.0575 [calc'd for M+Na+: 161.0573] (Data comparable to
literature values) 51
O
OH 0
H
O OO 12  0
60% H 2SO 4
33 34
Compound 33 (3.0 g, 0.020 mol) was dissolved in H2S0 4 (15 ml, 60% aqueous solution) and
stirred at r.t. for 10 min. Compound 12 (2.76 g, 0.020 mol) was added, and the reaction mixture
was stirred for 3h at r.t. The reaction mixture was then poured into ice water, and the resulting
mixture was stirred until it reached r.t. The mixture was extracted with EtOAc, and the combined
organic layers were washed with saturated aqueous NaHCO 3 and brine, dried over MgSO 4, and
concentrated in vacuo. Flash chromatography (silica gel, EtOAc) afforded 34 as a white solid
(3.3 g, 0.012 mol, 61% yield)
'H NMR (500 MHz, CDC13): 7.95 (1H, d, 7.6 Hz), 7.66 (1H, t, 7.5 Hz), 7.56 (1H, t, 7.6 Hz), 7.31
(1H, d, 7.8 Hz), 7.17 (2H, d, 8.9 Hz), 6.90 (2H, d, 8.9 Hz), 6.37 (1H, s), 4.08 (2H, t, 4.3 Hz),
3.96 (2H, q, 4.3 Hz), 2.23 (1H, t, 6.3 Hz) 13C NMR (125 MHz, CDCl3): 170.5, 159.4, 149.6,
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134.3, 129.3, 128.8, 128.6, 125.8, 125.5, 122.9, 114.9, 82.6, 69.2, 61.3 HRMS (ESI): 293.0786
[calc'd for M+Na+: 293.0784]
O N!\::: O
i NH
THF, TIPSCI
34 35
O -oH O OTIPS
Phthalide 34 (1.0 g, 3.6 mmol) and imidazole (0.88 g, 13 mmol) were dissolved in THF (6 ml).
Triisopropylsilyl chloride (1.2 ml, 5.7 mmol) was added drop wise and the reaction mixture was
stirred at r.t. overnight. The reaction was then quenched by the addition of 5 ml saturated
aqueous NaHCO3. The mixture was then poured into water and extracted with DCM. The
combined organic layers were dried over MgSO 4 and concentrated in vacuo. The resulting
product was purified by recrystallization from MeOH to afford 35 (0.82 g, 2.0 mmol, 56% yield)
1H NMR (500 MHz, CDC13): 7.96 (1H, d, 7.6 Hz), 7.65 (1H, t, 7.5 Hz), 7.56 (1H, t, 7.9 Hz), 7.31
(1H, d, 7.6 Hz), 7.16 (2H, d, 8.9 Hz), 6.91 (2H, d, 8.7 Hz), 6.37 (1H, s), 4.10-4.00 (4H, m), 1.12-
1.01 (21H, m) 13C NMR (125 MHz, CDC13): 170.5, 159.8, 149.7, 129.2, 128.7, 128.2, 125.9,
125.5, 122.9, 114.9, 82.7, 69.4, 62.1, 17.9, 11.9 HRMS (ESI): 449.2113 [calc'd for M+Na+:
449.2119]
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Bromo-thiophene 41 (0.40 g, 1.7 mmol) was dissolved in dry THF (8 ml) and cooled to -78 oC.
To this solution was added n-BuLi (1.1 ml 1.6 M solution, 1.7 mmol) dropwise and the solution
was stirred at -78 OC for 1.5h. A solution of phthalide 35 (0.71 g, 1.7 mmol) in dry THF (8 ml)
was then added dropwise, and the solution was stirred for an additional 45 min at -78 C, after
which Ac20 (0.18 ml, 1.9 mmol) was added. The reaction mixture was allowed to warm to room
temperature, and was then refluxed for 10 min. The solution was then poured into saturated
aqueous NaHCO 3, and extracted with EtOAc. The organic layer was washed with brine, dried
over MgSO 4, and concentrated. The resulting orange viscous product was dissolved in THF (12
ml) and TBAF (2.0 ml, 1.0 m solution, 2.0 mmol) was added dropwise and the solution was
stirred for 2 hours 52 room temperature under argon atmosphere. The resulting red solution was
poured into water and extracted with EtOAc. The combined organic layers were washed with
brine, dried over MgSO 4 , and concentrated. The resulting orange viscous product was stirred
with AcOH (20 ml of 90% solution in water) for 4 hours at room temperature under argon
atmosphere. The resulting red solution was poured into water and stirred. A small portion of
saturated aqueous NaHCO 3 was added, and the solution was extracted with EtOAc. The
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combined organic layers were washed with saturated NaHCO 3, dried over MgSO 4, and
concentrated. The red residue was taken up in DCM and precipitated in hexane to afford 36a as a
red solid (0.32 g, 0.88 mmol, 52% yield). Aldehyde 36a (0.15 g, 0.41 mmol) was dissolved in
DCM (12 ml) with malonitrile (0.030 g, 0.46 mmol). Triethylamine (3 drops) was added and the
reaction mixture was stirred for lh. Hexane (7 ml) was added and the blue precipitate was
collected by suction filtration. Flash chromatography (silica gel, 10 % MeOH in DCM) afforded
IBF-NIAD 22 (0.019 g, 0.046 mmol, 11% yield, 5.7% yield for two steps) as a blue solid.
1H NMR (500 MHz, CDC13): 8.39 (1H, s), 7.93 (1H, d, 8.9 Hz), 7.85 (2H, d, 8.7 Hz), 7.78 (1H,
d, 4.3 Hz), 7.69 (1H, d, 8.7 Hz), 7.62 (1H, d, 4.4 Hz), 7.25 (1H, dd, 8.7 Hz, 6.6 Hz), 7.13 (1H,
dd, 8.9 Hz, 6.6 Hz), 7.08 (2H, d, 8.9 Hz), 4.97 (1H, t, 5.5 Hz), 4.07 (2H, t, 4.7 Hz), 3.76 (2H, q,
5.0 Hz) 13C NMR (125 MHz, CDC13): 159.4, 150.8, 147.9, 142.8, 137.3, 132.0, 128.7, 127.0,
126.2, 125.4, 122.3, 122.0, 121.30, 121.27, 119.2, 115.5, 115.4, 114.7, 70.6, 69.8, 59.5 (1
missing) HRMS (ESI): 413.0948 [calc'd for M+H+: 413.0954] UV-Vis Xmax: 577 nm (MeOH, E=
25500), 597 (CHC13, e= 27400)
S 1. nBuLi, THF, -78 OC HO O
6 0 OO OTIPS
35 36b
2. Ac20
3. TBAF, THF
4. AcOH
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Bromo-furan 6 (0.40 g, 1.8 mmol) was dissolved in dry THF (8 ml) and cooled to -78 oC. To this
solution was added n-BuLi (1.25 ml 1.6 M solution, 1.9 mmol) dropwise and the solution was
stirred at -78 C for 1.5h. A solution of phthalide 35 (0.75 g, 1.8 mmol) in dry THF (8 ml) was
then added dropwise, and the solution was stirred for an additional 45 min at -78 oC, after which
Ac20 (0.25 ml, 2.7 mmol) was added. The reaction mixture was allowed to warm to room
temperature, and was then refluxed for 10 min. The solution was then poured into saturated
aqueous NaHCO 3, and extracted with EtOAc. The organic layer was washed with brine, dried
over MgSO 4, and concentrated. The resulting orange viscous product was dissolved in THF (13
ml) and TBAF (2.0 ml, 1.0 m solution, 2.0 mmol) was added dropwise and the solution was
stirred for 2 hours 52 room temperature under argon atmosphere. The resulting red solution was
poured into water and extracted with EtOAc. The combined organic layers were washed with
brine, dried over MgSO 4, and concentrated. The resulting orange viscous product was stirred
with AcOH (20 ml of 90% solution in water) for 4 hours at room temperature under argon
atmosphere. The resulting red solution was poured into water and stirred. A small portion of
saturated aqueous NaHCO 3 was added, and the solution was extracted with EtOAc. The
combined organic layers were washed with saturated NaHCO 3, dried over MgSO 4, and
concentrated. The red residue was taken up in DCM and precipitated in hexane to afford 36b as a
red solid (0.224 g, 0.64 mmol, 36% yield). Aldehyde 36b (0.10 g, 0.29 mmol) was dissolved in
DCM (10 ml) with malonitrile (0.020 g, 0.30 mmol). Triethylamine (1 drop) was added and the
reaction mixture was stirred for lh. Hexane (5 ml) was added and the blue precipitate was
collected by suction filtration to afford IBF-NIAD 24 (0.035 g, 0. 088 mmol, 30% yield, 11%
yield for two steps) as a blue solid.
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'H NMR (500 MHz, DMSO-d 6): 8.23 (1H, d, 8.7 Hz), 8.04-7.99 (4H, m), 7.56 (1H, d, 4.1 Hz),
7.33 (1H, d, 4.1 Hz), 7.21 (1H, dd, 8.4 Hz, 6.6 Hz), 7.17 (1H, dd, 8.9 Hz, 6.6 Hz), 7.10 (2H, d,
9.0 Hz), 4.96 (1H, t, 6.3 Hz), 4.09 (2H, t, 4.7 Hz), 3.76 (2H, q, 4.7 Hz) 13C NMR (125 MHz,
DMSO-d6): 159.4, 148.7, 147.6, 146.1, 143.5, 143.4, 133.6, 127.1, 127.0, 126.5, 126.0, 124.0,
122.6, 122.3, 120.8, 115.4, 115.0, 114.7, 109.9, 69.8, 68.8, 59.5 HRMS (ESI): 397.1171 [calc'd
for M+H+: 397.1183] UV-Vis max: 572 nm (MeOH, e= 34200), 589 nm (CHC13, e= 43800)
OH O OH O OH
" DCM, NEt 3
32 37
Phenol 32 (3.81 g, 0.041 mol) and glycidol (3.0 g, 0.041 mol) were mixed together in dry EtOH
(8 ml) with triethylamine (0.51 ml, 3.7 mmol) and the solution was refluxed for 3h. The solution
was then cooled to r.t. and concentrated in vacuo. The resulting residue was purified by flash
chromatography (silica gel, EtOAC) to afford 37 (4.6 g, 0.027 mol, 66% yield) as a clear viscous
liquid that solidified into a white solid on standing. (Adopted from a literature procedure) 52
'1H NMR (500 MHz, CDC13): 7.30 (2H, dd, 8.7 Hz, 7.3 Hz), 6.99 (1H, t, 7.3 Hz), 6.92 (2H, dm,
7.8 Hz), 4.12 (1H, sex, 5.5 Hz), 4.06-4.02 (2H, m), 3.87-3.72 (2H, m), 3.07 (1H, 6.0 Hz), 2.59
(1H, t, 6.0 Hz) 13C NMR (125 MHz, CDC13): 158.3, 129.5, 121.3, 114.5, 70.4, 67.0, 63.6 HRMS
(ESI): 191.0681 [calc'd for M+Na+: 191.0679] (Adopted from literature procedure) 52
0
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OH C H
o oH 12 O 0
60% H2SO 4
37 38n
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2-Carboxylbenzaldehyde 12 (3.6 g, 0.024 mol) was dissolved in H2 SO 4 (16 ml, 60% aqueous
solution) and stirred at r.t. for 10 min. Compound 37 (3.2 g, 0.019 mol) was added, and the
reaction mixture was stirred for 3h at r.t. The reaction mixture was then poured into ice water,
and the resulting mixture was stirred until it reached r.t. The mixture was extracted with EtOAc,
and the combined organic layers were washed with saturated aqueous NaHCO 3 and brine, dried
over MgSO 4, and concentrated in vacuo. Flash chromatography (silica gel, EtOAc) afforded 38
as a white solid (1.5 g, 0.0050 mol, 26% yield)
'H NMR (500 MHz, CDC13): 7.91 (1H, d, 7.6 Hz), 7.62 (1H, t, 7.5 Hz), 7.52 (1H, t, 7.6 Hz), 7.26
(1H, d, 7.8 Hz), 7.08 (2H, d, 8.7 Hz), 6.82 (2H, d, 8.9 Hz), 4.06 (1H, sex, 3.8 Hz), 3.97-3.93 (2H,
m), 3.76 (1H, dd, 11.4 Hz, 3.7 Hz), 3.72-3.44 (3H, m) 13C NMR (125 MHz, CDC13): 170.8,
159.2, 149.6, 134.4, 129.3, 128.7, 128.4, 125.5, 125.4, 122.9, 114.8, 82.7, 70.3, 68.9, 63.4
HRMS (ESI): 323.0891 [calc'd for M+Na+: 323.0890]
0 MeO Me 0
pTsOH, DCM
38 . HO 39
Phthalide 38 (1.5 g, 5.0 mmol) was dissolved in DCM (10 ml) with 2,2-dimethoxypropane (1.25
ml, 10 mmol). p-Toluenesulfonic acid monohydrate (0.015 g, 0.079 mmol) was added, and the
solution was stirred at r.t. overnight. The reaction mixture was then concentrated in vacuo and
purified by flash chromatography (silica gel, EtOAc) to afford 39 (1.35 g, 3.96 mmol, 79% yield)
as a white solid.
'H NMR (500 MHz, CDC13): 7.95 (1H, d, 7.6 Hz), 7.65 (1H, t, 7.5 Hz), 7.56 (1H, t, 7.5 Hz), 7.31
(1H, d, 7.8 Hz), 7.17 (2H, d, 8.7 Hz), 6.91 (2H, d, 8.9 Hz), 6.37 (1H, s), 4.47 (1H, quin, 6.0 Hz),
174
4.16 (1H, dd, 8.5 Hz, 6.6 Hz), 4.05 (1H, ddd, 9.5 Hz, 5.5 Hz, 2.4 Hz), 3.94 (1H, ddd, 9.5 Hz, 5.8
Hz, 1.7 Hz), 3.89 (1H, dd, 8.2 Hz, 5.8 Hz), 1.45 (3H, s), 1.40 (3H, s) 13C NMR (125 MHz,
CDC13): 170.4, 159.3, 149.6, 134.2, 129.3, 128.7, 125.8, 125.5, 122.9, 114.8, 109.8, 82.6, 73.8,
68.8, 66.7, 26.7, 25.3 HRMS (ESI): 341.1387 [calc'd for M+H+: 341.1384]
Br 1. nBuLi, THF, -78 OC OH
41 00 A0
0 040a39+
2. Ac20
3. 90% AcOH
NCCN Ho0 o 0 IX
_OHON OHS
DCM, NEt 3  CN
IBF-NIAD 23
Bromo-thiophene 41 (0.20 g, 0.85 mmol) was dissolved in dry THF (3 ml) and cooled to -78 C.
To this solution was added n-BuLi (0.55 ml 1.6 M solution, 0.88 mmol) dropwise and the
solution was stirred at -78 oC for 1.5h. A solution of phthalide 39 (0.30 g, 0.88 mmol) in dry
THF (3 ml) was then added dropwise, and the solution was stirred for an additional 45 min at -78
oC, after which Ac20 (0.12 ml, 1.3 mmol) was added. The reaction mixture was allowed to warm
to room temperature, and was then refluxed for 10 min. The solution was then poured into
saturated aqueous NaHCO 3, and extracted with EtOAc. The organic layer was washed with
brine, dried over MgSO 4, and concentrated. The resulting orange viscous product was stirred
with AcOH (15 ml of 90% solution in water) for 4 hours at room temperature under argon
atmosphere. The resulting red solution was poured into water and stirred. A small portion of
saturated aqueous NaHCO 3 was added, and the solution was extracted with EtOAc. The
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combined organic layers were washed with saturated NaHCO3, dried over MgSO 4, and
concentrated. The red residue was subjected to flash chromatography (silica gel, 10% MeOH in
DCM) to afford 40a (0.15 g, 0.38 mmol, 43% yield) as a crude product. Aldehyde 40a (0.15 g,
0.38 mmol) was dissolved in DCM (15 ml) with malonitrile (0.025 g, 0.38 mmol). Triethylamine
(3 drops) was added and the reaction mixture was stirred for lh. Hexane (5 ml) was added and
the blue precipitate was collected by suction filtration to afford IBF-NIAD 23 (0.093 g, 0.21
mmol, 55% yield, 24% yield for two steps) as a blue solid.
'H NMR (500 MHz, DMSO-d 6): 8.13 (1H, d, 8.1 Hz), 7.96-7.90 (4H, m), 7.49 (1H, d, 4.1 Hz),
7.20 (1H, d, 4.0 Hz), 7.16-7.09 (2H, m), 7.07 (2H, d, 8.9 Hz), 5.10 (1H, d, 5.2 Hz), 4.81 (1H, t,
5.6 Hz), 4.09 (1H, dd, 9.9 Hz, 4.0 Hz), 3.95 (1H, dd, 10.1 Hz, 6.4 Hz), 3.84 (1H, sex, 5.6 Hz)
13C NMR (125 MHz, DMSO-d 6): 159.6, 153.1, 148.8, 147.7, 140.2, 133.7, 130.3, 128.3, 127.2,
126.6, 126.1, 122.4, 121.0, 120.8, 120.0, 116.1, 115.5, 115.2, 110.4, 70.1, 69.9, 68.9, 62.8
HRMS (ESI): 441.1084 [calc'd for M-H-: 441.0915] UV-Vis Xmax: 571 nm (MeOH, e= 42700),
589 nm (CHC13, E= 32000)
OHO -O / 1. nBuLi, THF, -78 OC OH
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Bromo-furan 6 (0.22 g, 1.0 mmol) was dissolved in dry THF (3 ml) and cooled to -78 oC. To this
solution was added n-BuLi (0.64 ml 1.6 M solution, 1.0 mmol) dropwise and the solution was
stirred at -78 OC for 1.5h. A solution of phthalide 39 (0.30 g, 0.88 mmol) in dry THF (3 ml) was
then added dropwise, and the solution was stirred for an additional 45 min at -78 oC, after which
Ac20 (0.13 ml, 1.4 mmol) was added. The reaction mixture was allowed to warm to room
temperature, and was then refluxed for 10 min. The solution was then poured into saturated
aqueous NaHCO 3, and extracted with EtOAc. The organic layer was washed with brine, dried
over MgSO 4, and concentrated. The resulting orange viscous product was stirred with AcOH (15
ml of 90% solution in water) for 4 hours at room temperature under argon atmosphere. The
resulting red solution was poured into water and stirred. A small portion of saturated aqueous
NaHCO3 was added, and the solution was extracted with EtOAc. The combined organic layers
were washed with saturated NaHCO 3, dried over MgSO 4, and concentrated. The red residue was
subjected to flash chromatography (silica gel, 10% MeOH in DCM) to afford 40b (0.14 g, 0.37
mmol, 42% yield) as a crude product. Aldehyde 40b (0.11 g, 0.29 mmol) was dissolved in DCM
(12 ml) with malonitrile (0.021 g, 0.32 mmol). Triethylamine (3 drops) was added and the
reaction mixture was stirred for lh. Hexane (5 ml) was added and the blue precipitate was
collected by suction filtration to afford IBF-NIAD 25 (0.051 g, 0.12 mmol, 41% yield, 17%
yield for two steps) as a blue solid.
'H NMR (500 MHz, DMSO-d 6): 8.20 (1H, d, 8.2 Hz), 8.01-7.96 (4H, m), 7.53 (1H, d, 4.0 Hz),
7.28 (1H, d, 4.1 Hz), 7.20-7.12 (2H, m), 7.09 (2H, d, 9.0 Hz), 5.05 (1H, d, 5.1 Hz), 4.76 (1H, t,
5.6 Hz), 4.10 (1H, dd, 9.8 Hz, 4.0 Hz), 3.97 (1H, dd, 9.8 Hz, 6.3 Hz), 3.84 (1H, dd, 10.4 Hz, 6.1
Hz), 3.49 (2H, t, 5.6 Hz) 1 3C NMR (125 MHz, DMSO-d6): 159.5, 153.0, 148.7, 147.6, 140.2,
133.6, 130.2, 128.2, 127.1, 126.4, 126.0, 122.3, 120.9, 120.7, 119.9, 115.9, 115.4, 115.1, 110.3,
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69.94, 69.87, 68.9, 62.7 HRMS (ESI): 449.1117 [calc'd for M+Na+: 449.1108]
572 nm (MeOH, e= 40900), 587 nm (CHC13, E= 39900)
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UV-Vis ax:
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Chapter 4
Synthesis of Donor-Acceptor-Donor
Chromophores Containing Isobenzofuran
223
4.1 Introduction
Recent years have seen numerous reports of organic molecules integrated into electronic
devices. 1 Their allure is based in part on their modularity; the electronic properties of an organic
material, be it a small molecule, oligomer, or polymer, may be controlled synthetically. With
possible applications including light emitting diodes,2 photovoltaics,3 field effect transistors,4
sensors, 5 and nonlinear optics, 6 research into new materials with unique electronic properties is
continually expanding. In particular, development of novel aromatic systems is of interest, and in
this chapter we present an initial synthetic investigation of oligomeric materials containing
isobenzofuran.
Under normal conditions, interactions of molecules and light are governed by Beer's law,
which shows a linear relationship between the extinction coefficient of a molecule and
absorption of light. This same principle applies to other interactions of light and mater, including
reflection, diffraction, and refraction which vary linearly with changing light intensity.7 Under
more extreme conditions, such as the high intensity light produced by lasers, this behavior no
longer holds true, and many materials exhibit nonlinear optical (NLO) properties. One way to
explain this phenomenon is by thinking of matter as combinations of anharmonic oscillators,
with electronic transition frequencies corresponding to their resonant frequencies. Light contains
an oscillating electric field, and at low field strengths, the resonant excitation of the molecular
oscillators is harmonic, and thus polarization of the medium is linear. However, as the electric
field strength increases, the anharmonicity begins to take effect, and polarization of the molecule
deviates from linearity.8 Equation 4.1 describes these nonlinear components.
P = P, + X ( )E + X ( 2 ) E 2 + X ( 3 ) E 3 + .... (4.1)
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P is the polarization of the medium, E is the electric field component of light, Po is the intrinsic
polarization of the medium and 7X ) , X(2), and X(3) are the first, second, and third order
susceptibilities respectively, and as the second and third susceptibilities are related to E2 and E3,
they are the nonlinear component. If the medium is a molecule then equation 4.2 describes its
dipole moment t, wherein to is the intrinsic dipole moment of the molecule. The terms 13 and y
are called the first and second hyperpolarizabilities.
i = yo + aE + PE2 + yE 3 + ... (4.2)
The utility of NLO materials is that they can control light in unique ways. For example, a
material with large hyperpolarizability (or (2)) can induce second harmonic generation (SHG) on
light passing through it, wherein the emerging light is half the wavelength (twice the energy) of
the incident light. These materials can also exhibit frequency mixing, in which beams of two
different wavelengths of light are focused on the same area and the resulting light has a
frequency that is the sum or the difference of the first two.9 Materials with large second
hyperpolarizabilities (third order NLO), can effect third harmonic generation, were the emerging
light is a third the wavelength of the incident light and degenerate four-wave mixing, in which
three beams of light with different directions combine to generate a fourth beam of the same
frequency. Two-photon absorption is also third order NLO process.' 0 These properties can be
exploited in a variety of ways. SHG can convert the 1064 nm light from a Nd:YAG laser into a
green laser (534 nm)."1 Two-photon absorption is a useful property in biological imaging (see
Chapter 1 and Chapter 3), and may also be used for optical limiting materials, which selectively
absorb high intensity light and can thus be used to protect delicate electronic sensors (and eyes)
from its effects. 12
One particular class of molecules that has generated interest in optical materials is Donor-
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acceptor-donor (DAD) compounds. These compounds are composed of two electron-donating
groups connected to a central electron-withdrawing group by a polarizable bridges. As with
donor-acceptor compounds, changing the donor-acceptor pairing or the nature of the conjugated
bridge can modulate their electronic and optical properties. DADs containing proquinoid units
such as bisthiadiazoles (1)13 and thiadiazoloquiloxalines (2),14 and electron-accepting ketene
dithioacetals (3)15 have been explored as components of NIR OLEDs (Figure 4.1) due to their
low bandgaps. With their highly polarizable conjugated backbones, other DADs have been
studied as third order nonlinear optical materials, including two-photon chromophore (4)16 and
NLO chromophore tetracyanobutadiene (TCBD) (5).17 As isobenzofuran's proquinoid nature
enhances the polarizability of conjugated systems, we wanted to explore its application in DAD
systems, particularly those with TCBD acceptors. Herein we present some initial synthetic
efforts toward this goal.
0 NsN N N
O O Ph2N N Ph 2
NSN O N SN
1 2
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/ N
I / I /cN
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N P h 2
4
Figure 4.1 Some DAD compounds. See text for discussion.
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4.2 Results and Discussion
4.2.1 Synthesis of IBF-DAD 0-2
Scheme 4.1 Synthesis of DAD Components
1. KOH
Aliquat 336
5 min, 60 OC
2. Octyl-Br
2h, 85 OC 7
88%
2 Hex-I NHex 2
K2CO 3
EtOH, A 10
77%
=--TMS
Pd(PPh3)2C1 2, Cul
Benzene, DBU, H20
Cat. HC10 4
100 0 C
Cat. HCIO 4
100 OC
O
8
41%
OOctyl
11
40%
NHex 2
14
14%
14%
As an investigation into donor-acceptor-donor oligomers containing isobenzofurans, we
decided to synthesize symmetrical dimers of the IBF-NIAD dyes series with a central TCBD
acceptor. The synthesis of IBF-DAD 0-2 is similar to that of the IBF-NIAD series in Chapters 2
and 3. Dithienyl-alkyne 14 was synthesized using the Sonagashira cross coupling with TMS-
acetylene. The yield for this reaction was not optimal, but did afford adequate quantities of 14 for
the present study. Aryl-phthalides 8 and 11 were synthesized by acid catalyzed condensation of
alkyl-benzene 7 and dihexyl-aniline 10 with 2-carboxybenzaldehyde (12 is commercially
available, see Scheme 4.1). Dilithiation of 14, followed by quenching with a phthalides 8, 11,
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H
6
NH
9
13
and 12, and subsequent dehydration with acetic anhydride yielded alkynes 15a-c, of which only
15a was stable to isolation (Scheme 4.2).
TCBDs are typically formed via reaction of tetracyanoethylene (TCNE) with electron
rich alkynes. The reaction proceeds by a [2+2] cylcoaddition to form a cyclobutene ring, which
then undergoes an electrocyclic ring opening (Figure 4.2) to afford the TCBD unit.' 8 Alkynes
15a and 15b reacted very quickly with TCNE to form the desired IBF-DAD 1 and IBF-DAD 2.
Less electron-rich alkyne 15c required an excess of TCNE and a longer reaction time. While the
yield for IBF-DAD 1 was good, low yields were obtained for IBF-DAD 2 and IBF-DAD 0,
presumably due to the instability of alkynes 15b and 15c.
NC CN N NC CN C
>KNC CN NNC ICN N CNN
R-- -R R R NCCN
NC
Figure 4.2 Mechanism of TCNE-alkyne interaction
Scheme 4.2 Synthesis of IBF-DAD 0-2
1. nBuLi
THF R
2.8, 11 or 12, THF S R
14 3. Ac 20, A
15a: R= OctylO- : 26% (isolated)
15b: R= Hex 2N- : 34% (crude)
15c: R= H-: 23% (crude)
NC><CN
NC N NC CN
15 b: DCM, 30 min, r.t. \ / S \ ~'
15c: DCM, 2h , r.t. CN
IBF-DAD 1: R= OctylO-: 78%
IBF-DAD 2: R= Hex2N- : 20% (6% over 2 steps)
IBF-DAD 0: R= H- : 11% (3% over 2 steps)
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4.2.2 Spectroscopic Properties of IBF-DAD 0-2
The absorption spectra of IBF-DAD 0-2 are shown in Figure 4.3.
6 10 '1'  1 1 0 , 6 10 4
510 - 810
4  
510
4
4 104 410
6 10
310' - M 310'
4 104
2104 210
1 10 - 2 10 1 101
06 0 30 
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0
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IBF-DAD 0 IBF-DAD 1 IBF-DAD 3
Figure 4.3 Absorption spectra (CHCl 3) of (left) IBF-DAD 0, kmax= 656 nm, e= 53300 M-1 cm' 1
(center) IBF-DAD 1, Xmax= 696 nm, e= 90400 M-1 cm'- (right) IBF-DAD 2, Xmax= 801 nm, e=
54800 M -1 cm -'
The IBF-DAD dyes all have absorption maxima in the NIR region. They also all exhibit a
shoulder peak at ~600 nm which becomes more pronounced with red-shifted absorption. As with
the IBF-NIAD dyes series, increasing the strength of the electron donor from hydrogen to
oxygen to nitrogen red shifts the absorption maxima of these chromophores. Compared to their
IBF-NIAD counter parts, the absorption maxima IBF-DAD 0, IBF-DAD 1, and IBF-DAD 2 are
red-shifted 78 nm, 97 nm, and 145 nm respectively. The IBF-DAD dyes are non-fluorescent in
CHC13, and while this difficiency limits their applicability in NIR two-photon imaging, it does
not preclude their use in other third order NLO optical processes.
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4.3 Conclusions
In conclusion, we have synthesized a series of tetracyanobutadiene donor-acceptor-donor
oligomers containing isobenzofuran. These compounds all absorb in the NIR region, and, while
nonfluorescent, may have interesting nonlinear optical properties, which are currently being
investigated at the Institute for Soldier Nanotechnology. Depending on the outcome of these
studies, these compounds may find utility in NLO material applications such as optical limiting.
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4.4 Experimental Section
Materials. Commercial reagents were purchased from Sigma Aldrich, Alfa Aesar, or GFS
Chemicals, and used as received. Dry solvents were obtained using a solvent purification system
(Innovative Technologies, Inc.), and handled under an argon atmosphere, unless otherwise noted.
Flash chromatography was performed using SiliaFlash F60 (230-400 mesh) from Silicycle.
Instrumentation. Melting points were determined in open capillaries using a Mel-Temp II
apparatus and are uncorrected. Proton nuclear magnetic resonance (1H NMR) spectra and carbon
nuclear magnetic resonance (13C NMR) spectra were recorded on a Varian Mercury-300 (300
MHz) or an Inova-500 (500 MHz) NMR spectrometer. Chemical shifts for protons are reported
in parts per million downfield from tetramethylsilane and are referenced to residual protium in
the NMR solvent (CHCl3: 6 7.27). Chemical shifts for carbon are reported in parts per million
downfield from tetramethylsilane and are referenced to the carbon resonances of the solvent
(CDC13: 6 77.0). Data are represented as follows: chemical shift, integration, multiplicity (br =
broad, s = singlet, d = doublet, t = triplet, q = quartet, sp = septet, m = multiplet), and coupling
constants in Hertz (Hz). High-resolution mass spectra (HRMS) were obtained at the MIT
Department of Chemistry Instrumentation Facility using a peak-matching protocol to determine
the mass and error range of the molecular ion, employing either electron impact or electrospray
as the ionization technique. Ultraviolet-visible absorption spectra were measured with an Agilent
8453 diode array spectrophotometer and corrected for background signal with a solvent-filled
cuvette.
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1. KOH
Aliquat 336
OH 5 min, 60 C OOctyl
2. Octyl-Br
6 2h, 85 OC 7
Powdered potassium hydroxide (3.5 g, 0.063 mol) and powdered phenol (4.7 g, 0.050 mol) were
added to round bottom flask with Aliquot 336 (0.57 ml), and the reaction mixture was stirred for
5 minutes at 60 oC. 1-Bromooctane (8.6 ml, 0.050 mol) was added, and the reaction mixture was
stirred for an additional 2 h at 85 oC. The reaction mixture was then cooled to r.t., diluted with
DCM, and filtered through Florisil. The filtrate was concentrated and purified by vacuum
distillation (120 oC, 300 mtorr) to afford 7 (9.0 g, 0.044 mol, 88% yield) as a clear liquid.
1H NMR (500 MHz, CDC13): 9.28-9.24 (2H, m), 8.93-8.87(3H, m), 5.93 (2H, t, 6.6 Hz), 3.76
(2H, quin, 6.6 Hz), 3.44 (2H, quin, 5.6 Hz), 3.32-3.25 (8H, m), 6.37 (1H, s), 2.88 (3H, t, 7.2 Hz)
13C NMR (125 MHz, CDC13): 159.1, 129.4, 120.4, 114.5, 67.8, 31.8, 29.4, 29.3, 29.2, 26.1, 22.7,
14.1 HRMS (El): 206.1666 [calc'd for M+: 206.1665] (Adapted from literature procedure) 19
O
Cat. HCIO 4
7 1000C 8
OOctyl
To a mixture of x (1.00 g, 6.67 mmol) in y (3.4 g, 16.5 mmol) were added 2 drops of 70%
HC10 4, and the solution was stirred at 100 oC for 2 hours. After cooling, the reaction mixture
was poured into water and stirred for 30 minutes. The sticky white product was collected by
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suction filtration and was washed with water and saturated sodium bicarbonate. Recrystalization
from methanol and then hexane afforded x as white crystals (0.933 g, mmol, 41% yield)
'H NMR (500 MHz, CDC13): 7.96 (1H, d, 7.6 Hz), 7.66 (1H, td, 7.5 Hz, 1.2 Hz), 7.56 (1H, t, 7.5
Hz), 7.32 (1H, dd, 7.6 Hz, 0.9 Hz), 7.16 (2H, dm, 8.5 Hz), 6.88 (2H, dm, 8.7 Hz), 3.95 (2H, t, 6.6
Hz), 1.76 (2H, quin, 6.6 Hz), 1.45 (2H, quin, 7.5 Hz), 1.38-1.25 (8H, m), 0.89 (3H, t, 7.2 Hz) 13C
NMR (125 MHz, CDC13): 170.5, 160.0, 149.8, 134.2, 129.3, 128.7, 127.9, 125.9, 125.5, 122.9,
114.8, 82.8, 68.1, 31.8, 29.3, 29.2, 29.1, 26.0, 22.6, 14.1 HRMS (ESI): 339.1961 [calc'd for
M+H+: 339.1955]
N Hex-I NHex 2
K2 CO3
9 EtOH, A 10
To a solution of aniline (2.0 g, 0.022 mol) in ethanol (20 ml), was added K2CO 3 (6.23 g, 0.0459
mol) and 1-iodohexane (9.57 g, 0.0451 mol), and the reaction mixture was refluxed overnight.
The reaction mixture was then cooled to r.t. and filtered, and the collected solid was washed with
DCM. The combined organic layer was dried over MgSO 4, concentrated in vacuo, and purified
by flash chromatography (1:1 DCM: petroleum ether (v:v), silica gel) to afford x (4.34 g, 0.0166
mol, 76% yield) as a pale yellow oil.
'H NMR (500 MHz, CDC13): 7.22 (2H, dd, 8.9 Hz, 7.2 Hz), 6.68-6.62 (3H, m), 3.27 (4H, t, 7.8
Hz), 1.64-1.54 (4H, m), 1.38-1.24 (12H, m), 0.93 (6H, t, 6.6 Hz) 13C NMR (125 MHz, CDC13):
148.1, 129.2, 115.0, 111.6, 51.0, 31.7, 27.2, 26.9, 22.7, 14.1 HRMS (ESI): 262.2532 [calc'd for
M+H+: 262.2529] (Adapted from literature procedure) 20
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ONHeX2 OCHO
Cat. HCIO 4
10 100 0C11 /
NHex 2
To a mixture of x (0.75 g, 5.0 mmol) in y (3.3 g, 12.6 mmol) were added 2 drops of 70% HCIO4 ,
and the solution was stirred at 100 oC for 2 hours. After cooling, the reaction mixture was poured
into water and stirred for 30 minutes. The resulting suspension was extracted with DCM, and the
combined organic layers were washed with water, saturated sodium bicarbonate, and brine, dried
over MgSO 4, and concentrated in vacuo. Purification by flash chromatography (1:4 hexane:DCM
(v:v), silica gel) afforded phthalide x (0.54 g, 1.4 mmol, 27% yield) as a viscous yellow oil.
'H NMR (500 MHz, CDC13): 7.95 (1H, t, 7.6 Hz), 7.65 (1H, t, 7.5 Hz), 7.55 (1H, t, 7.6 Hz), 7.36
(1H, d, 7.6 Hz), 7.04 (2H, d, 8.9 Hz), 6.57 (2H, d, 9.0 Hz), 6.35 (1H, s), 3.25 (4H, t, 7.8 Hz),
1.56 (4H, quin, 6.0 Hz), 1.38-1.24 (12H, m), 0.90 (6H, t, 6.9 Hz) 13C NMR (125 MHz, CDC13):
170.7, 149.9, 148.9, 133.9, 129.0, 129.0, 126.4, 125.3, 123.1, 121.5, 111.3, 83.7, 51.0, 31.7, 27.1,
26.8, 22.7, 14.0 HRMS (ESI): 394.2751 [calc'd for M+H+: 394.2741]
-- TMS
Pd(PPh 3)2CI2, Cul
13 Benzene, DBU, H20 14
A flame dried, argon purged schlenk flash was charged with 2-iodothiophene (1.05 g, 5.08
mmol), PdCl 2(PPh3)2 (0.105 g, 0.150 mmol), and Cul (0.095 g, 0.50 mmol), and was then
evacuated and purged with argon three times. Dry benzene (25 ml) was added, and the flask was
purged with argon. DBU (4.5 ml, 0.030 mol, distilled from CaH2) was then added, and the flask
was purged again with argon. Ice cold TMS-acetylene (0.356 ml, 2.7 mmol) was then added,
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followed immediately by water (36 tl). The flask was covered with aluminum foil and the
reaction mixture was stirred for 18h at r.t. The reaction mixture was then partitioned between
ethyl ether and distilled water, and the organic layer was separated, washed with 10% HCI and
brine, dried over MgSO4, and concentrated in vacuo. The residue was taken up in hot hexane and
filtered, and then concentrated in vacuo. Recrystallization from hexane afforded 14 (0.13 g, 0.68
mmol, 14% yield) as off-white crystals.
1H NMR (500 MHz, CDC13): 7.32 (2H, dd, 5.2 Hz, 1.1 Hz), 7.29 (2H, dd, 3.7 Hz, 1.1 Hz), 7.03
(2H, dd, 5.2 Hz, 3.7 Hz) 13C NMR (125 MHz, CDC13): 132.1, 127.6, 127.1, 122.9, 86.2 HRMS
(ESI): 190.9991 [calc'd for M+H+: 190.9984]
1. nBuLi
THF, -78 OC OctylO /
2. 8, THF
14 3. Ac 20, A
15a
n-BuLi (0.72 ml of 1.6M solution in hexanes, 1.15 mmol) was added to a solution of 14 (0.100
g, 0.526 mmol) in dry THF (4 ml) in a vacuum dried Schlenk flask at -78 oC under argon, and
the solution was stirred at -78 OC for 2 h. A solution of phthalide x (0.39 g, 1.2 mmol) in dry
THF (5 ml) was added dropwise, and the reaction mixture was stirred at -78 oC for an additional
hour. Acetic anhydride (0.15 ml, 1.6 mmol) was added, and the solution was warmed to room
temperature, and was then refluxed for 10 minutes. The reaction mixture was cooled to room
temperature, and was then diluted with ethyl acetate and washed with saturated aqueous sodium
bicarbonate and brine. The organic layer was dried over magnesium sulfate and concentrated in
vacuo. The residue was taken up in CHCl 3 and precipitated from MeOH. The precipitate was
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collected by suction filtration and sonicated in MeOH. Recrystallization from cyclohexane
afforded x (0.113 g, 0.136 mmol, 26% yield) as a purple solid.
1H NMR (500 MHz, CDC13): 7.84 (2H, dm, 8.9 Hz), 7.76 (1H, dt, 8.9 Hz, 1.1 Hz), 7.68 (1H, dt,
8.7 Hz, 1.1 Hz), 7.34 (1H, d, 4.0 Hz), 7.28 (1H, d, 3.8 Hz), 7.07-6.99 (4H, m), 4.03 (2H, t, 6.7
Hz), 1.83 (2H, quin, 6.7 Hz), 1.50 (2H, quin, 7.6 Hz), 1.51-1.29 (8H, m), 0.92 (3H, t, 7.2 Hz)13C
NMR (125 MHz, CDC13): 158.6, 144.6, 138.7, 135.3, 132.8, 126.3, 125.7, 125.0, 123.9, 122.4,
121.2, 120.9, 120.4, 120.2, 119.7, 115.1, 88.7, 68.1, 31.8, 29.4, 29.3, 26.0, 22.7, 14.1 HRMS
(ESI): 830.3550 [calc'd for M+H+: 830.3536]
OctylO
15a
NC CN N
NC CN OctylO 0 " S
DCM, 30 min, r.t. S OOctyl
NC CN
IBF-DAD 1
To a stirred solution of 15a (0.050 g, 0.060 mmol) in 5 ml DCM was added tetracyanoethylene
(0.0080 g, 0.063 mmol), and the reaction mixture was stirred for 30 minutes at r.t. The resulting
blue solution was purified by flash chromatography (DCM, silica gel) to afford IBF-DAD 1
(0.045 g, 0.047 mmol, 78% yield) as a dark solid.
'H NMR (500 MHz, CDC13): 7.88-7.76 (4H, m), 7.61 (2H, d, 8.7 Hz), 7.40 (2H, d, 4.6 Hz), 7.23
(2H, t, 8.0 Hz), 7.11 (2H, t, 8.1 Hz), 6.99 (4H, d, 8.9 Hz), 4.03 (4H, t, 6.6 Hz), 1.83 (4H, quin,
7.6 Hz), 1.48 (4H, quin, 7.6 Hz), 1.42-1.24 (16H, m), 0.90 (6H, t, 6.9 Hz) 13C NMR (125 MHz,
CDC13): 160.4, 154.4, 150.6, 145.5, 139.2, 137.7, 130.7, 129.3, 127.6, 127.4, 126.2, 122.9,
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122.2, 122.1, 121.6, 119.5, 115.3, 114.7, 113.6, 72.4, 68.3, 31.8, 29.4, 29.2, 29.1, 26.0, 22.6, 14.1
HRMS (ESI): 959.3659 [calc'd for M+H+: 959.3659] UV-vis Xmax: 696 nm (CHC13, E = 90400
M -1 cm -')
1. nBuLi Hex / \
THFI
-- 
Hex S~
s 2. 11, THF O N IHex
14 3. Ac 20, A Hex
15b
NC N He NC CN
Hex NN xHex
DCM, 30 min, r.t. \ S N 0 O,He x
N N Hex
IBF-DAD 2
n-BuLi (0.72 ml of 1.6M solution in hexanes, 1.15 mmol) was added to a solution of 14 (0.100
g, 0.526 mmol) in dry THF (5 ml) in a vacuum dried Schlenk flask at -78 OC under argon, and
the solution was stirred at -78 OC for 2 h. A solution of phthalide 11 (0.41 g, 1.0 mmol) in dry
THF (5 ml) was added dropwise, and the reaction mixture was stirred at -78 OC for an additional
hour. Acetic anhydride (0.15 ml, 1.6 mmol) was added, and the solution was warmed to room
temperature, and was then refluxed for 10 minutes. The reaction mixture was cooled to room
temperature, and was then diluted with ethyl acetate and washed with saturated aqueous sodium
bicarbonate and brine. The organic layer was dried over magnesium sulfate and concentrated in
vacuo to afford alkyne 15b (0.166 g, 0.177 mmol, 34%) as a crude product. 15b (0.085 g, 0.091
mmol) was dissolved in DCM (7 ml) with tetracyanoethylene (0.012 g, 0.094 mmol) and the
reaction mixture was stirred for 30 minutes. The reaction mixture was then purified by flash
chromatography (DCM, silica gel) to afford IBF-DAD 2 (0.0178 g, 0.018 mmol, 20% yield, 7%
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over 2 steps) 'H NMR (500 MHz, CDC13): 7.94 (2H, d, 8.9 Hz), 7.90-7.78 (6H, m), 7.72 (2H, d,
8.7 Hz), 7.42 (2H, d, 4.7 Hz), 7.32 (2H, dd, 8.7 Hz, 6.6 Hz), 7.14 (2H, dd, 8.9 Hz, 6.7 Hz), 6.74
(4H, d, 9.3 Hz), 3.37 (8H, t, 7.8 Hz), 1.64 (8H, quin, 7.0 Hz), 1.42-1.30 (24H, m), 0.92 (12H, t,
7.0 Hz) 13C NMR (125 MHz, CDC13): 153.7, 153.0, 149.2, 145.6, 139.1, 137.1, 129.9, 129.6,
128.5, 128.0, 125.5, 122.4, 122.0, 119.7, 116.4, 115.5, 114.2, 111.9, 69.9, 51.1, 31.7, 27.3, 26.8,
22.7, 14.0 HRMS (ESI): 1069.5301 [calc'd for M+H+: 1069.5231] UV-vis max: 801 nm
(CHC13, E = 54800 M-' cm-1)
1. nBuLi
THF
o
2.11, THF
14 3. Ac20, A
15e
NC CN NC CN
NC <CN S O
DCM, 30 min, r.t. CN
IBF-DAD 0
n-BuLi (0.72 ml of 1.6M solution in hexanes, 1.15 mmol) was added to a solution of 14 (0.100 g,
0.526 mmol) in dry THF (5 ml) in a vacuum dried Schlenk flask at -78 oC under argon, and the
solution was stirred at -78 oC for 2 h. A solution of phthalide 12 (0.22 g, 1.0 mmol) in dry THF
(5 ml) was added dropwise, and the reaction mixture was stirred at -78 oC for an additional hour.
Acetic anhydride (0.15 ml, 1.6 mmol) was added, and the solution was warmed to room
temperature, and was then refluxed for 10 minutes. The reaction mixture was cooled to room
temperature, and was then diluted with ethyl acetate and washed with saturated aqueous sodium
bicarbonate and brine. The organic layer was dried over magnesium sulfate and concentrated in
vacuo to 5 ml. This solution was added to hexane (15 ml) and 15c (0.066 g, 0.12 mmol, 23%
yield) was collected by suction filtration as a crude product. This solid was dissolved in DCM
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(10 ml) with tetracyanoethylene (0.016 g, 0.13 mmol) and the reaction mixture was stirred for 1
hour at r.t., and then additional tetracyanoethylene (0.0115 g, 0.093 mmol) was added and the
reaction was stirred for another hour. The reaction mixture was then purified by flash
chromatography (DCM, silica gel) to afford IBF-DAD 0 (0.0095 g, 0.014 mmol, 11% yield, 3%
over 2 steps)
1H NMR (500 MHz, CDC13): 8.03-7.96 (6H, m), 7.92 (4H, 4.6 Hz), 7.82 (2H, d, 8.9 Hz), 7.62
(2H, d, 4.6 Hz), 7.55 (4H, t, 8.1 Hz), 7.44 (2H, t, 7.5 Hz), 7.34 (2H, dd, 8.5 Hz, 6.3 Hz), 7.22
(2H, dd, 9.2 Hz, 6.7 Hz) '3C NMR (125 MHz, CDC13): 154.8, 149.9, 145.6, 139.1, 138.6, 131.4,
129.8, 129.4, 129.34, 129.25, 127.1, 126.8, 126.1, 123.6, 123.2, 121.4, 119.7, 114.2, 112.9, 74.2
HRMS (ESI): 703.1268 [calc'd for M+H+: 703.1257] UV-vis Xmax: 656 nm (CHC13, E = 53300
M-1 cm -')
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4.A Appendix
1H NMR and 13C NMR Spectra
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Figure 4.A.14 13C NMR (125 MHz, CDC13) of IBF-DAD 1
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